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Myocardial reperfusion injury is thought to be caused by reperfusion induced i) 
cytosolic ca2+ overload and/or, ii) the formation of oxygen derived free-
radicals. At the start of this study, data implicating cytosolic ca2 + overload in 
the genesis of reversible reperfusion injury were inconclusive. Although several 
workers have approached this problem by measurements of cytosolic calcium 
ions, it was my aim to examine the potential sources of such calcium overload. 
The experiments reported in this thesis were therefore designed to examine the 
role of altered intracellular and transsarcolemmal ca2 + fluxes in the genesis of 
reperfusion stunning and arrhythmias. The study was also aimed at elucidating 
the possible sources and entry pathways contributing to this proposed cytosolic 
ca2 + overload. 
In order to investigate the possible role of altered reperfusion ca2 + fluxes in 
reperfusion injury, we exposed the isolated working, and Langendorff perfused 
rat heart model to ischaemia and reperfusion to induce reperfusion stunning and 
arrhythmias. Hearts were pre-treated (before ischaemia) or reperfused with 
pharmacological compounds, or by interventions known to enhance or inhibit 
intracellular or transsarcolemmal ca2 + fluxes. The severity of reperfusion 
stunning (mechanical dysfunction) was measured by reperfusion aortic output, 
coronary flow and left ventricular pressure. The incidence of reperfusion 
ventricular arrhythmias was measured by the incidence of ventricular 
tachycardia and/ or fibrillation. In selected studies, the metabolic status of hearts 
was evaluated using biochemical assays performed on myocardial tissue samples. 
X 
Data obtained in these studies indicate that increased ca2 + fluxes through 
sarcolemmal L-type ca2 + channels during early reperfusion exacerbate 
stunning, while inhibition of these fluxes with the ca2 + antagonist drug 
nisoldipine or by Mg2 + or Mn2 + improve reperfusion function. These data also 
suggest that although interventions increasing ca2 + fluxes early in reperfusion 
exacerbate reperfusion stunning, these same interventions improve reperfusion 
function when performed later. 
The data also indicate that ca2 + may enter the myocyte indirectly via activation 
of the Na+ /H + and Na+ /Ca2+ exchanger during reperfusion. Inhibition of 
Na+ /H + exchange activity by HOE 694 during reperfusion attenuated 
reperfusion stunning and arrhythmias. Both activation of the Na+ /H + (and 
Na+ /Ca2+) exchanger and ca2+ influx via the ca2+ channel could contribute 
to reperfusion induced ca2 + overload and subsequent injury. 
The study also showed that altered intracellular ca2 + oscillations play a role in 
reperfusion stunning and arrhythmias as shown by the use of the SR ca2 + 
release channel blocker, ryanodine. Inhibition of the sarcoplasmic reticulum 
ca2 + A TP-ase pump by two novel inhibitors, thapsigargin and cyclopiazonic 
acid, during ischaemia and early reperfusion improved reperfusion function and 
reduced the incidence of ventricular arrhythmias. 
Finally, it seems unlikely that endothelin contributes to reperfusion stunning in 
this model. Despite the ca2 + mobilising properties of this endogenous peptide, 
the levels of endothelin released by the isolated rat heart were to low to 
significantly exacerbate reperfusion stunning in this model. Exogenously 
administered endothelin was only detrimental to reperfusion myocardial 
xi 
function when unphysiologically high concentrations of the peptide were infused 
into the heart during reperfusion. 
Taken together, these data suggest that: 1) ca2+ fluxes during early reperfusion 
(intracellular and transsarcolemmal) play a role in reperfusion injury, 2) that 
both the ca2+ channel and Na+ /H + exchange activity contribute to 
reperfusion injury by possibly contributing to cytosolic ca2 + overload and that, 
3) altered intracellular ca2+ oscillations through the SR play a role in both 
stunning and arrhythmias. 
Thus the proposal is that modulation of ca2 + fluxes through either the 
sarcolemma or the sarcoplasmic reticulum, lessen reperfusion injury (stunning 
and arrhythmias). Although these data do not provide direct evidence of 
reperfusion ca2 + overload, they support the concept that calcium ions play a 




1.0 Historical Survey of Coronary Artery Occlusion and Reperfusion. 
The first studies investigating the effects of coronary artery occlusion and 
reperfusion on myocardial function were performed in the late 1860s by an A 
Bezold who clamped the left coronary artery of the rabbit heart He documented 
an occlusion induced decrease in heart rate with an eventual terminal "fibrillar 
activity" (probably ventricular fibrillation) of the left ventricle in 9 of the 20 
hearts studied. He also noticed that in 7 of these hearts, normal "regular 
pulsations" (presumably normal heart rhythm) returned on removal of the 
coronary artery clamp (cited from Porter, 1894). 
In 1894, Porter published data from studies using the canine model in which he 
ligated one or more coronary arteries to investigate the effect of these ligations 
on mechanical function (intraventricular pressure), time to mechanical failure, 
and heart rate. He noticed that the degree of mechanical failure of the heart was 
related to the number of arteries ligated (severity of ischaemia) and that 
coronary artery occlusion invariably altered heart rate and led to abnormal heart 
rhythm. 
Later, Baumgarten ( 1899) who collaborated closely with Porter, wrote a 
manuscript dealing with myocardial infarction in which he concluded that 
ischaemia induced loss of contractile function in the heart could be restored by 
reperfusion of the experimentally occluded coronary artery. This is evidently one 
of the earliest documentations recognising the possible beneficial effects of 
reperfusion of the ischaemic heart 
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These studies by Porter and Baumgarten were of great significance in the 
recognition of the clinical syndrome of ischaemic heart disease. In 1899, William 
Welch, a leading American pathologist declared, "Thrombosis of the coronary 
artery is an affection of great clinical importance" and, "cardiac infarction is 
more common than would appear from the meagre attention usually given to the 
subject in text books". (cited from Fye, 1991). There was also a growing 
awareness that coronary occlusion was not invariably fatal In 1901, Ludolf Krehl 
proposed that sudden coronary occlusion was not always fatal and that a severe 
attack of angina or a temporary attack of cardiac failure might be the result of 
coronary occlusion. 
In 1912 James Herrick attributed myocardial infarction to a coronary thrombosis 
and delineated the clinical features of acute coronary thrombosis. These 
observations of the clinical features of coronary thrombosis attracted little 
attention while physicians sought an objective means of demonstrating that a 
patient's chest discomfort and associated symptoms were unequivocally cardiac 
of origin. The advent of electrocardiography in 1909, provided physicians with 
the confirmation they wanted and enabled them to confirm subjective clinical 
symptoms with an objective electrocardiogram. 
The proposal by Herrick, that coronary thrombi caused myocardial infarction 
however sparked decades of debate concerning the causality of coronary 
thrombosis in myocardial infarction. However, in 1980, angiographic findings of 
DeWood and co-workers showed that obstructive coronary thrombi were present 
in the large majority (87 % ) of patients presenting with myocardial infarction. 
This finding finally gave conclusive evidence for coronary thrombi as the major 
cause of myocardial infarction. 
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In the late 1920s, the importance of cardiac arrhythmias after acute myocardial 
infarction was being recognised. In 1929, Samuel Levine published a book 
devoted to coronary thrombosis in which he addressed concepts such as "risk 
factors", and more importantly, cardiac arrhythmias associated with myocardial 
infarction. He noted that, "The frequency with which they will be observed will 
depend entirely upon the care and frequency with which the patient is studied, for 
many of these disturbances are very transient, lasting only hours or might not 
even be detected except with more complicated methods of graphic representation 
of the hean beat, like the electrocardiograph". 
In the mean time, laboratory investigations were being conducted to elucidate 
the effects of coronary artery occlusion and reperfusion on the myocardium. In 
1935 Tennant and Wiggins studied the effects of coronary artery ligation on 
mechanical function of the dog heart and noticed that reperfusion was 
accompanied by ventricular fibrillation in one of two dogs. The earliest study 
looking at the consequences of reperfusion on the myocardium was that of 
Blumgart, Gilligan and Schlesinger (1941) who studied the effects of coronary 
artery occlusion of varying times, followed by reperfusion, on infarct size. 
Although their objective was to determine the effects of ischaemia and 
reperfusion on infarct size in the dog model, they also documented ischaemic and 
reperfusion arrhythmias (ventricular fibrillation) during their study. 
In 1960, Jennings and co-workers performed a similar study to determine the 
ischaemic time needed to induce irreversible injury in the canine model They 
noticed that 25-30 minutes of ischaemia was sufficient to induce some tissue 
necrosis and that reperfusion after 20-21 minutes of ischaemia, resulted in 
reperfusion ventricular fibrillation (VF). Reperfusion VF was also the major 
cause of death in animals that did not survive the operative procedure. During 
3 
these investigations, Jennings and co-workers (1960) came to the conclusion that 
reperfusion may accelerate cell necrosis in the ischaemic heart This is probably 
the earliest study that documented the possible deleterious consequences of 
reperfusion. 
The concept of reperfusion injury was only fully developed by Rozenkranz and 
Buckberg (1983) when, in a series of studies, they showed that modified arresting 
and reperfusion solutions could improve the functional recovery of hearts 
arrested by cardioplegic solutions. In 1985, Braunwald and Kloner discussed the 
possible consequences of reperfusion on the ischaemic myocardium. They 
concluded that myocardial reperfusion could be considered a double edged 
sword, with distinct deleterious effects on severely ischaemic hearts, but when 
carried out early in the course of ischaemia, its effects are usually beneficial. 
The findings of DeWood and co-workers (1980), together with some early 
experimental observations that the myocardium can be salvaged by reperfusion 
(Ginks et al., 1972; Reimer et al., 1977), lead to efforts to dissolve, mechanically 
compress, or surgically remove the offending thrombi in patients with acute 
ischaemic syndromes. 
This was the beginning of an era where much emphasis and effort has gone into 
developing revascularisation techniques such as thrombolysis and fibrinolysis. 
Subsequent studies demonstrating that administration of both intravenous 
plasminogen activator (Collen et al., 1984), and intracoronary streptokinase 
(Laffel and Braunwald, 1984) can successfully lyse thrombi in patients, raised 
hopes that timely reperfusion of the myocardium by such means could save 
jeopardised cells otherwise destined to become necrotic. 
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There are at present numerous international studies such as the ISIS-3 and -4 
(International Study of Infarct Survival) and GISSI-2 trials involving thousands 
of patients being undertaken to develop and identify the best and most successful 
fibrinolytic and antithrombotic regimen for revascularisation of the ischaemic 
myocardium under clinical conditions. 
1.1 Myocardial Ischaemia and Reperfusion: A Review of Definitions. 
By definition, ischaemia exists "whenever the flow of anerial blood through the 
diseased vessels is reduced to a volume below that required by the myocardium 
for adequate function". From the metabolic point of view, ischaemia exists 
"whenever the anerial blood flow is insufficient to provide enough oxygen to 
prevent intracellular respiration from shifting from aerobic to the anaerobic 
form" (Jennings, 1970; Jennings and Yellon, 1992). 
Ischaemia, if prolonged and severe enough, causes changes in the cellular 
ultrastructure in the form of mitochondrial swelling, membrane disruption, 
shortening of the sarcomeres, and an overall loss of contractile function 
(Jennings and Ganote, 1976; Schaper et al., 1979). These changes are thought to 
be brought about by complex mechanisms involving depletion of energy stores 
(Neely et al., 1973; Jennings and Ganote, 1976; Jennings et al., 1983), 
accumulation of metabolic side-products (Neely et al., 1973) including lipid 
metabolites (Corr, Gross and Sobel, 1984), membrane disruption (Schaper et al., 
1979), intracellular acidosis (Cobbe and Poole-Wilson, 1980), intracellular ca2+ 
accumulation (Clusin et al., 1983; Nayler et al., 1988; Opie, 1989a), and oxygen 
derived free-radical activity (Hess and Manson, 1984; Kako, 1987). 
After the early studies by Tennant and Wiggers (1935) and Blumgart, Gilligan 
and Schlesinger (1941) and also the later work of Jennings and co-workers (1960) 
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the two basic concepts of i) irreversible, and ii) reversible ischaemic injury 
· developed. The former condition being a consequence of prolonged severe 
ischaemia, caused cell death (myocardial infarction), while the latter was 
associated with brief ischaemia and a rapid total recovery of the myocardium 
with reperfusion (Jennings et al., 1960). 
Although the phenomenon of ischaemic injury had been recognised for years, 
the concept of reperfusion induced injury only developed in the late 1970s and 
1980s (Hearse, 1977; Becker and Ambrosio, 1987; Opie, 1989a; Hearse, 1990) 
when it was realised that reperfusion may in itself induce injury of the ischaemic 
myocardium. 
Reperfusion injury occurs as a direct consequence of the reperfusion of 
ischaemic tissue (Hearse 1977; Jennings, Reimer and Steenbergen, 1985) and is 
defined as "those metabolic, functional, and structural consequences of restoring 
coronary anerial flow that can be avoided or reversed by modification of the 
conditions of reperfusion" (Rozenkranz and Buckberg, 1983). Despite the risk 
that reperfusion may worsen ischaemic injury, it is an absolute prerequisite for 
the survival and recovery of ischaemic tissue (Hearse, 1977; Braunwald and 
Kloner, 1985; Becker and Ambrosio, 1987; Opie, 1989b). 
In the mid 1970s the effects of ischaemia on myocardial mechanical function 
were restudied, and a new phenomenon was documented. Reperfusion after 
brief ischaemia of 15 minutes elicited a condition where mechanical dysfunction 
was prolonged but eventually totally reversible (Heyndrickx et al., 1975). Such a 
delayed recovery of mechanical function was later termed myocardial stunning 
(Braunwald and Kloner, 1982). 
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Stunning is defined as "a persistent post-ischaemic mechanical dysfunction 
despite the absence of irreversible damage" (Bolli, 1990). The important point in 
the definition is that no matter how severe the dysfunction is, it must be 
completely reversible. Stunning is therefore sublethal injury which is distinctly 
different from myocardial infarction which is the consequence of lethal 
ischaemic injury caused by an occluded artery. Recently, Bolli ( 1992) drew 
attention to an important point not previously emphasised when defining 
stunning. He made the point that for stunning to be diagnosed in patients, 
coronary blood flow must be known to be normal, or near normal Contractile 
dysfunction in patients may otherwise be incorrectly diagnosed as being due to 
stunning when it is actually silent ischaemia. 
A second consequence of ischaemic reperfusion lies in the development of 
ventricular arrhythmias, which, in their mildest form present as ventricular 
premature beats and in their most severe form as ventricular fibrillation (Figure 
1.1 ). Ventricular fibrillation causes a collapse of mechanical pumping of the 
heart with a potentially fatal decrease in cardiac output and an increase in 
ventricular wall tension and energy consumption in the face of a lack of oxygen 
(Manning and Hearse, 1984). Because reperfusion after cardio-pulmonary 
bypass often predisposes to the development of reperfusion ventricular 
fibrillation, its prevention is crucial for the survival of the reperfusion salvaged 
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FIGURE 1.1 A typical left ventricular pressure trace and electrocardiogram 
recorded during reperfusion of the isolated rat hean model. Note the loss of a 
left ventricular developed pressure with the transition from ventricular 
tachycardia to ventricular .fibrillation (reproduced from traces obtained during 
experiments described in chapter 8). 
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CHAPTER2 
CURRENT CONCEPTS IN REPERFUSION INJURY. 
Controversy Concerning the Existence of Reperfusion Injury. 
Since the early observations of Hearse (1977), the relevance of reperfusion 
injury to the clinical situation has been the topic of much debate and controversy. 
Decisive evidence for the existence of reperfusion injury would require either 
the appearance of a new phenomenon with reperfusion, or proof that 
reperfusion induced events can be prevented by interventions given at the onset 
of reperfusion. Because evidence for the existence of reperfusion injury was 
initially scant, it was suggested that reperfusion injury (in its various forms) may 
only occur under experimental conditions and thus be a laboratory artifact 
(Nayler and Elz, 1986), or, alternatively, that it may merely be an acceleration of 
damage which actually occurred during ischaemia (Hearse, 1991a). Most 
recently, Hearse, (1991b) proposed that stunning may merely be a form of 
convalescence during which time the heart recovers from the trauma induced by 
ischaemia. He suggests that the decreased mechanical function observed is 
merely the expression of a post-ischaemic "hangover", a phase of organ 
malfunction and recuperation that inevitably follows a period of trauma. 
The investigations into the phenomenon of reperfusion stunning in man has been 
plagued by problems such as the limited accuracy of the methods available to 
non-invasively measure regional left ventricular function, the inability to 
quantify regional myocardial blood flow during ischaemia and reperfusion, and 
the uncontrolled influence of variables such as preload, afterload and adrenergic 
tone which have an effect on post-ischaemic dysfunction. The evolution of better 
non-invasive measuring techniques have helped the cardiovascular researcher 
determine that stunning does indeed occur in man after certain pathological 
conditions and clinical procedures. 
9 
Doubts concernmg the existence and/ or relevance of reperfusion injury in 
patients, have been negated by studies showing that reperfusion injury does 
indeed occur under clinical conditions (Patel et al., 1988; Ferrari et al., 1990; 
1991; Renkin et al., 1990; Breisblatt et al., 1990; Braunwald, 1990; Kloner et al., 
1990). Bolli (1992), in a detailed review presented good evidence for the 
occurrence of reperfusion stunning in man after unstable angina, acute 
myocardial infarction with early reperfusion, open heart surgery, and cardiac 
transplantation. 
These two pathological complications of reperfusion stunning and arrhythmias, 
are features of reversible reperfusion induced injury. Although both conditions 
are considered to be reperfusion related, the severity of reperfusion stunning and 
arrhythmias may be the net result of two distinct pathological processes. One 
being ischaemia related, and the other reperfusion related (Hearse, 1991b). 
Ischaemia related events and conditions may therefore contribute to the severity 
of reperfusion injury with interventions performed to act during ischaemia, 
decreasing ischaemic, and ultimately also reperfusion injury. Although stunning 
and reperfusion arrhythmias must be considered the two most important 
manifestations of reperfusion injury, this phenomenon also includes 
microvascular damage and reperfusion induced tissue necrosis (Opie, 1989b; 
Hearse, 1991a). 
There are currently two major hypotheses implicating excess cytosolic ca2 + and 
oxygen derived free-radicals in the genesis of reperfusion injury and which have 
thus far received considerable attention from numerous cardiovascular research 
groups. 
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2.1. l Ca2 + and Reperfusion Injury. 
The earliest study linking ca2 + to reperfusion injury was performed by Jennings 
and co-workers ( 1960), who documented an increase in total tissue ca2 + levels 
and the appearance of contracture bands with reperfusion of the canine 
myocardium. In 1974, Fleckenstein and co-workers introduced the concept that 
intracellular ca2 + overload may induce myocardial fibre necrosis. Since then, 
numerous studies have shown that both reoxygenation after hypoxia (Allshire et 
al., 1987), and reperfusion after ischaemia (Steenbergen et al., 1987; Allen, Lee 
and Smith, 1988; Marban et al., 1989) is associated with an increase in 
intracellular ca2 + levels. These increases in intracellular ca2 + levels in the 
heart have also been related to an increase in the incidence of reperfusion 
arrhythmias (Clusin 1983; Koretsune and Marban, 1989; Kihara and Morgan, 
1991) and/or decreased mechanical function (Kusuoka et al., 1987; Kitikaze, 
Weisman and Marban, 1988; Kusouka et al., 1990). 
Recently, the concept of ca2 + overload induced reperfusion injury evolved 
further. It has been proposed that while a prolonged accumulation of total cell 
ca2+ may be indicative of irreversible cell damage (Shen and Jennings, 1972a), 
an early transient increase in intracellular ca2 + levels may cause, and be 
indicative of reversible reperfusion injury (Opie 1991c). Two hypotheses 
proposed by Opie (1991c) form the basis upon which the work documented in 
this thesis are based. First, he proposed that reperfusion after a brief period of 
ischaemia induces a transient ca2+ overload (in the already ca2+ loaded 
ischaemic heart) which contributes to reperfusion stunning (post-ischaemic 
mechanical dysfunction) and arrhythmias, and secondly, that elevated 
intracellular ca2 + levels during ischaemia and early reperfusion may promote 
abnormal intracellular ca2 + transients ( oscillations between the sarcoplasmic 
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reticulum and the cytosol) which could exacerbate stunning and/or initiate and 
perpetuate arrhythmias (Figure 2.1 ). Figure 2.2 is a schematic representation of 
the possible cellular consequences of a loss in ca2 + homeostasis as proposed by 
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FIGURE 2.1 Proposed changes in cytosolic ca2+ levels during ischaemia and 
early and late reperfusion based on the data by Marban et al., (1990), 
Steenbergen et al., (1987), and Kusuoka et al., (1990) (figure reproduced from 
Opie, 1991c). Recent data published by Harada et al., (1994) confirm these 
proposals. This group has shown that cytosolic ca2 + levels do indeed increase 
during ischaemia, with a subsequent Jun her increase in cytosolic ca2 + levels 
occurring during early reperfusion. 
Several studies provide evidence for the pathogenic role of ca2 + in reperfusion 
stunning: 1) Perfusion of the isolated ferret heart with transient high 
concentrations of ca2+ causes mechanical dysfunction (Kitakaze, Weisman and 
Marban, 1988), 2) Low ca2+ reperfusion of the isolated ferret (Kusuoka et al., 
1987) and rat heart (Kuroda, Ishiguro and Mori, 1986) improves reperfusion 
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function and, 3) Ventricular fibrillation is accompanied by an elevated 
intracellular ca2+ (Kihara and Morgan, 1991) and decreased post-fibrillatory 
mechanical function (Koretsune and Marban, 1989). Similarly, abnormal 
intracellular ca2 + levels can be linked to arrhythmias as: 1) Strophanthidin 
induced ventricular fibrillation is associated with an increase in intracellular 
ca2+ levels and oscillations (Kihara and Morgan, 1991), and 2) ventricular 
fibrillation is associated with an increase in intracellular ca2 + levels measured 
in BAPTA loaded non-ischaemic ferret hearts (Koretsune and Marban, 1989). 
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FIGURE 2.2 Schematic representation of the direct consequences of loss of 
ca2 + homeostasis during post-ischaemic reperfusion (figure reproduced from 
Nayler and Elz, 1986). 
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2.1.2 Free-radicals and Reperfusion Injury. 
Although ca2 + has been implicated as a major factor in reperfusion injury, it is 
not the only cause of this type of injury (Bolli, 1990; Bolli et al., 1990; Hearse 
1991a, 1991b). A second and possibly equally important cause of reperfusion 
injury is the generation of oxygen derived free radicals during ischaemia and 
reperfusion (Hess and Manson, 1984; Myer et al., 1985; Gross et al., 1986). These 
oxygen derived free radicals are highly reactive molecules that may cause a 
variety of types of cell damage including phospholipid peroxidation and the 
degradation or cross-linking of protein or nucleic acid molecules (Halliwell and 
Gutteridge, 1985; Miki et al., 1988; Gutteridge and Halliwell, 1990). 
Free-radicals are normally produced by cells from about 5 % of the available 
oxygen, but are broken down by naturally occurring free-radical scavenger 
enzymes in the normally functioning non-ischaemic myocyte (Hess and Manson, 
1984 ). During ischaemia, these enzymes may be inhibited allowing increased 
accumulation of these intermediates. 
During hypoxia and ischaemia, ATP metabolites such as xanthine, hypoxanthine 
and ca2+ accumulate, leading to free radical formation (McCord, 1985). 
McCord (1985) proposed that intracellular ca2+ accumulation may activate a 
protease, possibly calpain, which converts xanthine dehydrogenase to xanthine 
oxidase. In the presence of molecular oxygen, this enzyme will convert 
hypoxanthine to urate with the formation of free-radicals (Figure 2.3). This 
proposal has been confirmed by data showing that this process may be a 
significant contributor to oxygen free-radical formation in capillary endothelial 
cells in the isolated rat heart model (Chambers et al., 1989). It must however be 
stressed that this mechanism appears to be species specific and may not relevant 
to man (Podzuweit et al., 1988). 
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Reperfusion after an ischaemic episode is also associated with the generation of 
free-radicals such as superoxide anions (02-), hydrogen peroxide (H202), and 
hydroxyl radicals (OH)(Mc Cord, 1985). These free-radicals could be formed by 
1) increased activity of xanthine oxidase, which is active in dogs (Holzgrefe and 
Gibson, 1989; Przyklenk, Whittaker and Kloner, 1990) and the rat (Bernier, 
Hearse and Manning, 1986) but may not operate in man, 2) activation of 
neutrophils, 3) activation of the arachidonate cascade, 4) accumulation of 
reducing equivalents during oxygen deprivation, and probably most important, 5) 
derangement of the intramitochondrial electron transport system resulting in 
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FIGURE 2.3 The proposed mechanism for the generation of superoxide and 
secondary species of active oxygen after ischaemia and reperfusion in the rat and 
dog hean (figure reproduced from McCord, 1985). 
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The respective quantitative contributions of free-radicals and ca2 + to 
reperfusion injury has not been investigated, but it is suggested that they may be 
two facets of the same phenomenon (Bolli, 1990). It is possible that free-radicals 
cause membrane disruption, which facilitates abnormal ca2 + redistribution in 
the cell (Figure 2.4) (Vandenplassche et al., 1990). This ca2+ redistribution may 
exacerbate cell damage and further promote free-radical formation (Hearse, 
1991b). 
j 1scHAEMIA AND REPERFus10N I 
FREE RADICALS c,1• OVERLOAD 
\ 
membrane damage 
oontraotlle meohanleme Impaired 
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FIGURE 2.4 Illustration of the two major mechanisms for reperfusion injury, 
which are believed to be by formation of oxygen derived free-radicals and ca2 + 
overload. This scheme reconciles these apparently conflicting hypothesis, showing 
the proposed combined role of free radicals and ca2 + overload in causing 
membrane damage and relative ca2 + insensitivity of contractile mechanisms 
(actin-myosin interaction on left and sarcoplasmic reticulum on the right) (figure 
reproduced from Opie, 1989b). 
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2.2 Factors Governin2 the Severity of Reperfusion Injury. 
Although reperfusion injury is recognised as a reperfusion related pathology, 
conditions during ischaemia set the stage for reperfusion and thus contribute to 
the severity of reperfusion injury (Manning and Hearse, 1984; Opie, 1989b; Bolli, 
1990; Opie, 199 lc ). 
i) lschaemic time. The incidence of reperfusion arrhythmias increases as the 
ischaemic time is increased up to 10-20 minutes after which there is a gradual 
decline in these arrhythmias (Manning and Hearse, 1984). This is consistent with 
the idea that ATP and viable (reversibly injured) myocardium are required for 
reperfusion arrhythmias to occur (Manning and Hearse, 1984; Coetzee and Opie, 
1987; Opie, 1989b). Further prolongation of the ischaemic time, leads to 
depletion of ATP and cell necrosis, thus decreasing the likelihood of arrhythmias 
occurring. 
Ischaemic time also markedly influences the severity of metabolic injury in the 
reperfusion period. As the duration of ischaemia is increased from 30-90 
minutes, there is a marked increase in total tissue and mitochondrial ca2 +, a 
worsening of ischaemic contracture and exaggerated enzyme release (Ferrari et 
al., 1986b; 1988). Ischaemic injury measured as the percentage tissue necrosis, 
increases as the ischaemic time increases while tissue ATP and phosphocreatine 
(PCr) contents fail to recover during reperfusion after extended ischaemia 
(Schaper et al., 1987; Schaper and Schaper, 1988). Also, the longer the ischaemic 
time, the more severe the ensuing mechanical abnormalities (Heyndrickx et al., 
1975; Preuss et al., 1987). There is thus evidence that the longer the period of 
ischaemia, the more severe the ischaemic and subsequent reperfusion injury. 
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Consequences of brief and prolonged ischaemic episodes on viability of 
reperfused myocardium: When the heart is exposed to a relatively short 
ischaemic episode of a few minutes, it ultimately recovers (Braunwald and 
Kloner, 1982), resumes active tension generation, regenerates its endogenous 
energy rich phosphate reserves (Jennings et al., 1985), and retains a fairly normal 
ultrastucture (Schaper et al., 1979) upon reperfusion. Equally important is that 
there is no excess total tissue ca2 + accumulation under these conditions (Shen 
and Jennings, 1972). 
On the other hand, hearts reperfused after prolonged ischaemic episodes (30 
minutes and more) are unable to regenerate depleted energy rich phosphates 
(Jennings et al., 1985). These hearts become oedematous (Jennings et al., 1985; 
Jennings et al., 1990; Schaper et al., 1979), gain Na+ and ca2+ (Shen and 
Jennings, 1972), lose K+ (Kantor et al., 1990; Carney et al., 1989) and are 
electrically unstable (Opie, Nathan and Lubbe 1979; Manning and Hearse, 1984). 
There are also ultrastructural changes such as mitochondrial swelling and the 
development of contracture bands which are concomitant with intracellular 
ca2+ accumulation (Schaper et al., 1979). These hearts are irreversibly or 
lethally injured. 
Ultrastructural changes during ischaemia and reperfusion in the reversibly 
injured myocardium: The ultrastructural changes observed late in the 
reversible phase of ischaemia (15 minutes) are marked but reversible on 
reperfusion (Jennings et al., 1985). Such hearts show signs of glycogen depletion, 
marked relaxation of myofibrils, and alterations in mitochondrial structure. 
Matrix granules normally present in the mitochondria of control hearts are 
absent in ischaemic hearts and there is a degree of mitochondrial swelling with 
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disorganisation of cristae but no evidence of sarcolemmal disruption (Jennings et 
al., 1985). 
On reperfusion after 15 minutes ischaemia, there are no ultrastructural changes 
evident in the first half minute of reperfusion. At 3 minutes, there is however 
evidence of ultrastructural changes with further mitochondrial swelling, less 
glycogen in the sarcoplasm, and myofibrils remain relaxed. After 20 minutes 
reperfusion, ultrastructure is almost normal with glycogen present, nuclear 
chromatin evenly distributed and the mitochondria mostly indistinguishable from 
controls (Jennings et al., 1985). 
ii) Severity of ischaemia. The effect of the severity of ischaemia on reperfusion 
injury has not been well documented but it has been shown that increased heart 
rate worsens the severity of ischaemic injury as measured by infarct size (Schaper 
et al., 1987) and incidence of reperfusion arrhythmias (Lederman et al., 1987) in 
the canine model. The ca2+ antagonist, diltiazem used during ischaemia 
decreased heart rate and the incidence of reperfusion arrhythmias but was 
ineffective when heart rate was maintained by pacing (Tosaki, Szekeresh and 
Hearse, 1987). The higher the ischaemic heart rate, the worse the ischaemic 
injury (Schaper et al., 1987). Similarly, the greater the degree of myocardial 
hypoperfusion, the greater the reperfusion induced formation of free-radicals 
and the worse the reperfusion stunning (Bolli et al., 1988a). 
iii) Rate of reperfusion. There is some evidence to show that uncontrolled 
sudden, rather than controlled reperfusion exacerbates reperfusion injury. 
Reperfusion arrhythmias (Yamazaki et al., 1986; Peng et al., 1989) and function 
(Yamazaki et al., 1986) can be improved by controlled staged reperfusion in the 
dog model. The beneficial effects of controlled reperfusion on reperfusion 
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arrhythmias may however be species specific as staged reperfusion in the isolated 
rat heart model merely delayed, but did not prevent the onset of reperfusion 
arrhythmias (lbuki, Hearse and Avkiran, 1992). 
2.3 Possible ca2 + Sources and Entry Pathways Contributina: to Elevated 
Cytosolic ca2 + levels on Reperfusion. 
The exact mechanisms responsible for increased cytosolic ca2 + levels upon 
reperfusion are at present poorly understood and have not been well defined. 
Although ca2 + may enter the myocyte through holes in the sarcolemma in the 
irreversibly damaged myocardium, this would be unlikely in the reversibly 
injured myocardium where ultrastructural evidence for membrane disruption is 
absent (Schaper et al., 1979; Jennings et al., 1985; Schaper and Schaper, 1988). 
There are numerous potential sources of ca2 +, and pathways via which 
extracellular ca2 + may enter the myocyte and induce reperfusion stunning 
and/ or arrhythmias. It may be secondary to a decrease in the ability of the 
sarcoplasmic reticulum (Krause and Hess, 1985a; 1985b) or mitochondria (Opie, 
1989b) to take up and buff er excess ca2 +, or due to activation of the 
Na+ /Ca2+ exchanger secondary to an ischaemia induced increase in cytosolic 
Na+ levels (Lazdunski et al., 1985; Tani and Neely, 1989; Murphy, Smith and 
Marsh, 1988). Ischaemia induced acidification of the intracellular space may 
cause reperfusion induced activation of the Na+ /H + exchanger which would in 
turn be expected to increase Na+ /Ca2 + exchanger activity (Figure 2.5). 
Whatever the mechanisms, ca2 + influx at the onset of reperfusion appears to 
exceed the handling capacity of systems responsible for ca2 + extrusion from the 







FIGURE 2.5 Illustration of proposed mechanisms of early gain of Ca2+ in the 
reperfusion period. Cytosolic ca2+ may accumulate as a result of metabolic 
inhibition in the ischaemic period (reduced glycolysis and tissue ATP levels). 
During reperfusion, ca2+ enters in a controlled manner through the Ca2+ 
channel or via Na+ I Ca 2 + exchange. Uncontrolled Ca 2 + entry may result from 
sarcolemmal damage, either from the activity of phospholipases or free radicals 
(figure reproduced from Opie, 1989b). 
i) ca2 + channels. The maximal rate of ca2 + uptake on reperfusion after 30 
minutes ischaemia is approximately 0.3 µmol/g/min for the first 30 minutes of 
reperfusion (Tani and Neely, 1989). Although this value is similar to that 
considered the normal influx rate in myocytes (0.1-0.3µmol/g/min (Lullmann, 
Peters and Preuner, 1983)), it does not exclude the possibility that the ca2+ 
channel or the proposed "Ca2+ leak channel" (Cragoe, Post and Langer, 1993) 
may be partially responsible for the ca2+ overload during reperfusion. 
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As ca2 + flux through the ca2 + channel is modulated by intracellular pH and 
tissue ATP availability, and 5-15 minutes of ischaemia decreases tissue ATP and 
pH levels sufficiently to inactivate these channels (Sperelakis, 1988), they would 
be expected to only contribute to ca2 + influx during reperfusion when 
intracellular pH and ATP are normalised. Data showing that ca2 + channel 
blockade (and transsarcolemmal flux inhibition) by verapamil or nitrendipine 
suppressed the inducibility of electrically induced ventricular fibrillation in the 
non-ischaemic isolated perfused rabbit heart (Merillat et al., 1990) also indicate 
that abnormal ca2 + fluxes through these slow channels may contribute to the 
genesis of ischaemic and reperfusion ventricular arrhythmias. 
If however, the ca2+ channels are responsible for the increase in ca2+ on 
reperfusion, then ca2 + channel antagonists given before, or at the onset of 
reperfusion should decrease reperfusion induced ca2 + overload and reperfusion 
injury. Many investigators failed to show a decrease in ca2 + overload and 
reperfusion stunning when Ca2 + antagonists were administered at the onset of 
ischaemia or reperfusion (Bourdillon et al., 1985; Lamping and Gross, 1985; 
Ferrari et al., 1986a; Przyklenk and Kloner, 1988). There are however studies 
that did demonstrate that ca2 + antagonists given either before ischaemia 
(Watts, Koch and LaNoue, 1980; Nayler, Ferrari and Williams, 1980; Higgins and 
Blackburn, 1984; Poole-Wilson et al., 1984; Watts, Maiorano and Maiorano, 1986; 
Warltier et al., 1988; Nayler et al., 1987; Nayler, Buckley and Leong, 1990; Watt 
et al., 1990.), or during reperfusion (Higgins and Blackburn, 1984; Przyklenk and 
Kloner, 1988.) could attenuate ca2 + accumulation and/ or reperfusion injury. 
ca2 + antagonists given before ischaemia may however also protect the 
ischaemic heart by reducing high energy phosphate consumption by 1) decreasing 
heart rate and/or, 2) decreasing contractility (Lange et al., 1984) and may not 
necessarily act by decreasing reperfusion injury. 
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Indications are that the ca2 + channel may contribute to reperfusion induced 
increases in cytosolic ca2 + levels that have thus far remained undetected 
because of the relatively slow response time of ca2 + measuring techniques. 
ii) Ischaemic intracellular H + and Na+ levels and the Na+ /H + 
exchanger. Ischaemic increases in intracellular Na+ levels are thought to 
activate the Na+ /H + exchanger and cause increases in cytosolic ca2+ levels 
during reperfusion. Unlike the ca2+ channel, the Na+ channel may be active 
during ischaemia as the Na+ channel blocker, lidocaine given before ischaemia 
could attenuate ischaemia induced elevations in intracellular Na+ concentration 
(Pike, Kitikaze and Marban, 1988). The fact that amiloride or dichlorobenzamil 
(a Na+ /Ca2+ exchange inhibitor) pretreatment did not decrease Na+ 
accumulation during ischaemia, but did decrease ca2 + accumulation on 
reperfusion may also suggest that the ischaemic increase in intracellular Na+ 
levels is independent of the Na+ /H+ and Na+ /Ca2+ exchangers (Tani and 
Neely, 1989; Tani, 1990). 
Independent of the Na+ channel, intracellular acidosis may also contribute to 
ischaemia induced elevations in the intracellular Na+ concentration by 
activating the Na+ /H + exchanger(. Ischaemia causes a decrease in intracellular 
pH (Cobbe and Poole-Wilson, 1980) which may stimulate the Na+ /H + 
exchanger and account for the elevated intracellular Na+ concentration during 
ischaemia (Lazdunski, Frelin and Vigne, 1985). This proposal that there may be a 
direct link between intracellular H + concentration and the elevation in Na+ 
during ischaemia is controversial. Although an ischaemic elevation of the 
intracellular Na+ concentration was proportional to the reduction in 
intracellular pH (Neubauer et al., 1987), it has been suggested that the Na+ /H + 
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exchanger may be inhibited at the low extracellular pHs occurring during 
ischaemia (Tani, 1990). 
Despite the uncertainty surrounding the role of the Na+ /H + exchanger in Na+ 
loading during ischaemia, there seems no doubt that the exchanger will be 
reactivated when extracellular pH is normalised during reperfusion. The 
intracellular/ extracellular pH gradient created during early reperfusion will 
activate the Na+ /H + exchanger and indirectly contribute to elevated cytosolic 
ca2+ levels on reperfusion (Figure 2.6). A role for this exchanger in reperfusion 
injury (presumably induced by cytosolic ca2 + overload) was demonstrated by 
Kitikaze, Weisfeldt and Marban (1988) who reperfused ferret hearts with an 
acidotic reperfusion solution, thus inhibiting the Na+ /H + exchanger during 
early reperfusion, and improved subsequent reperfusion function. The concept 
that reperfusion induced Na+ /H + exchanger activation may contribute to the 
genesis of reperfusion ventricular arrhythmias was also supported by data 
showing that a stepped pH (6.6-7.4) restoration during reperfusion decrease the 
incidence of reperfusion ventricular fibrillation in isolated rat hearts (Avkiran 
and Ibuki, 1992). 
Tani and Neely ( 1989) found that the increase in Na+ levels during ischaemia 
was further elevated during reperfusion and remained high throughout the 30 
minutes reperfusion. Although they (Tani and Neely, 1989) could eliminate this 
rise in reperfusion Na+ influx by using pre-ischaemic glycogen depletion (thus 
decreasing ischaemia induced H + production) or amiloride treatment, this was 
only achieved when ischaemia was fairly severe. This reperfusion induced 
increase in cytosolic Na+ was only evident when the ischaemia was so severe 
and prolonged that it caused a significant increase in tissue lactate, a decrease in 
pH and inactivation of Na+ ,K + -ATP-ase activity. This raises the question of 
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whether this increase in the Na+ accumulation during reperfusion is relevant to 
the stunned heart where ischaemic times are relatively short (10-20 minutes) 
compared to the model of 30 minutes ischaemia used in the above-mentioned 
study. 
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FIGURE 2.6 Tentative scheme illustrating how recovery from ischaemia-
induced acidosis may lead to myocardial stunning and affhythmias. The 
hypothesis is that an accelerated Na+ 0 I H + i exchange on reperfusion might be 
affhythmogenic and I or contribute to reperfusion stunning. The reperfusion 
induced intracellular Na+ loading may activate the Na +tea 2+ exchanger and 
induce a transient cytosolic ca2 + overload (figure reproduced and modified 
from Dennis et al., 1990). 
One of the major problems facing researchers has been the unavailability of a 
specific pharmacologic inhibitor of the Na+ /H + exchanger. Although there are 
reasonable data to implicate the Na+ /H + exchanger in reperfusion injury, the 
nonspecificity of amiloride and its various derivatives implies that it may also 
have acted by various other mechanisms other than the Na+ /H + exchanger as 
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intended. Amiloride and its derivatives are all known to have effects on 1) the T-
type Ca2+ channels (Tang, Presser, Morad, 1988), 2) the Na+ channels in 
various other tissue types (unknown for myocardium) (Benos, 1982) 3) Na+,K+-
ATP-ases and the Na+ /Ca2+ exchanger (Siegl et al., 1984; Kennedy et al., 
1986). Data thus far published using these compounds is therefore imperfect and 
should be interpreted with caution. 
iii) The Na+ /Ca2+ Exchanger. Although Na+ /Ca2+ exchange is inhibited 
by ischaemic acidosis (Philipson, Bersohn and Nishimoto, 1982) thus excluding a 
role for the exchanger during ischaemia, several researchers have proposed that 
the Na+ /Ca2+ exchanger may contribute to cytosolic ca2+ overload during 
reperfusion (Grinwald, 1982; Renlund et al., 1984) or hypoxia (Hagney et al., 
1992) and reoxygenation (Grinwald and Bosnahan, 1987; Murphy et al., 1991; 
Marsh and Smith, 1991 ). The elevated cytosolic Na+ concentration observed 
during ischaemia (Pike, Kitikaze and Marban, 1988; Wilde and Kleber, 1986) led 
to the hypothesis that an ischaemia induced increase in intracellular Na+ 
concentration may activate the Na+ /Ca2+ exchanger on reperfusion and 
therefore indirectly contribute to ca2 + overload. 
Whilst it could be argued that the intracellular Na+ concentration would have to 
remain elevated for some time during reperfusion to significantly activate the 
Na+ /Ca2+ exchanger and increase cytosolic ca2+ levels during reperfusion, 
the ischaemia induced Na+ "overloading" which is thought to be rectified by the 
Na+ /Ca2+ exchanger at the onset of reperfusion would contribute to a transient 
intracellular ca2 + overload. It is also possible that the intracellular Na+ 
concentration may remain elevated for a couple of seconds after reperfusion as 
the Na+ /H + exchanger, which is thought to be responsible for ±35 % of the H + 
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extrusion on reperfusion (Vandenberg et al., 1993) extrudes tt+ in exchange for 
Na+. 
The most promising data to implicate the Na+ /Ca2+ exchanger in reperfusion 
ca2 + overload and reperfusion injury were those showing that monensin ( a 
Na+ ionophore) increases intracellular Na+ accumulation during ischaemia 
(Tani and Neely, 1989). Subsequent reperfusion after 30 minutes ischaemia was 
associated with an increase in 45ca2 + accumulation and a decrease in 
reperfusion mechanical function (increased stunning). Reperfusion of hearts 
with a low ca2 +, high K + containing solution at the onset of reperfusion also 
improved reperfusion function, presumably by inhibiting Na+ /Ca2+ exchange 
activity (Tani and Neely, 1990a). These findings were also confirmed by data 
showing that reperfusion with a high Na+ (Kusuoka, de Hurtado and Marban, 
1993), or NiCl containing reperfusion solution (Lee and Allen, 1992), two 
interventions thought to decrease reperfusion Na+ /Ca2+ exchange activity 
improved reperfusion function. 
iv) Sarcolemmal ca2+ ATP-ase pumps, the sarcoplasmic reticulum and 
mitochondria. Although the contribution of the sarcoplasmic reticulum and 
mitochondria to reperfusion ca2 + overload is thought to be relatively small, 
these organelles may act as ca2+ buffers (Meno et al., 1984; Opie, 1991c) 
and/or sources (Steenbergen et al., 1990; Pesaturo and Gwathmey, 1990) during 
ischaemia and reperfusion. The normal function of these two organelles may 
therefore be important in the regulation of cytosolic ca2 + levels during 
ischaemia and early reperfusion. 
The role of mitochondria in ca2 + homeostasis during brief ischaemia and 
reperfusion appears to be insignificant After 45 minutes no-flow ischaemia, 
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mitochondria isolated from these hearts only have slightly elevated ca2 + levels 
and generate ATP at only slightly reduced rates (Nayler, Ferrari and Williams, 
1980). Continuation of ischaemia to 90 minutes causes a slight increase in 
mitochondrial ca2 + content with reperfusion causing a massive influx of ca2 + 
into the cells, and severe mitochondrial damage (Hearse, 1977). These findings 
were interpreted as being an indication that although ca2 + is normally lower in 
the mitochondria than in the cytosol, ischaemia induced elevation of cytosolic 
ca2 + levels may lead to mitochondrial ca2 + loading with the mitochondria 
acting as a ca2+ source on reperfusion (Pesaturo and Gwathmey, 1990). 
Pesaturo and Gwathmey ( 1990) proposed that the reoxygenation induced twitch 
prolongation and increase in ca2 + transients seen in the ferret papillary muscle 
preparation was possibly the result of ca2 + release from the mitochondria 
and/ or sarcoplasmic reticulum on reoxygenation. They found that oligomycin 
and cyanide (thought to decrease ca2+ release from mitochondria) and 
ryanodine (which acts on the SR ca2+ release channel) could attenuate 
reoxygenation induced increased ca2 + transients and twitch prolongation. 
Although these reoxygenation induced increases in cytosolic ca2 + transients 
may not be directly relevant to reperfusion after ischaemia, these data may imply 
that these organelles have the capacity to act as ca2 + sources on reoxygenation 
or possibly even reperfusion. 
Very little is known about the possible contribution of the sarcoplasmic reticulum 
to ca2 + induced stunning. In an early study, investigating the potential role of 
intracellular ca2 + stores in ischaemic and reperfusion injury, Koomen, Schevers 
and Noordhoek (1983) preperfused hearts with a low ca2+ containing perfusate 
and recorded improved mechanical function when reperfused. This was 
suggested to be due to pre-ischaemic intracellular ca2 + store depletion which, 
may protect the heart by decreasing ischaemic intracellular ca2 + overload. 
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Porterfield and co-workers ( 1987), found that ryanodine, in concentrations that 
induced sarcoplasmic reticulum ca2 + release channel closure in the rat heart, 
could decrease morphologic changes and improve mechanical function on 
reperfusion. Also, pretreatment of isolated atrial tissue with caffeine or 
ryanodine decreased a simulated ischaemia induced increase in end-diastolic 
ca2 + concentrations as measured with Indo-1 (Northover, 1991 ). Similarly, 
arresting the isolated rat heart with either high magnesium or potassium 
containing solution before an ischaemic period had different effects on the 
severity of ischaemic injury. Potassium arrest, thought to induce intracellular 
ca2+ store (the SR) loading exacerbated ischaemic injury, while magnesium 
induced arrest, thought to deplete intracellular stores of ca2 +, decreased the 
severity of ischaemic injury (Steenbergen et al., 1990). Although no direct 
evidence for a role for the SR as a potential source of ca2 + has been published, 
it does seem possible that ischaemia and/ or reperfusion induced elevations in 
cytosolic ca2 + levels may induce SR ca2 + loading, and/ or ca2 + induced 
ca2 + release from the sarcoplasmic reticulum. This may trigger: 1) futile ca2 + 
oscillations, which would squander already deficient ATP levels, and/or 2) large 
ca2 + oscillations (with large systolic peaks) which may further damage already 
jeopardised cellular components. 
Because the sarcolemmal ca2 + pumps are ATP dependent, it is possible that 
these pumps may fail to extrude excess ca2 + during ischaemia and early 
reperfusion. The importance of sustained glycolysis during reperfusion was 
demonstrated by Jeremy and co-workers (1992) who showed that glycolytic 
inhibition at early reperfusion decreased reperfusion mechanical function, 
increased reperfusion end-diastolic pressure, and prolonged reperfusion cytosolic 
Ca2 + overload. It is however evident that under normal physiologic conditions, 
these pumps only work at half their maximal rate (Carafoli, 1985) and would be 
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expected to be capable of responding to the elevated cytosolic ca2 + levels under 
pathophysiological conditions. Also, the sarcolemmal Na+ /Ca2+ exchanger has 
a much larger capacity to move ca2 + than the A TP-ase pump and should 
therefore be capable of compensating for the reduction in function of these ATP-
dependent pumps ( Carafoli, 1985). The sarcolemmal A TP-ase pumps therefore 
appear to play an insignificant role in ca2 + homeostasis during reperfusion. 
One of the reasons the role of the SR in reperfusion stunning and arrhythmias 
has not been further investigated, is the lack of consensus among researchers on 
the mechanism of action of ryanodine and other SR specific compounds on the 
SR ca2 + release channels. Some researchers believe ryanodine acts by opening 
the release channel (Rousseau, Smith and Meisner, 1987), while a second group 
believes it closes these channels (Marban and Weir, 1985; Inui et al., 1988). 
These controversies have restricted numerous studies and rendered data 
obtained using these compounds inconclusive. 
v) Indirect influence of endothelin on ca2+ fluxes. Although endothelin is 
not a source of ca2+, the endogenous 21-amino-acid peptide has been reported 
to have multiple biological actions (Yanagisawa et al., 1988). It contracts vascular 
and non-vascular smooth muscle and is known to exert a positive inotropic action 
on atrial and ventricular muscle (Nayler, 1990). Endothelin, by stimulating the PI 
(phosphoinositol) pathway, increases cytosolic IP3 (inositol triphosphate) levels 
which stimulate SR IP3 receptors to release ca2+ into the cytosol (Nayler, 
1990). By virtue of its ca2+ mobilising properties (Vigne et al., 1990; Nayler, 
1990), endothelin may also contribute to cytosolic ca2+ overloading and 
reperfusion injury (Opie et al., 1989; Nayler, 1990) 
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It has been found that ischaemia caused a time dependent externalisation of 
endothelin-1 binding sites (Liu, Casley and N ayler, 1989), thus increasing the 
number of receptors available for the interaction with blood borne endothelin. A 
possible role for endothelin has also been suggested by data that shows that 
circulating endothelin levels increased within hours of onset of myocardial 
infarction in humans (Miyauchi et al., 1989; Salminen et al., 1989; Yasada et al., 
1990). There is thus good evidence to suggest that endothelin may play a role in 
the pathogenesis of ischaemic and reperfusion injury. 
2.4 Proposed Mechanisms Underlying Decreased Mechanical Function in 
Stunning. 
The exact mechanisms by which the proposed transient cytosolic ca2 + overload 
causes contractile dysfunction is unknown, but may be related to cellular damage 
caused by ca2 + activated phospholipase and/ or other degradative enzyme 
(Opie, 1989a; Marban et al., 1989; Hearse, 1991a) which may have an effect on 
contractile proteins. It is also believed that ca2 + may activate the production of 
highly reactive oxygen free-radicals via xanthine oxidase in certain species (Mc 
Cord, 1985; Hearse, 1991a). 
Since it became evident that stunning was not due to severe morphological 
damage and the stunned heart showed reversible ultrastructural changes, the 
mechanisms responsible for the characteristic decrease in mechanical function 
have been elusive. Of the numerous proposed hypotheses, many have been 
disproved while others remain unresolved. 
i) Inadequate high energy phosphate production. An early proposal was that 
the stunned heart had incompetent mitochondria, unable to synthesise adequate 
ATP to support normal mechanical function which was possibly related to an 
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inadequate supply of adenine nucleotide precursors (Braunwald and Kloner, 
1982; Reimer, Hill and Jennings, 1981). Early studies showed that the stunned 
heart had low ATP levels (Kloner et al., 1983; Ellis et al., 1983a; Reimer, Hill 
and Jennings, 1981) and that the ATP levels increased with a similar time course 
as recovery of function (Kloner et al., 1983; Ellis et al., 1983a). These findings 
were later disproved by reports showing that not only was there no correlation 
between tissue ATP levels and mechanical function (Taegtmeyer et al., 1985; 
Kusuoka et al., 1987), but there were also normal or supranormal 
phosphocreatine levels present in the stunned heart (Kloner et al., 1983; 
Taegtmeyer, Roberts and Raine, 1985; Kusuoka et al., 1987; Przyklenk and 
Kloner, 1986). Also, the PCr /Pi ratio (which is an indication of the balance 
between energy utilisation and production), was higher than baseline in the 
stunned heart (Kusuoka et al., 1987). The latter finding would imply that the 
mitochondria of the stunned hearts were intact and functional Another factor 
which indicated that ATP depletion was not the major cause of the decreased 
mechanical function was that stunned hearts were still able to respond to positive 
inotropic stimuli and perform mechanical work at levels above their pre-
ischaemic baseline level (Arnold et al., 1985; Becker et al., 1986; Ambrosio et al., 
1987; Mercier et al., 1982; Ellis et al., 1983b; Ito et al., 1987). These increases in 
mechanical function were not accompanied by a decrease in ATP or 
phosphocreatine levels and had no detrimental effect on subsequent mechanical 
function (Ambrosio et al., 1987; Arnold et al., 1987) In summary, all indications 
are that the decreased mechanical function associated with stunning is in no way 
related to total tissue high energy phosphate levels in the heart 
ii) Impaired energy utilisation by myofibrils. Another possible cause of 
decreased mechanical function was proposed by Greenfield and Swain (1987) 
who reported a decrease in creatine kinase activity after 15 minutes of ischaemia. 
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They noted a decrease in the free ADP used by the myofibrillar creatine kinase 
to produce ATP at the contraction site. This hypothesis is however questioned as 
it does not explain the contractile and metabolic reserve of the stunned heart 
The fact that inotropic interventions used by some researchers could still elicit 
above normal mechanical work would suggest that the myofibrillar creatine 
kinase is adequate to run the myofibrillar A TP-ase reaction at normal levels even 
when the heart is stunned. 
iii) SR dysfunction and excitation-contraction uncoupling. Although very 
little is known about the role of the sarcoplasmic reticulum in the decreased 
mechanical function associated with stunning, Krause and co-workers ( 1989) 
found that the A TP-ase pumps, of SR vesicles isolated from the stunned dog 
heart, exhibited a reduced capacity to transport ca2 + into the vesicle. These 
findings were ascribed to a decreased ca2 + A TP-ase pump capacity to sequester 
ca2+ (Krause et al., 1989; Limbruno et al., 1989). The mechanism responsible 
for this decreased A TP-ase pump activity is not known but may be due to 
ischaemia induced changes in the characteristics of phospholamban (Schouten et 
al., 1989). SR fractions from the stunned heart exhibited a decrease in 32p 
incorporation in phospholamban which correlated well with the decrease in 
ca2 + pump activity. 
The hypothesis of dysfunction of the A TP-ase pump, although attractive, is 
difficult to reconcile with the finding that the stunned heart exhibited increased 
Ca2 + transients despite the decreased mechanical function (Kusuoka et al., 
1990). If we assume that the sarcoplasmic reticulum is responsible for 
intracellular ca2 + transients associated with diastole and systole, then the 
sarcoplasmic reticulum ca2 + A TP-ase pumps appear to be normal in the intact 
stunned heart These changes in the SR ca2 + A TP-ase pump activity may thus 
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be related to the preparation used and/ or technique used to isolate the SR 
vesicles from the stunned myocardium. 
Not only the ca2+ uptake mechanisms, but also the ca2+ release channels have 
been implicated in stunning. It has been suggested that the apparent decreased 
ca2+ uptake capacity previously seen in post-ischaemic stunned SR vesicles was 
not due to a decreased ca2 + uptake rate but an increased release through 
ryanodine sensitive channels (Feher, LeBolt and Manson, 1989). This would 
imply that the ca2 + may leave the SR of the stunned heart faster than the ca2 + 
A TP-ase pumps can sequester it thus leaving the SR ca2 + depleted. Recently, 
two independent research groups reported that not only ca2 + uptake, but also 
ca2 + release from the sarcoplasmic reticulum was impaired in stunned heart 
ventricular homogenates (Hohl, Garleb and Altschuld, 1992; Davis, LeBolt and 
Feher, 1992). There is thus conflicting evidence concerning the proposal that 
excitation-contraction uncoupling occurs due to the inability of the sarcoplasmic 
reticulum to remove and/ or supply adequate ca2 + to the contractile proteins. 
Despite data showing that there is no link between tissue ATP levels and 
reperfusion stunning (Taegtmeyer et al., 1985; Kusuoka et al., 1987), the 
possibility of ATP depletion in direct proximity of the SR cannot be ruled out If 
ATP were compartmentalised in the myocyte (Bricknell, Daries and Opie, 1981), 
then inadequate ATP in direct proximity of the SR may be responsible for a 
decreased A TP-ase pump function. The SR ca2 + A TP-ase pump is responsible 
for 50-80 % of the cyclic ca2 + sequestration from the cytosol (Bers, Bridge and 
Spitzer, 1989) and may exacerbate ATP depletion induced contracture (Barry et 
al., 1987). The latter group proposed that an increase in cytosolic ca2+ (as 
occurs during ischaemia) could induce SR ca2+ loading which may hasten ATP 
depletion by activation of the A TP-ase pumps in the energy deprived myocyte 
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(Barry et al., 1987). More recently, it was also shown that the dissociation 
between reperfusion mechanical function and oxidative metabolism (Laster et 
al., 1989) could be attenuated by ruthenium red treatment of the reperfused 
isolated rat heart (Benzi and Lerch, 1992). Benzi and Lerch (1992) proposed that 
an increased energy expenditure by intracellular ca2 + transport systems may be 
involved in the mechanisms underlying the dissociation between left ventricular 
performance and myocardial oxidative metabolic rate during reperfusion. The 
importance of the SR, and its A TP-ase pumps in reperfusion stunning may 
therefore be underestimated. 
iv) Damage to extracellular collagen matrix. Although stunning occurs in 
hearts in the absence of myocyte necrosis, there is the concept that this decreased 
mechanical function may be related to damage to the extracellular collagen 
matrix which is responsible for mechanical coupling of myocytes. Collagen 
responsible for mechanical coupling between cells is disrupted and thus allows 
elasticity in the myocardial tissue (Zhao et al., 1987; Camey et al., 1989). It has 
recently become evident that although stunning can be linked to collagen 
breakdown, this breakdown is model dependent and occurred when the heart 
was subject to repeated bouts of ischaemia but not when a single ischaemic 
episode was used to induce stunning (Whittaker et al., 1989). Collagen 
breakdown during ischaemia and early reperfusion may therefore only 
contribute to reperfusion stunning when multiple ischaemic episodes are used to 
induce stunning. 
v) Decreased myofibrillar sensitivity to ca2+. As the availability of cytosolic 
activator ca2+ does not seem to be at fault (Kusuoka et al., 1990), it has been 
proposed that stunning may be due to decreased sensitivity of the contractile 
proteins to normal cytosolic ca2+ levels (Kusuoka et al., 1987; Kihara, 
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Grossman and Morgan, 1989; Allen, Lee and Smith, 1989; Marban et al., 1990; 
Hofmann, Miller and Moss, 1993). Kusuoka and co-workers (1987) found that 
the myocardium of stunned isolated perfused ferret hearts were less responsive 
to extracellular ca2 + added to the perfusate. These findings would imply that 
there is a myofilament ca2 + insensitivity in the stunned heart in the presence of 
normal cytosolic ca2 + levels. They also found that the maximal ca2 + activated 
force (Fmax) the stunned heart could generate was lower than in the normal 
heart This decrease in the Fmax of the stunned heart was later confirmed by 
Carrozza and co-workers (1992). They however report no decrease in the ca2+ 
sensitivity of the myofilaments of the stunned heart They proposed that the 
decreased Fmax observed in the stunned heart may be due to an accumulation of 
metabolites such as inorganic phosphates rather than to decrease in myofilament 
sensitivity as had previously been suggested. Numerous studies have also shown 
that positive inotropes (Becker et al., 1986; Mercier et al., 1982; Ellis et al., 1983) 
can still elicit normal and above normal myocardial contraction in the stunned 
heart which would argue against the concept that the stunned heart was 
insensitive to ca2 +. 
The major criticism of the studies on the ca2+ response of the stunned heart was 
that they were done on in vitro models. The in vivo stunned heart however also 
retains a normal contractile reserve with an elevated intracoronary ca2 + 
concentration eliciting normal contractile function in the stunned dog heart (Ito 
et al., 1987). Whatever the mechanism of decreased mechanical function of the 
heart, interventions that increase cytosolic ca2 + levels in the already stunned 
heart are able to improve mechanical function. The major problem therefore 
appears to be an impairment of ca2 + function. 
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2.5 Cytosolic ca2 + and Stunnin2. 
The measurement of intracellular ca2 + levels in the heart has been a major 
challenge to the cardiovascular scientist Since the early 1970s, when it first 
became possible to measure changes in intracellular ca2 + levels in actively 
contracting myocytes and the whole heart by bioluminescent, fluorescent and 
nuclear magnetic resonance measuring techniques (Snowdowne, Ertel and Borle, 
1985; Steenbergen et al., 1987; Koretsune and Marban, 1990; Marban et al., 1990; 
Kihara, Grossman and Morgan, 1989; Lee et al., 1988), these measurements have 
been controversial 
One of the first studies that successfully measured ca2 + levels during ischaemia 
in the intact heart was performed by Steenbergen and co-workers (1987). Using 
nuclear magnetic resonance (NMR) techniques and the ca2+ probe BAPTA 
(l,2-bis(2-aminophenoxy)ethane-N,N,N',N'-teatraacetic acid) in an isolated rat 
heart model, they showed that the cytosolic ca2 + concentration was elevated 
within 10 minutes of the onset of ischaemia. These data were later extended by 
Lee and co-workers (1987) who showed that the rise in cytosolic ca2+ was very 
rapid and occurred within 30 seconds of the onset of ischaemia in the isolated 
Indo-1 loaded rabbit heart A major weakness of these ca2 + measuring 
techniques are that especially quin-2 and F-BAPT A, buffer ca2 + and severely 
depress contractile function of the myocyte. To compensate for the ca2 + 
buffering capacity of these ca2 + indicators, some researchers have been 
compelled to use abnormally high perfusate ca2 + concentration of up to 8 mM 
(Marban et al., 1990). These high ca2+ concentrations in the perfusate may 
have significant effects on ca2 + fluxes and data obtained under these conditions 
should be interpreted with caution. Also, BAPT A measurements have to be 
performed at low temperatures (30°C) which decreases myocardial metabolic 
rate and the severity of ischaemia. 
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With the evolution of intracellular ca2 + measuring techniques, Kihara, 
Grossman and Morgan (1989) measured changes in the cytosolic ca2+ 
concentration with aequorin in intact isolated ferret hearts under conditions of 
hypoxia and true global ischaemia. Under hypoxic conditions, both diastolic 
ventricular pressure and cytosolic ca2 + levels were elevated. During ischaemia 
however, ca2 + levels increased substantially but ventricular pressure declined 
(Kihara, Grossman and Morgan, 1989). Compounds such as aequorin, a 
bioluminescent dye which emits light when bound to ca2 + is not only sensitive 
to ca2 + but also to Mg2 +, an ion the concentration of which is also elevated in 
the ischaemic myocardium. Also, aequorin has to be injected into the cell by 
methods that may alter sarcolemmal membrane integrity and permeability 
(Kihara, Grossman and Morgan, 1989). 
An early study by Lee and co-workers (1988) usmg the fluorescent ca2+ 
indicator indo-1 in the intact heart showed increases in diastolic and systolic 
ca2 + transients in the ischaemic heart. These increased light signals were 
assumed to originate from the ischaemic myocytes. This data was later 
challenged by Lorell and co-workers (1990) who showed that the endothelial 
cells of the myocardium also contain elevated intracellular ca2 + levels under 
certain conditions and could contribute to the ca2 + signal seen during normal 
and ischaemic conditions in studies using the intact heart model. Indo-1 also 
fluoresces when bound to NADH which may complicate interpretation of the 
indo-1 fluorescence signal measured under control and ischaemic conditions 
when the level of these metabolites may differ. Compounds such as Indo-1 are 
loaded into the cell in the ester form (Indo-1-AM). Incomplete intracellular de-
esterification of the AM form of Indo complicates calibration with no 
satisfactory calibration technique presently available (Lee et al., 1988). 
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A further defect of these studies is that the intracellular ca2 + levels measured in 
the intact heart are only a reflection of the levels of ca2 + in the epicardium and 
not of the presumably more ischaemic endocardium. Figueredo and co-workers 
(1993) reported a difference in the endo- and epicardial diastolic intracellular 
ca2 + levels during low flow ischaemia in the rat heart. The intracellular Ca2 + 
concentration data collected from the whole heart preparation are thus imperfect 
and may not be representative of intracellular ca2 + levels throughout the whole 
myocardium. 
More recent studies using BAPT A and NMR techniques to measure intracellular 
ca2+ levels in the ischaemic rat (Steenbergen et al., 1990) and ferret heart 
(Marban et al., 1989) confirm that cytosolic ca2+ levels, and transients rise 
during ischaemia and that intracellular ca2 + unavailability is not the cause of 
the decreased mechanical function seen in the ischaemic heart. This apparent 
myofilament insensitivity to ca2 + may be due to competitive binding between 
H + and ca2+ during ischaemia induced intracellular acidosis (Chapman, 1983, 
1984; Barry et al., 1987). 
Although there is conclusive evidence that cytosolic ca2 + levels rise during 
ischaemia, the mechanism for this increased ca2 + influx remains obscure. 
Studies using a model of simulated ischaemia in the isolated ferret ventricular 
papillary muscle preparation reported a striking rise in cytosolic ca2 + levels, 
diastolic ca2+ oscillations and ca2+ transients (Allen, Lee and Smith, 1988, 
1989). Because similar results were observed when hearts were perfused with 
high concentrations of lactic acid, they concluded that the rise in cytosolic ca2 + 
was caused by ischaemic acidosis in their model of simulated ischaemia (Allen, 
Lee and Smith, 1989). 
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Cytosolic ca2 + transients and stunning. When Fleckenstein and co-workers 
(1974) proposed that cytosolic ca2+ overload may be due to high energy 
phosphate deficiency, they speculated that ca2 + dependent A TP-ase pump 
activation during ischaemia may contribute to ATP depletion. Later studies 
showing large increases in ca2+ transients during ischaemia (Lee et al., 1987, 
1988; Lee and Allen, 1992) and reperfusion (Kusuoka et al., 1990) led some 
researchers to propose that these abnormal transients may exacerbate 
reperfusion stunning by causing ATP depletion (wastage) (Barry et al., 1987; 
Kusuoka et al., 1990) or by damaging the already jeopardised contractile 
apparatus during ischaemia. In a study of simulated ischaemia, the maximal 
amplitude of ca2 + transients during ischaemia, was approximately 339 % of the 
control value after 18 minutes ischaemia (Lee and Allen, 1992). These large 
oscillations are thought to be caused by elevated cytosolic ca2 + levels, causing 
SR ca2 + loading and spontaneous SR ca2 + release induced by intracellular 
acidosis (Orchard et al., 1987). The increased ca2+ transients (diastolic and 
systolic) seen in the reperfused, already stunned heart may also cause ATP 
wastage and contribute to the decreased mechanical function of the stunned 
heart (Kusuoka et al., 1990). 
Reperfusion, ca2 + and stunning. The net gain in tissue ca2 + on abrupt 
reperfusion has been known for many years (Jennings and Shen, 1972). 
However, despite the advances in technology, conclusive data concerning 
cytosolic ca2 + concentrations during early reperfusion and its involvement in 
reversible reperfusion injury has been elusive. 
The limited success achieved in measuring cytosolic ca2 + levels on reperfusion 
has been due to the slow response time of the cytosolic ca2 + measuring methods 
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presently available to researchers. If the concept that reperfusion may induce a 
transient increase in cytosolic ca2 + in the reversibly injured myocardium is 
correct, then measurements would have to be performed at short intervals 
throughout early reperfusion (within the first 2 minutes). Marban and co-workers 
( 1989), and Steenbergen and co-workers ( 1987) measured intracellular ca2 + 
concentrations during reperfusion but were unable to measure the cytosolic 
ca2 + concentrations within the first 2.5 minutes of reperfusion. By the time the 
first ca2 + measurement was made after 2.5 minutes of reperfusion, intracellular 
ca2+ levels had normalised (Marban et al., 1989). In 1990, Marban and co-
workers performed another study measuring reperfusion ca2 + levels during 
early reperfusion. They documented a persistent elevation in the reperfusion 
cytosolic ca2 + levels. This prolonged elevation of intracellular ca2 + levels 
during reperfusion was however only evident when perfusate ca2 + 
concentration was 8 mM (to compensate for the BAPT A induced buffering of 
ca2+) and hearts were paced throughout ischaemia (causing severe ischaemia) 
and reperfusion. In another study, simulated ischaemia of 45 minutes caused a 
large prolonged increase in cytosolic ca2 + levels and mechanical failure in 
isolated ferret papillary muscle preparation (Lee and Allen, 1992). This study 
was however dealing with simulated ischaemia and a long "ischaemic" period 
which caused reperfusion mechanical failure and does not reflect a model of true 
reversible reperfusion injury. There is thus far no direct evidence to show that 
cytosolic ca2 + levels are elevated during the first couple of seconds or minutes 
of reperfusion in the reversibly injured myocardium. 
The most direct evidence to support the role of transient ca2 + overload in 
inducing stunning was the observation that it (in the absence of ischaemia) 
induced mechanical and metabolic abnormalities similar to those seen with 
stunning (Kitikaze, Weisman and Marban, 1988). Also, electrically induced 
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ventricular fibrillation, which is associated with increased cytosolic ca2 + levels 
(Kihara and Morgan, 1991), causes contractile dysfunction (Koretsune and 
Marban, 1989). 
2.6 '1schaemia. ca2 + and Ventricular Arrhythmias. 
Historically, the earliest hypothesis to explain the ionic basis of ventricular 
arrhythmias was ischaemic potassium loss (Harris et al., 1954; Hirche et al., 
1980). Later, the role of sympathetic nerve activity and its messenger, cyclic 
AMP was investigated (Podzuweit, Lubbe and Opie, 1976; Lubbe et al., 1978) 
and in the past two decades, increased cytosolic ca2 + concentrations have been 
associated with, and implicated in the genesis of arrhythmias (Clusin 1983; 1989; 
Lee et al., 1988; Koretsune and Marban, 1989; Merillat et al., 1990; Kihara and 
Morgan 1991; Kusuoka, Chacko and Marban, 1992). 
Although ischaemic K + loss is still linked to the genesis of arrhythmias, the cyclic 
AMP theory has been somewhat controversial It has been found that forskolin, 
which increases cyclic AMP levels in the rat heart, does not increase the 
incidence of ventricular fibrillation (Manning et al., 1985). These data are further 
supported by data showing that metoprolol (a fl-blocker) decreased the incidence 
of ischaemic ventricular fibrillation without having an effect on the cyclic AMP 
levels in the ischaemic myocardium (Muller et al., 1986). Despite this 
contradictory evidence showing that there is no strict correlation between the 
incidence of arrhythmias and increases in cAMP levels, it is believed that a 
correlation between the levels of this messenger, elevated cytosolic ca2 +, and 
arrhythmias does exist (Lubbe, Podzuweit and Opie, 1992). The two ischaemia 
induced ionic changes that are still thought to play a major role in the genesis of 
ventricular arrhythmias are, 1) an ischaemia induced K+ loss, and, 2) an 
ischaemia and reperfusion induced intracellular ca2 + gain. Data presently 
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available suggests that an elevated cytosolic ca2 + concentration is the final 
common path of several arrhythmogenic mechanisms including those related to 
sympathetic nerve activity and elevated cAMP levels. 
Electrophysiolo~cal evidence for the role of ca2 + in arrhythmo~enesis. In the 
early 1970s, Ferrier, Saunders and Mendez (1973) studied the effects of 
strophanthidin (digitalis) on the action potential of the isolated canine Purkinje 
fibre (Figure 2. 7 illustrates two possible modes of action of digitalis on the fibre 
to increase ca2 +). They noticed that after cessation of a train of IO stimuli, 
strophanthidin superfusion of the fibre induced an electrophysiological 
manifestation which was called a transient afterpotential (Figure 2.8). They 
concluded that these transient afterpotentials could be the underlying mechanism 
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FIGURE 2. 7 Two possible modes of action of digitalis (strophanthidin) in 
increasing internal ca2+ concentration. By inhibiting the Na+,K +-ATP-ase 
pump, digitalis poisoning may promote intracellular Na+ loading, Na +1ca 2+ 
exchange activation and finally, cytosolic ca2+ loading. Alternatively, digitalis 
may act on its receptor, and promote (mechanism unknown) ca2 + influx across 
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FIGURE 2.8 Effect of acetylstrophanthidin (JXJ()"7gtml) on the 
transmembrane potentials of Purkinje fibres (top trace) and muscle (bottom 
trace). The first action potential is the last of a train of ten driven potentials. 
During the pause in stimulation, two transient depolarisations (or DADs) 
coupled to the last action potential occur in the Purkinje fibre but not in the 
muscle (figure reproduced from Ferrier, Saunders and Mendez, 1973). 
Transient depolarisations (afterpotentials) were subsequently given the more 
appropriate name of oscillatory afterpotentials ( OAP) and it was determined 
that ca2 + played an important role in the genesis of OAPs as the amplitude of 
these OAPs was directly related to the ca2 + concentration of the superfusion 
solution (Ferrier and Moe, 1973). Removal of extracellular ca2+ or the use of 
MnCl2 (manganese is a ca2+ channel blocker) quickly and reversibly abolished 
OAPs. In this study, they (Ferrier and Moe, 1973) suggested that the OAPs may 
be caused by a transient inward current carried by ca2+. Shortly after these 
observations were made, a strophanthidin induced oscillatory inward current 
(Tl) was linked to OAPs (Lederer and Tsien, 1975). 
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In 1985, when Ferrier, Moffat and Lukas did electrophysiological studies on 
isolated canine Purkinje fibre-papillary muscle preparations, they documented 
an ischaemia induced loss of membrane potential, shortening of action potential, 
decreased excitability, and spontaneous electrical activity. With reperfusion, 
there was an increase in the incidence of oscillatory afterpotentials and 
automaticity (and susceptibility to arrhythmias) of these papillary muscles which 
was thought to be a direct consequence of the electrophysiological changes seen 
during ischaemia. The term OAP subsequently evolved further and is at present 
better known as the delayed afterdepolarisation (DAD) (Ferrier, 1977). 
Work in our laboratory has shown that DADs could be evoked by, fast pacing, 
isoproterenol, cAMP and intracellular ca2+ injections (Coetzee and Opie, 
1987). The factor common to these stimuli is an elevated cytosolic ca2 + 
concentration. These DADs could however not be evoked during severe 
ischaemia (Coetzee and Opie, 1987; Opie and Coetzee, 1988). Based on these 
findings, they proposed that at least some ATP was necessary for ca2 + 
dependent arrhythmias to occur and that these ca2 + induced arrhythmias are 
more likely to occur during early or mild ischaemia, or during reperfusion when 
ATP levels are high enough to promote and maintain intracellular ca2 + 
oscillations. With reperfusion after severe ischaemia, ATP may be regenerated 
and may become available to the SR ca2 + A TP-ase pump for oscillatory 
intracellular ca2+ cycling (Coetzee et al., 1988). 
The mechanism underlying DADs is the ca2 + dependent transient inward 
current (Iti)(Figure 2.9). It is proposed that the rhythmic internal ca2+ 
oscillations cause rhythmic switching on and off of the transient inward current 
which presents as delayed afterdepolarisations after the normal action potential. 
46 
In ventricular muscle, delayed afterdepolarisations are a gross 
electrophysiological abnormality which can lead to triggered automaticity and 
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FIGURE 2.9 Ventricular myocytes were voltage clamped from a holding 
potential of -55 m V to a test potential of -5 m V using rectangular voltage pulses 
with a duration of 500 msec. When the pipette filling solution contained 0.5 mM 
EGTA, the /ti was elicited within 3 minutes after changing over to an 
extracellular solution of 0.54 mM K+ and 5.4 mM ca2+ (reproduced from 
action potential traces recorded by Dr WA Coetzee and published in Opie and 
Coetzee, 1990)). 
Later studies showed beyond doubt that delayed afterdepolarisations are 
associated with reperfusion arrhythmias (Priori et al., 1988), and that neither 
delayed afterdepolarisation, nor the transient inward current occurs without 
intracellular ca2+ oscillations (Berlin, Cannell and Lederer, 1989; Boutjir, El-
Sherif and Gough, 1990). It has also been found that both caffeine and ryanodine 
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given during ischaemia in the dog model decreased the incidence of DADs and 
triggered activity (Boutjir, El-Sherif and Gough, 1990), providing further 
evidence to show that DADs are related to intracellular ca2+ oscillations 
between the SR and the cytosol. Figure 2.10 is a diagrammatic summary of the 
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FIGURE 2.10 Cell ca2+ and arrhythmias. Assuming that intracellular ca2+ 
does increase during ischaemia, there are a number of potential mechanisms by 
which the ca2 + current could be arrhythmogenic: ( a) ca2 + influx might elicit 
slow responses; (b) an additional increase in cytosolic ca2+ could activate 
oscillatory inward current flow and precipitate DADs; (c) if the ca2+ activation 
of this inward current were sustained, then accelerated depolarisation might 
increase injury current across the ischaemic boundary and precipitate 
.fibrillation; (d) through promoting depolarisation and increasing the coupling 
resistance between cells, a raised cytosolic [Ca2+] might also slow conduction 
and increase the likelihood of reentry. ca2+ entry blockers should be effective 
against the effects of a gain of intracellular ca2+ resulting from enhanced 
ca2+ entry through the ca2+ channels (figure reproduced from Opie et al., 
1988). 
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Indirect evidence for the role of intracellular ca2 + oscillations in 
arrhythmo~enesis. In a study investigating the possible role of abnormal cytosolic 
ca2 + levels in the genesis of arrhythmias, it was seen that acidosis, in the 
absence of ischaemia could induce spontaneous ca2 + release ( and thus diastolic 
ca2+ oscillations) from the SR in isolated papillary muscles (Orchard et al., 
1987). This group concluded that ischaemia induced acidosis could increase the 
spontaneous release of ca2 + from the ca2 + loaded SR, increase diastolic ca2 + 
oscillations and the incidence of spontaneous action potentials, and may thus 
promote arrhythmias in the ischaemic heart Data obtained with the isolated 
ferret papillary muscle under conditions of simulated ischaemia, also show that 
an mcrease in the incidence of spontaneous cytosolic ca2 + oscillations 
corresponds well with the period in ischaemia during which ischaemic 
arrhythmias are most frequent (Lee and Allen, 1992). 
Indirect evidence from our laboratory also suggests that abnormal intracellular 
ca2 + oscillations between the sarcoplasmic reticulum and the cytosol may play a 
role in the genesis and perpetuation of both ischaemic and reperfusion 
arrhythmias (Figure 2.11 ). Thandroyen and co-workers ( 1988), showed that both 
ryanodine and caffeine could decrease the incidence of arrhythmias in the rat 
heart model These compounds, known to act on the SR ca2 + release channel to 
prevent Ca2 + release from the sarcoplasmic reticulum may decrease or 
eliminate these oscillations that may play a role in the initiation or perpetuation 
of ca2 + induced arrhythmias. 
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FIGURE 2.11 A possible sequence of events occurring in normal, ischaemic, or 
reperfused myocardial cells. In each case, a schematic representation of the 
myocardial cell and the sarcoplasmic reticulum is shown. In the bottom panel, 
action potentials are illustrated along with the hypothetical changes in the 
intracellular ca2 + concentrations. Note that in severe ischaemia, although the 
internal cytosolic ca2 + rises, ca2 + flux in and out of the sarcoplasmic 
reticulum is inhibited, and therefore oscillatory lti cannot develop. On the other 
hand, sustained inflow of current via lti leads to increased depolarisation, which 
enhances the difference between the ischaemic and non-ischaemic zones and 
predisposes to arrhythmias. With reperfusion, when ATP becomes available, and 
ca2+ fluxes in and out of the sarcoplasmic reticulum are resumed, an 
oscillatory /ti can develop at the lower postulated intracellular ca2 + 
concentration and arrhythmias dependent on DADs may be provoked (figure 
reproduced from Opie et al., 1988). 
More recently, Thandroyen and co-workers (1991), investigated the effect of 
elevated extracellular ca2 + concentrations in the perfusate on intracellular 
ca2 + levels in isolated myocytes, and found that elevated extracellular ca2 + 
concentrations caused an elevation in intracellular ca2 + and lead to 
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spontaneous ca2+ oscillations during diastole (Thandroyen et al., 1991). These 
spontaneous oscillation were characteristic before the initiation of spontaneous 
arrhythmia-like activity in these cells. In these cells, ryanodine could inhibit 
membrane potential oscillations that were characteristic of the transient inward 
current This data was substantiated by Kihara and Morgan (1991) who measured 
I 
intracellular ca2 + transients before and during electrically induced ventricular 
fibrillation and found that increased diastolic ca2 + transients (oscillations) 
preceded the initiation of ventricular fibrillation. Also, ryanodine could decrease 
these oscillations and the susceptibility of the heart to ventricular fibrillation. 
Thus, not only elevated cytosolic ca2 + levels, but also augmented ca2 + 
oscillations may contribute to the initiation and perpetuation of certain types of 
arrhythmias. 
A role for free radicals in the genesis of ischaemic and reperfusion arrhythmias 
was proposed by Manning and co-workers (1984; 1988) who showed that 
allopurinol (xanthine oxidase inhibitor) decreased the incidence of reperfusion 
arrhythmias from 67 to 11 %. Although various subsequent studies have 
confirmed this data and presented conclusive evidence for the role of free-
radicals in arrhythmogenesis (Riva, Manning and Hearse, 1987; Bolli et al., 
1988b; Bolli et al., 1989; Bernier, Manning and Hearse, 1986; Hearse and Tosaki, 
1987) this aspect of reperfusion injury falls beyond the scope of this study and 




HYPOTHESIS UNDER TEST. 
3. 1 Evolution of Concepts in our Laborator_y Leadin2 to the Hypothesis 
that ca2 + Contributes to Arrhythmo2enesis and Stunnin£. 
After early observation indicating that catecholamine stimulation increased the 
vulnerability of the heart to ventricular fibrillation (Hoffman et al., 1955), and 
those linking coronary artery ligation to activation of the adrenergic system, 
(Karlsberg et al., 1979), researchers in our laboratory performed extensive 
studies aimed at elucidating the possible mechanisms causing myocardial 
ischaemic and reperfusion arrhythmias. At this stage, several studies showed that 
administration of norepinephrine could elicit arrhythmias (Lubbe et al., 1978; 
Opie et al., 1980; Podzuweit, 1980), while beta-receptor blockade administration 
protected against arrhythmias (Muller et al., 1986) in the ischaemic heart in a 
number of animal models. 
In 1978 Podzuweit and co-workers linked the ischaemic elevation of cAMP to 
ventricular fibrillation. Subsequently, various researchers in our laboratory 
studied the effects of acute regional myocardial ischaemia on the baboon and 
isolated rat heart model (Podzuweit, Lubbe and Opie, 1976; Lubbe et al., 1978; 
Opie, Na than and Lubbe, 1979) from which the cyclic AMP hypothesis evolved 
According to this hypothesis, cyclic AMP, the second messenger of the 
adrenergic system, plays a key role in the mediation of the adrenergic effects on 
vulnerability to fibrillation. 
This hypothesis was based on the following: i) Podzuweit and co-workers, 1978, 
and others (Opie, Nathan and Lubbe, 1979) noted an increase in cAMP levels 
prior to the development of ventricular fibrillation in the baboon and pig model 
respectively, and ii) Lubbe and co-workers (1979, 1981, 1983) found that 
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suppressing the increases in ischaemic cAMP levels with propranolol, 
amiodarone or labetalol prevented the ischaemia induced decrease in ventricular 
fibrillation threshold in the isolated rat heart model 
After a relation between cellular levels of cAMP, ca2+ mediated inward current 
and electrical excitability had been established (Watanabe and Berch, 1974), it 
was proposed that ca2 + may be involved in arrhythmogenesis. Thandroyen, 
(1982) and Lubbe, McLean and Nguyen (1983) started investigating the possible 
protective . effects of ca2 + antagonists against arrhythmias and found that 
verapamil prevented a decrease in the ventricular fibrillation threshold in the 
isolated rat heart model 
Electrophysiological evidence for the role of ca2 +: The next series of 
studies performed in our laboratory were electrophysiologic and were aimed at 
trying to establish whether a ca2 + current caused delayed afterdepolarisations 
(DADs) as proposed by Janse (1980). Saman, Coetzee and Opie (1988) found 
that DADs could be exacerbated by dibutyryl cAMP and isoproterenol under 
control conditions but not during ischaemia in isolated papillary muscle 
preparation. DADs were again precipitated on reperfusion, which was 
interpreted as an indication that DADs are ATP dependent and only occur 
during mild ischaemia or during reperfusion (Coetzee and Opie, 1987). 
After these successful studies investigating the possible role of ca2 + in 
ischaemic and reperfusion arrhythmias, Coetzee and co-workers ( 1990) 
investigated the possible role of oxygen derived free radical in reperfusion 
arrhythmias. Their data using the isolated guinea pig papillary muscle, showed 
that the time course of electrophysiological changes induced by free-radical 
generating systems are slow. Based on this data showing that free-radical 
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generating and scavenging systems, when used in their preparation, had no effect . 
on arrhythmias, they concluded that it is unlikely that free-radicals are a prime 
cause of early reperfusion arrhythmias. They felt that the mechanism of early 
reperfusion arrhythmias was more likely to be a ca2 + sensitive process with 
free-radicals mediating delayed membrane changes. 
These studies presented good evidence for a role for ca2 + but not free-radicals 
in the genesis of reperfusion arrhythmias. We subsequently proposed that 
abnormal ca2 + fluxes at the onset of reperfusion may, in conjunction with 
oxygen derived free radicals contribute to reperfusion stunning and arrhythmias. 
3.2 Aim of the Study. 
The purpose of this study was to obtain a better understanding of the role of 
ca2 + and the sources contributing to ischaemic and reperfusion ca2 + overload 
and reperfusion injury. Although measurements of intracellular ca2 + levels 
would indicate whether ca2 + levels are elevated during reperfusion, the slow 
response time of present ca2 + measuring techniques prevents one from 
measuring intracellular ca2 + levels from the onset of reperfusion. Also, these 
measurements would not elucidate the origin, or the entry pathways which 
contribute to this increase in cytosolic ca2+ levels. For our investigation looking 
at the possible contribution of transient intracellular ca2 + overload to 
reperfusion injury, we therefore chose to manipulate cellular ca2 + fluxes with 
pharmacological compounds specific to certain channels, pumps and exchangers. 
These interventions were usually made before ischaemia, or during reperfusion 
in an attempt to modulate transsarcolemmal and intracellular ca2 + fluxes 
during ischaemia or at the onset of reperfusion. 
In order to achieve this, we endeavoured to manipulate ischaemic and 
reperfusion induced intracellular and transsarcolemmal ca2 + fluxes by: 
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1) Altering reperfusion transsarcolemmal ca2+ fluxes with a) fl-receptor 
stimulants, ca2 + channel agonists, ca2 + channel antagonists or an endogenous 
peptide, endothelin, orb) indirectly, by Na+ /H + exchange inhibition. 
2) Altering intracellular ca2 + fluxes between the sarcoplasmic reticulum (SR) 
and cytosol with SR ca2 + release channel blockers or, SR ca2 + A TP-ase pump 
inhibitors (Figure 3.1 ). 
The end points to these studies were the severity of reperfusion stunning, the 
incidence of ventricular arrhythmias, and various biochemical parameters which 
will be described and discussed in the following chapters. 
I te I Bay K 8844 nlaoldlplne aopro reno @ - - -8 /._ 
~.,.,.:, / oatooholoml-
Ca.. ti! ca•· at 






FIGURE 3.1 Diagrammatic representation of the cell, the pharmacologic 
compounds used, and their mode of action on the respective channels, pumps and 
exchangers in the hean. 
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CHAPTER4 
EXPERIMENTAL MODEL, MATERIALS AND METHODS 
4.0 The Isolated Rat Heart Model. 
The isolated rat heart model was used to study the effects of interventions aimed 
at modulating ca2 + fluxes during ischaemia and/ or at the onset of reperfusion 
on the severity of reperfusion stunning and the incidence of arrhythmias after 
regional or global ischaemia. The apparatus used was first described by 
Langendorff (1895), and later modified by Neely and co-workers, (1967) (Figure 
4.1 ). The system consists of two parts; the Langendorff perfusion side, used to 
perfuse the heart in a retrograde fashion, and the working heart side used to 
perfuse the heart in the working heart mode. 
Animal used: Male Long-Evans rats weighing 250-350 grams and fed a standard 
rat chow diet were used for all experiments performed in this study. All animals 
received care in compliance with the "Principles of Laboratory Animal Care" 
formulated by the National Society for Medical Research and the "Guide for the 
Care and Use of Laboratory Animals" prepared by the National Academy of 
Sciences and published by National Institutes of Health (NIM Publication No. 
80-23, revised 1978). 
i) Langendorff model. 
Rats were anaesthetised by diethyl ether inhalation, heparinised with 200 IU of 
' 
heparin injected into the femoral vein, and the hearts were removed rapidly and 
plunged in cold (4°C) Krebs-Henseleit buffer for transfer to the perfusion 
apparatus. Arrest was induced to afford the hearts maximal protection during the 
brief ischaemic episode during transfer to the perfusion apparatus. The aorta was 
cannulated and perfusion re-established within I minute of excision from the 
donor animal Normothermic Krebs-Henseleit buffer was oxygenated with 95 % 
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02 and 5 % CO2 (to a p02 of more than 550mmHg) and filtered through 
cellulose filters (0.8µm pore size), before being allowed to flow retrogradely into 
the aorta at a pressure of 100 cmH20. The pulmonary artery was incised to allow 
free drainage of the coronary effluent Hearts were maintained at 37°c 
throughout the experiment by surrounding them with a water jacketed chamber 
maintained at this temperature. The Langendorff perfusion apparatus was used; 
1) to allow the heart to stabilise at the beginning of the experiment and to initiate 
reperfusion of the heart after ischaemia and, 2) when regional ischaemia was 
induced to promote ischaemic and reperfusion arrhythmias during the 
arrhythmia studies. 
Working Heart Circuit Langendorff Reservoir 
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FIGURE 4.1, A diagrammatic representation of the Langendorf! and working 
hean preparation used in this study. 
ii) Working heart model. 
In order to measure mechanical functional and metabolic recoveries of the heart 
and evaluate the severity of reperfusion stunning, the working heart model was 
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used. For the working heart preparation, the left atrium and aorta were 
cannulated and atrial perfusion (the preload) was maintained at a perfusion 
pressure of 20 cmH20 while the afterload was 100 cmH20. Perfusate 
temperature was again maintained at 37°C. 
Under normal working heart conditions, the left atrium ejects the perfusate to 
the ventricle which then pumps the crystalloid perfusate through the aortic 
cannula 
To monitor left ventricular pressure, the left ventricle was cannulated using 
Abbocath 20G drip administration needles (Abbott, Kent, UK.). To the needle 
was attached a Stratham Gould P23ID pressure transducer and a Lectromed 
Multitrace 2 chart recorder (Lectromed Limited, Rue Fondon, St Peter, Jersey 
Channel Islands, USA.) to monitor the pressure throughout the experiment 
In the Langendorff perfused rat heart, mechanical function was evaluated using a 
left ventricular "Clingfilm" balloon. The balloon was inserted into the left 
ventricle via the atrium, inflated to a diastolic pressure of 4-8 mmHg and 
attached to the Stratham Gould P23ID pressure transducer and Lectromed chart 
recorder. 
Unless otherwise specified, hearts were paced at 5 Hz (300 bpm) for the entire 
experiment except during ischaemia and the first 2 minutes of reperfusion using 
a Grass S88 stimulator (Grass Medical, Quincy, Massachusetts, USA) and two 
platinum pacing electrodes placed at the base of the left ventricle. Pacing from 
the onset of reperfusion invariably induced reperfusion tachycardia and/ or 
fibrillation and early pacing was therefore avoided. Pacing pulse width was 
maintained at 0.2 msec, and voltage at 2-5 volts. 
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For all experiments performed to determine functional parameters before and 
after ischaemia, left ventricular pressure, aortic flow, coronary flow and cardiac 
output was determined and compared with pre-ischaemic values. Aortic output 
and coronary flow were measured manually. 
4. 1 Exclusion Criteria: failed experiments. 
In the pre-ischaemic control period, hearts were evaluated and those not 
satisfying certain minimum requirements, were excluded. These were:-
Aortic outputs< 40 ml/min. 
Coronary flows> 22 ml/min. 
Heart rates below 200 beats/min., or irregular rhythm. 
In the post-ischaemic reperfusion period, hearts that had coronary flow rates 
higher than 50 % of the aortic output, were excluded. These high values were 
normally indicative of a left atrial or an aortic leak 
4.2 Perfusion Solution Used. 
Standard perfusion solution: A modified Krebs-Henseleit buffer (mmol/1 
NaCl-118.5, NaHC03-25, KCl-4.75, KH2P04-l.l8, MgS04-l.19, CaCl2-1.25, 
glucose-11), aerated with a carbogen mixture of95%02 and 5%C02 was used to 
perfuse the hearts at 37°C. The buffer was made up from stocks solutions daily. 
To avoid precipitation of the ca2+, all solutions were first aerated with the 
carbogen mixture before the CaCl2 was added. Solutions were filtered through 
5.0 µ.m and 0.8 µ.m (Millipore Corporation, Bedford, MA, USA) cellulose filters 
before use. 
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Modified solutions used during early reperfusion. When reperfusion 
solutions contained high cation concentrations which tended to precipitate with 
bicarbonate, a modified Hepes buffered Tyrode's solution was used to replace 
the Krebs-Henseleit buffer. (mmol/L NaCl 137, KCl 5.4, Hepes buffer 10, 
MgCl2 0.5, c.acli-1...25.. and glucose 10). This solution was gassed with 100% 02. 
4.3 Experimental Protocol used for Reperfusion Mechanical Function 
Studies. 
For all experiments performed to determine reperfusion function after brief 
ischaemia, the same protocol was employed. 
Hearts were mounted on the perfusion apparatus, allowed a 10 minute 
equilibration period in the Langendorff mode and then made to work in the 
working heart mode. Hearts were made to work for 10 minutes and function 
measured at 5 and 10 minutes. Hearts subjected to pre-ischaemic drug treatment 
were treated in the Langendorff mode for 2-5 minutes before being made 
globally ischaemic for 20 minutes at 35-37°c. Hearts subjected to the drug at 
reperfusion were reperfused with the drug in the Langendorff mode for 2 
minutes after which drug infusion was stopped and pacing engaged for 3 minutes 
before the working heart mode was again employed (Figure 4.2). Hearts were 
made to work for 10-30 minutes after switching to the working heart mode, and 
mechanical function was monitored. 
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FIGURE 4.2 Experimental protocol used during studies for this thesis. 
Interventions were made before ischaemia (25 minutes), at the onset of 
reperfusion (45 minutes) or late in reperfusion (60 minutes). 
Model for induction of re~onal ischaemia in arrhythmia studies, 
For studies in which ischaemic and reperfusion arrhythmias were to be induced 
and documented, a model of regional ischaemia was employed. The left anterior 
descending coronary artery was ligated using a 3-0 Ti-cron suture (Davis & Geck, 
Wayne, NJ, USA). This procedure reduced coronary flow by a minimum of25% 
and about 35 % of the left ventricle was rendered ischaemic (Lubbe, Daries and 
Opie, 1978). Electrocardiograph (ECG) electrodes were attached to the aortic 
cannula and the right ventricle and the incidence of ischaemic and reperfusion 
arrhythmias were monitored by means of an electrocardiogram on a Lectromed 
Multitrace 2 chart recorder. 
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4.4 Parameters Evaluated. 
To evaluate reperfusion recovery, mechanical, metabolic and morphological 
parameters were measured. In this study, mechanical function recovery was the 
most important parameter to evaluate the severity of reperfusion injury. 
A. Haemodynamic parameters. 
Because the majority of experiments were performed using paced hearts, the 
heart rate was consistent and thus had no effect on cardiac output (CO) or aortic 
outputs (AO) values. 
Coronary flow (CF) was measured and used in conjunction with aortic output to 
give the CO values. 
CO= AO+ CF. 
Left ventricular developed pressure (LVDP) was measured using the left 
ventricular cannula in the working heart preparation, and the left ventricular 
balloon in the Langendorff preparation. L VDP was obtained by subtracting the 
diastolic pressure from the systolic pressure. 
L VDP = systolic pressure - diastolic pressure. 
Values (AO or CO) obtained in the post-ischaemic working period were 
expressed as a percentage of their individual pre-ischaemic values and presented 
as a % recovery. 
% AO or CO recovery= reperfusion AO or CO x 100 
pre-ischaemic AO or CO 
In all cases, drug treated groups of hearts were performed with a concurrent 
control group for comparative purposes. 
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B. Metabolic parameters. 
Tissue extraction procedure: Hearts were freeze clamped with Wollenberger 
clamps pre-cooled in liquid nitrogen and freeze dried for 24 hours in a Christ 1-4 
freeze drier ( Osterode /Harz, Germany). Freeze dried tissue (20 mg) was added 
to 1.2 ml 6 % perchloric acid and homogenised for approximately 20 sec (while 
on ice) with a Polytron homogeniser (Luzern, Switzerland). The extracts were 
then spun down in a Sigma 202MK centrifuge at 5000 RPM and 4°C for 10 
minutes, and the supernatant separated and neutralised with Tris/KOH buffer to 
a pH of 7.0. Universal indicator was used to determine the neutral pH. The 
sample was again spun at 5000 rpm and the supernatant removed. The sample 
was now ready for cAMP, ATP and PCr assays. All compounds were assayed 
enzymatically by spectrophotometry or with the use of radioimmunoassay kit 
Standards, internal standards and blanks were included in every assay. 
i) ATP and CP (PCr). 
The ATP and CP of samples from heart tissue were determined according to the 
method of Lamprecht and Trautschold (1963) based on the breakdown of 
glucose to form glucose-6-phosphate (G-6-P). 
Creatine phosphokinase 
CP + ADP-------> ATP+ creatine 
Hexokinase 
ATP+ Glucose-----> ADP+ G 6-P 
Glucose 6-phosphate dehydrogenase 
G 6-P + NADP---> 6 PGA + NADPH+ +-H+ 
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The following cocktail was used: 
Stock 
MgCI2 1 mol/1 
Tris 0.2 mol/1 
NADP 1 % (w/v) 
Glucose 100 mmol/1 
Dist H20 
Sample 
Enzymes used were: 
G6PDH 1 mg/ml 
HK 10 mg/ml 
ADP lOmM 
CK lOmg/ml 







0.2 ml sample and 5 µl G6PDH was added to 2.8 ml cocktail per cuvette. The 
extinction at 340 nm was read with a Beckman DU-7 Spectrophotometer 
(Beckman Instruments Inc., Irvine, California). 5 µl hexokinase was added to 
each cuvette, and the extinction at 340 nm read after 10 minutes when stable. 
The difference m optical density was obtained and used to calculate ATP 
concentration. 
(o OD- blank)/0.414 * F = µmol/gm dried weight 
F = the dilution factor taken into consideration with the neutralising of the Tris 
buffer. 
F=[l.2ml(PCA) x total volume]/wt (g) 
Total volume = neutralising volume + 5 µl Universal indicator. 
For the determination of CP (PCr) levels, 0.05 ml of ADP was added to the 
cuvette. After 10 minutes, a reading was taken at 340 nm. This was taken as the 
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baseline reading of PCr. CK was added the cuvette allowed to stand for 20-30 
minutes and the absorbance read. PCr values were again calculated using the 
formula given above. 
The tissue high energy phosphate levels were expressed as µmol / gm fresh 
weight Vahies obtained for freeze-dried tissue were divided by a factor of 5 to 
obtain their wet weights: 
Although high-performance liquid chromatography has gained favour over 
enzymatic techniques for the determination of tissue high energy phosphate 
levels, we chose to use enzymatic methods in this study. Previous published 
(Victor et al., 1987) and unpublished data from our laboratory has shown that 
high energy phosphate levels obtained using these two measuring techniques are 
highly comparable. 
ii) Cyclic AMP. 
Cyclic AMP ( cAMP) was measured by the method described by Tovey and co-
workers (1974). This competitive protein binding assay is based on the following 
principles: 
If a stable compound A is introduced into a system which contains a constant 
amount of radioactive compound A* and is binding to protein P, A will displace 
A* from the protein binding sites, in proportion to its concentration. 
* * P + A <------> PA (labelled complex) 
P + A <------> PA (unlabeled complex) 
The amount of radioactivity bound in the labelled complex decreases as the 
amount of unlabeled compound is increased. Cyclic AMP in the sample and a 
fixed quantity of tritium labelled cAMP compete for binding to a protein with 
high specificity and affinity for cyclic AMP. The amount of labelled cAMP -
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protein complex formed is inversely proportional to the amount of labelled cyclic 
AMP in the sample. The unbound nucleotide is removed by a precipitation 
reaction using activated charcoal A supernatant, containing the bound 
nucleotide is obtained by centrifugation and removed for scintillation counting. 
A standard curve is constructed. Co/Cx is plotted against concentration of cyclic 
AMP in the standard dilutions. Co: labelled nucleotide bound in the absence of 
unlabeled nucleotide. Cx: labelled nucleotide bound in the presence of a 
standard quantity of unlabeled nucleotide. 
Assay kits were obtained from the Radiochemical Center, Amersham, England 
and contain: Tris/EDTA buffer; purified bovine muscle protein; (8-3H) cyclic 
AMP; cyclic AMP standard and charcoal absorbent 
iii) Endothelin. 
Sample collection: Coronary effluent samples were collected in containers 
spiked with dipotassium ethylene diamine tetra-acetic acid (EDTA) and triton 
XIOO (TTX) to give a final concentration of approximately 5 mmol/1 and 0.5 %, 
respectively. Samples were frozen at -70°c until processed. The entire perfusate 
was loaded onto pre-conditioned (3 ml methanol, 5 ml water) Sep-Pak C1g 
cartridges (Waters Ass., Milford, MASS, USA), and endothelin was eluted with 2 
ml 60 % acetonitrile in 0.1 % trifluoroacetic acid yielding a recovery of 57-67 %. 
All endothelin-like immunoreactivity levels were corrected for a mean recovery 
of 60 %. The eluates were freeze-dried and the dry residue stored at -20°c 
pending analysis. Since the residue was redissolved in 0.5 ml of assay buffer (see 
below), the coronary effluent samples were concentrated 60 to 200 times. 
Columns were reused after extensive washing with methanol and water. 
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Endothelin determination: Endothelin (ie, endothelin-1, -2, and -3) of coronary 
effluents was measured using a commercial endothelin-2 (human) 
radioimmunoassay (RIA) kit (RIK 6910, Peninsula Laboratories, Belmont, CA, 
USA) and following established methods with slight modifications (Cemacek 
and Stewart, 1989; Kohno et al., 1990). Samples were reconstituted in 0.5 ml 
phosphate buffer containing 19 mmol/1 NaH2P04, 81 mmol/1 Na2HP04, 50 
mmol/1 NaCl, 0.1 % BSA, 0.01 % NaN3, and 0.1 % TTX (pH 7.4). Duplicate 
samples were used in the assay. Standard curves were constructed using 
endothelin-2 to give a range of 0.25 to 16 pg/tube. Samples and standards (100 
µl) were incubated with 100 µl assay buffer containing polyclonal anti-
endothelin-2 antibody for 22 to 26 hours at 6°c before adding 100 µl of assay 
buffer containing 1251-Endothelin-2 (specific activity approximately 1,000 
Ci/mmol, 10,000 cpm/tube). The antiserum was diluted 3.5-fold, resulting in a 
fourfold increase in sensitivity compared to undiluted serum. The vortexing and 
incubation steps were repeated. Aliquots of buffer (100 µl) containing undiluted 
goat anti-rabbit antibody and normal rabbit serum, respectively were added to 
each tube and incubated at 6°c overnight Upon addition of 500 µl assay buffer 
(0.2 % BSA), bound and free radioactivity were separated by centrifugation at 
3,500 rpm for 25 minutes. The supernatant was removed by aspiration and the 
pellet counted for 1251 in a gamma counter. To determine the amount of 
immunoreactive endothelin, the value of specific binding (total binding minus 
non-specific binding) was determined from the standard curve using a logistic fit 
Total binding in the absence of competing endothelin amounted to 23.5±3.3 % 
and non-specific binding to 3.2±0.5 % (n=6). The IC50 was 1.9±0.28 pg/tube. 
The limit of detection was 0.81±0.13 pg/tube. Since all samples were highly 
concentrated, most concentrations to be measured were higher than the IC50-
The intra-assay coefficient of variation was determined by chromatography of 20 
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ml of perfusate spiked with 2 pg endothelin-2 and was 7.7 % (n=3) and the inter-
assay coefficient of variation in two consecutive runs was 13.0%. 
Endothelin-1 (human, porcine; synthetic), endothelin-2 (human; synthetic) and 
endothelin-3 (human, rat; synthetic) were obtained from Sigma Chemical 
Company (St Louis, Mo, USA). Foetal calf serum was from Highveld Biological 
Ltd, Kelvin (South Africa). The peptides were dissolved in perfusion medium 
with 0.1 % BSA or RIA buff er as appropriate to prevent loss due to non-specific 
adhesion, aliquoted, freeze-dried and stored at -20°c. 
iv) Electrolyte composition and pH of arterial and coronary effluent 
samples. 
Aortic and venous samples were taken at predetermined times, placed on ice and 
immediately analysed in an AMDEV Lytening 6 electrolyte analyser (Danvers, 
Massachusetts) and a Instrumentation Laboratory 1302 blood gas analyser 
(Milan, Italy). Electrolyte concentrations were presented in mmol /L 
C. Arrhythmias. 
Ischaemic and reperfusion arrhythmia studies were performed using the 
Langendorff perfused rat heart model. Electrocardiograms were recorded 
throughout the ischaemic and reperfusion period to monitor the incidence of 
ventricular arrhythmias. Two electrodes were used; one attached to the aortic 
cannula and the other placed superficially into the right ventricle. The electrode 
was so placed to avoid damage to coronary vessels. Recordings were made on a 
Lectromed Multitrace 2 chart recorder. 
Criteria for arrhythmias. Ventricular tachycardia was defined as 3 or more 
consecutive morphologically similar ventricular extrasystoles. These 
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extrasystoles were usually associated with a sharp rise in left ventricular diastolic 
pressure. 
Ventricular fibrillation was defined as more than 6 consecutive ventricular 
complexes showing total irregularity of morphology. This pattern was associated 
with a loss of left ventricular pressure generation and mechanical failure (Lubbe, 
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FIGURE 4.3 Electrocardiogram (ECG) and left ventricular pressure (L VP) 
trace showing the reperfusion phase in a control heart. Pressure trace changes 
clearly show the occurrence of VT with a sharp increase in diastolic pressure 
while the transition to VF was marked by the complete loss of left ventricular 
developed pressure. 
In experiments where we were interested in reperfusion arrhythmias and 
mechanical function, fibrillating hearts were allowed 15 sec in ventricular 
fibrillation in which to spontaneously revert to normal sinus rhythm. Failing this, 
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hearts were defibrillated by submersion in ice cold (±4°C) Krebs-Henseleit 
buffer for 3-5 sec. 
4.5 Characteristics of the Isolated Rat Heart Model. 
A. Advantages of the model. 
1) The model is not prone to hormonal and homeostatic changes that are 
operative in the intact animal and that may influence mechanical function and 
vulnerability of the heart to arrhythmias. 
2) The model is not subjected to prolonged anaesthesia which may cause changes 
in blood pressure, heart rate, and mechanical function of the heart 
3) This model allows precise control of the perfusion solution composition and 
concentrations of drugs and substrates being used, and is less prone to 
fluctuations in perfusion conditions often experienced with more complicated in 
vivo models. 
4) The rat is small, cheap to obtain and accommodate and freely available. 
5) Haemodynamic parameters such as the preload and/or afterload of the 
perfusion system can be altered, and their effects on aortic output, coronary flow 
and ventricular pressure monitored. 
6) The model is also suitable for investigating biochemical and metabolic profiles 
before ischaemia, during ischaemia, and during reperfusion. 
B. Disadvantages of the model 
1) The crystalloid perfusate does not contain the essential amino acids and 
protein components present in blood and may therefore only be a suitable 
substitute for blood for a relatively short period Hearts subject to prolonged 
periods of isolated crystalloid perfusion are prone to a deterioration in 
mechanical function. 
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2) The isolated heart is devoid of autonomic nerve control and data obtained 
under these conditions should be interpreted with caution. 
3) The hearts perfused with a Krebs-Henseleit buffer, have unphysiologically 
high coronary flows due to the absence of haemoglobin and the low viscosity of 
the solution. 
4) These hearts have no peripheral circulation and/ or collateral flow. 
4.6 Development of a model of stunning. 
A. Mechanical studies: To establish a model of stunning, a senes of 
experiments using different ischaemic times thought to induce reversible 
ischaemic damage were performed. Twenty minutes global ischaemia at ±35°c 
caused prolonged post-ischaemic dysfunction. Subsequent experiments were 
performed in which hearts were exposed to 20 minutes ischaemia at ±35°c, 
reperfused, and aortic output, coronary flow and left ventricular developed 
pressure monitored over 2 hours. A concurrent control group was perfused for 
the same period without being exposed to ischaemia. 
Mechanical evidence for stunning: Hearts exposed to 20 minutes ischaemia 
were perfused for two hours after reperfusion to determine whether the function 
would return to normal. There was a gradual increase in the cardiac output of the 
reperfused heart with a maximal value ( +85 % of the pre-ischaemic value) being 
reached after about an hour of reperfusion (Figure 4.4 ), after which the function 
again started to deteriorate. Perfusion of non-ischaemic working hearts also 
resulted in a gradual decline in the cardiac output When the hearts were 
perfused for up to two hours, the function of the stunned and the control hearts 
appear to decline at approximately the same rate, in a parallel fashion (Table 
4.1). 
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FIGURE 4.4 Line graph represents two groups of heans perfused for 120 
minutes following ischaemia. Control he ans were perfused for 25 minutes in the 
working mode and then switched to Langendorf/ mode for 20 minutes, while the 
ischaemia group was subjected to 25 minutes perfusion followed by 20 minutes 
ischaemia. Beans were now switched to work mode and mechanical function was 
monitored for 120 minutes. 
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TABLE 4.1 Pre-ischaemic and reperfusion coronary flow (ml/ min)( CF), 
aortic output (ml/min)(AO), cardiac output (ml/min)(CO), developed 
pressure (mmHg)(DP) aortic output recoveries (%)(AO REC) and cardiac 
output recoveries (%)(CO REC) of non-ischaemic control hearts(A) and time 
matched ischaemic hearts(B). 
A. CQntrQI nQn-is~ha~mi~ h~arts 
Initial observations 
CF AO co DP AO REC COREC 
15.6 45.1 60.7 82.4 - -
0.5 2.3 2.6 3.8 - -
2Qmin 15.6 44.0 59.6 80.4 97.7 98.3 
0.5 2.0 2.4 3.4 2.3 1.7 
4Qmin 15.5 41.7 57.2 79.0 92.9 94.7 
0.6 1.7 2.6 2.7 3.0 2.2 
6Qmin 15.6 39.5 55.1 76.7 87.8 90.9 
0.5 1.6 1.8 2.3 2.5 1.8 
8Qmin 15.6 36.9 52.5 74.3 81.6 86.4 
0.5 2.3 2.5 2.1 2.4 1.8 
IOOmin 15.1 35.6 50.7 74.3 78.6 83.6 
0.3 2.3 2.3 2.4 3.0 2.0 
B. MQd~l (20min Qf tQtal glQbal is~ha~mi~) 
Pre-ischaemic 
CF AO co DP AO REC CO REC 
16.2 47.1 63.3 79.1 - -
0.9 2.2 2.7 5.0 - -
Reperfusion 
2Qmin 16.2 36.1 * 52.3 * 74.4 74.1 ** 82.7 
** 
0.9 2.0 2.1 5.1 1.4 2.3 
40min 16.5 39.7 56.2 76.0 82.4 * 88.8 
0.5 1.8 2.6 4.3 1.6 2.0 
6Qmin 16.6 40.0 56.6 76.3 83.2 89.0 
1.2 2.7 3.4 4.3 3.0 2.4 
8Qmin 16.6 39.1 55.7 75.0 82.9 87.5 
1.2 2.8 3.5 4.5 2.9 2.1 
IOOmin 17.0 37.1 54.1 77.7 76.1 83.2 
0.3 4.1 5.1 5.4 5.6 4.4 
Values are means+ SEM for n=7 for panel A. and n=8 for panel B. 
~ Cardiac output recoveries reach control values after 60 minutes, and 
aortic outputs recoveries reach control values after 80 minutes. 
* p< 0.05 vs control 
** p<0.002 vs control 
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B. Morphological studies: One of the important provisos in the definition of 
reperfusion stunning is that the reperfused myocardium must be entirely viable 
(Bolli, 1990). Bolli ( 1990) goes as far as to say that stunning is relatively mild, 
sublethal injury that must be kept quite distinct from myocardial infarction. In 
order to determine whether the reperfused hearts we were dealing with were 
indeed stunned and not infarcted, we did a series of experiments in which we 
performing ultrastructural studies. The objective was to determine whether the 
ultrastructural changes observed at the end of ischaemia and during reperfusion 
were similar to those defined by Schaper and co-workers (1979) and Jennings 
and co-workers ( 1985). These ultrastructural changes which are characteristic of 
reversibly injured myocytes are discussed in chapter 2 of this thesis. 
At predetermined stages (immediately before ischaemia, at the end of ischaemia, 
and after 20 minutes reperfusion) of the experimental protocol, hearts were fixed 
for transmission electron microscopy by perfusion with 1 % glutaraldehyde in 
sodium cacodylate buffer (0.1 M, pH 7.4) for 5 minutes. After removal from the 
cannula, the heart was sectioned transmurally, and lmm3 samples were fixed in 
osmium tetroxide, dehydrated, and embedded in ERL resin (Harper, Williams 
and Lochner, 1990). 
Ultrastuctural evidence of stunning: After perfusion fixation, electron 
microscopy showed that the myocardium had developed intracellular oedema, 
swollen mitochondria, and loss of mitochondrial granules during ischaemia. 
There was no obvious myofibrillar damage. After 20 minutes of reperfusion, 
oedema was absent, and the myofibrils were relaxed with no signs of 
mitochondrial abnormalities. There were extremely few necrotic myocytes, not 
more than 1 % of the total. (Figures 4.5 and 4.6) 
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~ 
FIGURE 4.5 Ultrastructural detail from a subendocardial region showing the 
effects of 20 minutes of global ischaemia. Note the slight intracellular oedema 
(a"ows), swollen mitochondria and loss of mitochondrial granules. No obvious 
myo.fibrillar damage is visible. 
Bar= lµm. 
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FIGURE 4.6 Normal ultrastructure from the subendocardial region of a hean 
reperfused for 20 minutes following global ischaemia. Note the relaxed 
myo.fibrils and the absence of oedema. Mitochondria have a compact appearance 
and contain normal dense granules (a"owed). 
Bar= lµ.m. 
C. Response of the model to inotropic interventions: To determine whether 
the already stunned hearts in our model were able to respond to inotropic 
interventions, we performed 3 groups of experiments in which we subjected 
already stunned hearts to isoproterenol (lo-7M)(a 6-receptor stimulant, 
Winthrop), Bay K 8644 (10-8M) (a ca2+ agonist, Bayer), or high extracellular 
ca2 + concentrations (2.25mM) 15 minutes after reperfusion. 
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Inotropic response of the stunned heart: Isoproterenol 15 minutes after 
reperfusion increased AO from 15.9±2.1 to 66.7±2.3 ml/min (n=8), Bay K 8644 
increased AO from 33.6±2.1 to 52.0±2.8 ml/min (n=5), and an increase in 
extracellular ca2+ (2.25 mM) increased CO from 26.3±2.1 to 39.4±1.8 ml/min 
(n =7)(Figure 4. 7). 
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FIGURE 4.7 Histogram presenting aortic outputs (AO) of hearts under control 
conditions (filled column), during pre-ischaemic inotropic stimulation (cross-
hatched column), stunned after ischaemia (grid-patterned column), and stunned 
and inotropically stimulated (cross-hatched column). Hearts were treated with 
isoproterenol, Bay K 8644 or 2.25mM ca2+. 
When isoproterenol, Bay K 8644, or forskolin were used in the late reperfusion 
of the already stunned heart, the expected positive inotropic response was 
obtained without significant negative effects on the post-treatment mechanical 
function. Aortic output values similar to the values obtained in the pre-ischaemic 
(untreated) hearts were achieved during inotropic treatment of these hearts. 
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These data are supported by the work done by Mercier and co-workers (1982), 
Taegtmeyer and co-workers (1985), and Becker and co-workers (1986) who 
showed that the already stunned heart still had the ability to respond to inotropic 
interventions. 
Reservations and benefits of the model of stunnin~ used in these studies: 
Although the in vivo coronary occluded dog heart model is considered the classic, 
model of myocardial stunning (Heyndrickx et al., 1975), the simpler isolated 
ferret (Kusuoka et al., 1987; 1990), rabbit (Ambrosio et al., 1987) and rat heart 
(Nayler, Buckley and Leong, 1990; Steenbergen, Fralix and Murphy, 1993) model 
has been used Despite controversy regarding the suitability of the isolated heart 
as a model of stunning, isolated hearts reperfused after transient ischaemia 
exhibit complete normalisation of phosphocreatine content and pH (Taegtmeyer 
et al., 1985; Porterfield et al., 1987; Ambrosio et al., 1987), indicating that 
viability is generally preserved. Despite the fact that reversibility of contractile 
abnormalities cannot be verified, the metabolic recovery of these hearts suggests 
that the injury is mostly nonlethal (Bolli, 1990). Bolli (1990) concludes that 
despite numerous obvious differences from ischaemia in vivo, isolated heart 
preparations can mimic myocardial stunning under selected circumstances. 
The failure of the working heart to maintain normal mechanical function after 
some hours may be due to the composition of the perfusion solution which 
differs in many ways from blood, for example by not containing amino acids. 
Furthermore, the abnormally high coronary flow of the crystalloid perfused heart 
may by the hydraulic or erectile effect (Vogel et al., 1982) place an excess 
workload on the myocardium. However, an advantage of the crystalloid 
perfusion preparation is the absence of neutrophils, which may play a role in 
certain models of reperfusion injury. In addition, the isolated heart model 
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eliminates the possibility that peripheral effects of certain drugs may complicate 
the interpretation of the results. 
4. 7 Statistical Methods. 
The results are presented as a mean ± standard error of the mean (SEM). 
Significances between groups was determined using the unpaired Student's t-test 
When multiple comparisons were made, the Bonferroni correction or ANOV A 
test were made. 
The Fisher's exact test was used to assess the significance of the differences in 




EXPERIMENT AL DAT A 
CHAPTER 5. 
Reperfusion Stunnina:: Its Modulation by Agents Altering ca2 + Flux at the 
Onset of Reperfusion 
a) Rationale. 
This study tested the hypothesis that a reduction in ca2 + flux across the 
sarcolemma and/ or the sarcoplasmic reticulum at the onset of reperfusion could 
attenuate subsequent mechanical stunning. 
Although stunning may be lessened by pretreatment with ca2 + antagonists 
(Nayler, Buckley and Leong, 1990), these results may reflect amelioration of the 
severity of ischaemic injury and hence, less reperfusion injury (Opie, 1989b; 
Manning and Hearse, 1984). A specific role for ca2+ overload is suggested by 
three observations. First, transient ca2 + overload induced by perfusing the 
isolated heart with a high ca2 + perfusate results in contractile dysfunction and 
ATP depletion (Kitikaze, Weisman and Marban, 1988). Second, during 
ventricular fibrillation there is an increase in intracellular ca2 + concentration 
with subsequent contractile dysfunction in the post-fibrillating period (Koretsune 
and Marban, 1989). Third, measurement of cytosolic ca2 + in the stunned rat 
heart show high ca2+ transients (Kusuoka et al., 1990) Nonetheless, data are 
conflicting in that Ito and co-workers ( 1987) found that an increased external 
ca2 + improved the mechanical function of the stunned dog myocardium. 
Catecholamine stimulation, a procedure which should increase cytosolic ca2 + 
levels, is also able to overcome the mechanical impairment in the canine heart 
(Mercier et al., 1982; Ellis et al., 1983b). 
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The major hypothesis tested in this study was that transient ca2 + overload at the 
onset of reperfusion could give rise to stunning. An additional hypothesis was 
that once stunned, the myocardium behaved as if there were a deficiency of 
Ca2 + available to the contractile apparatus, so that at this stage the mechanical 
function could be improved by agents thought to enhance cytosolic ca2+_ To 
determine whether ca2 + fluxes at the onset of reperfusion could be modulated 
to exaggerate or attenuate stunning, we subjected isolated hearts in the first 2 
minutes of reperfusion to procedures thought to increase ca2 + influx (high 
extracellular ca2 +, isoproterenol, forskolin, or the ca2 + agonist Bay K 8644) or 
to inhibit ca2 + flux, (low external ca2 +, nisoldipine or ryanodine, or inorganic 
blockers Mn2 + or Mg2 +). We also subjected hearts already stunned to some of 
these procedures 15 minutes after reperfusion. 
b) Experimental procedures. materials and methods. 
i) Model Used: The model and the perfusion solutions and protocol are as 
described in chapter 4. 
Myocardial temperature during ischaemia: In this study, hearts were 
subjected to 20 minutes of total global ischaemia at 35 ±0.5 °c before being 
reperfused at 37°c for 5 minutes in the Langendorff mode. During total global 
ischaemia the myocardial temperature decreased to 30°c unless the temperature 
of the water-jacket surrounding the heart was increased to 40-42°C ( depending 
on the ambient temperature). During the first 2 minutes of reperfusion, the 
different pharmacologic compounds were infused ( again at 37°C) or the ionic 
composition of the reperfusion solution was altered with the aim of modulation 
of ca2 + flux across the sarcolemma or sarcoplasmic reticulum. Thereafter, the 
standard perfusion medium was used again, free of any such changes (For a 
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diagrammatic representation of the experimental protocol, see Figure 4.2 of 
chapter 4). 
ii) Interventions in the initial 2 minutes of reperfusion: Each of the following 
series of experiments had its own group of concurrent controls. 
a) Varying ( 1.25-10.0 mM) ca2 + concentrations in a Tyrode's reperfusion 
solution. 
b) Reperfusion with isoproterenol (lo-7 M), forskolin (lo-8 M) or Bay K 
8644 (lo-8 M) was investigated. 
c) Hearts were reperfused with low Ca2+ (0.75 mM), nisoldipine (lo-8 M) 
(Bayer, Germany) or ca2 + channel blocking cations (magnesium 16 mM 
or manganese 2 mM), or ryanodine 3x10-9 M (Calbiochem). 
d) Hearts were reperfused with a high K+ concentration (21 mM) solution 
to maintain arrest because asystole itself (as seen with Mn2+ and Mg2+) 
might be protective. The effect of each of the two ca2 + blocking cations 
added to this high K + containing solution was also investigated. The effects 
of a low K + (2mM) concentration in the reperfusion solution was also 
tested. 
iii) Additional interventions: 
a) Hearts were pre-treated with nisoldipine or with ryanodine given over 2 
minutes before the onset of ischaemia. 
b) Post-ischaemic stunned hearts were treated with nisoldipine (lo-8 M) 15 
minutes after reperfusion for 2 minutes and cardiac output was measured at 
the end of the 2 minutes and then again after an 8 minute washout period. 
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c) Results 
Haemodynamic data: There was a linear relationship between cardiac output 
and developed pressures. There were no significant changes in coronary flow 
between the various groups of hearts. Changes in heart rate during mechanical 
function measurements were avoided by electrical pacing (Figure 5.1 ). 





IBC AEMIA REPERFUSION 
FIGURE 5.1 Diagrammatic representation of a typical left ventricular pressure 
tracing recorded during an experiment. On the left is the pre-ischaemic systolic 
and diastolic left ventricular pressure tracing (measured in millimeters of 
mercury), followed by ischaemia and reperfusion (in the Langendorf! [Lang] 
mode) and then post-ischaemic work. 
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i) Changes in early reperfusion ca2+ concentration: With increases (above 1.25 
mM) in the extracellular ca2 + concentrations of the early reperfusion solution 
there was a dose dependent decrease in post ischaemic functional recovery 
(Figure 5.2). CO recovery was 82.3±1.8% (n=8) with a ca2+ concentration of 
1.25 mM, 76.1 ±2.8 % (n =9) with a ca2 + of 3. 75 mM with a further decrease to 
56.3±3.7% (p< 0.05) (n=7) with a ca2+ concentration of 10.0 mM. 
Haemodynamic parameters ( aortic output, coronary flow and developed 
pressure) are presented in Table 5.1. 
ii) Inotropic intervention in early reperfusion: Figure 5.2 shows that 
isoproterenol in the reperfusion solution gave CO recoveries of 53.4±3.6 % 
(p<0.05) (n=8) which were similar to those reperfused with a ca2+ 
concentration of 10.0 mM. Forskolin decreased CO recoveries from 80.9±0.9 % 
(control) (n=7) to 62.7±2.4% (p<0.002) (n=8). Bay K 8644 added in the 
reperfusion period decreased CO recovery from 66.72±2.4% (n=4)(control) to 
43.4±5.9% (p<0.05) (n=6). 
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FIGURE 5.2 Cardiac output expressed as % recovery of pre-ischaemia values 
for heans initially reperfused with Tyrode's solution containing varying ca2+ 
concentrations or Krebs-Henseleit with one of the inotropes (cross-hatched 
columns). Mechanical function measurements were done JO minutes into the pre-
ischaemia work period and again 10 minutes into the post-ischaemia work 
period. For each group of experiments performed, there was a concurrent control 
group of hearts [Ca2+-J.25mMJ (filled columns). 
* p<0.05 treated vs control. 
** p<0.002 treated vs control. 
iii) ca2 + anta~onists in early reperfusion: The use of a lower (0. 75 mM) 
extracellular ca2 + concentration in the reperfusion solution resulted in 
improved CO recoveries of 91.8±0.8 % (p< 0.05) (n=6) (control 79.2±2.6% ), 
while the reperfusion with nisoldipine gave a CO recovery of 99.0±2.8 % (p< 
0.002) (n=8) (control 82.11±2.0%) (Figure 5.3). Manganese or magnesium 
added to the reperfusion solution improved CO to 88.9±2.4% (p< 0.05) (n=8) 
and 91.9±1.4% 
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(p< 0.002) (n=6) respectively in companson with the control value of 
75.4±2.6 % (n= 10). Ryanodine in the reperfusion solution resulted in CO 
recoveries of 103.6± 1.8 % (p<0.002) (n= 15). Haemodynamic parameters for 
hearts reperfused with these ca2 + flux modulators are presented in Table 5.2. 
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FIGURE 5.3 Cardiac output recoveries expressed as a % of the pre-ischaemia 
values for heans reperfused with low ca2+, a ca2+ antagonist, a SR ca2+ flux 
modulator or ca2+ channel blocking cation (cross-hatched columns) and their 
controls (filled columns). Function measurements were done 10 minutes into the 
pre-ischaemia work period and again 10 minutes into the post-ischaemia work 
period. 
* p<0.05 treated vs control. 
** p<0.002 treated vs control. 
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TABLE 5.1 Post-ischaemic aortic outputs, coronary flows and developed 
pressures for different reperfusion solutions. 
Reperfusion Aortic Coronary Developed 
solution output(ml/min) flow(ml/min) pressure( mm Hg) 
ca2+ [3.75mM] 34.9+2.7 17.8+1.2 83.2+2.9 
n=9 
Control 29.8+2.3 17.2+0.6 77.2+ 1.2 
n=6 
Isoproteren ol 14.5±2.3 18.2±0.9 60.4±0.9 
n=8 
ca2+ [lOmM] 18.0±2.9 15.7±0.7 59.3±3.1 
n=7 
Control 29.8±2.3 17.1 ±0.6 67.2±1.6 
n=6 
Forskolin 21.4± 1.7 16.2±0.4 71.3± 1.2 
n=8 
Bay K 8644 16.1 ±3.7 17.1 ±0.6 70.3± 1.5 
n=6 
Control 34.3± 1.4 16.9±0.6 75.0±1.2 
n=7 
Table 5.1 represents hearts (with controls) reperfused with ca2+ agonists or 
inotropes in the early reperfusion solution. All control groups were reperfused 
with a reperfusion solution containing a ca2 + concentration of 1.25mM. 
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TABLE 5.2 Post-ischaemic aortic outputs, coronary flows and developed 
pressures for different reperfusion solutions. 
Reperfusion Aortic Coronary Developed 
solution output(ml/min) flow(ml/min) pressure( mm Hg) 
Ryanodine 43.6+ 1.9 17.9+0.8 94.3±2.0 
n=l5 
Control 37.3±2.8 18.3± 1.7 92.0±4.1 
n=6 
Nisoldipine 46.0±2.8 17.2±0.9 97.4±2.0 
n=8 
Control 34.4±3.9 17.2±1.1 93.0±0.1 
n=8 
LowCa2+ 43.5±2.4 20.7± 1.3 86.0±1.6 
n=6 
Control 29.4±2.1 15.5±0.5 74.5±1.7 
n=8 
Mn2+ 37.4± 1.4 15.5±0.6 82.1 ± 1.8 
n=8 
Mg2+ 38.7± 1.8 18.7±0.3 79.3± 1.0 
n=6 
Control 26.8± 1.4 16.0±0.3 69.9±2.5 
n=lO 
Table 5.2 represents hearts (with controls) reperfused with ca2 + antagonists 
in the early reperfusion solution. All control groups were reperfused with a 
reperfusion solution containing a ca2+ concentration of 1.25mM. 
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iv) Effect of a low or a high potassium concentration in the reperfusion solution 
to~ether with ca2+ channel blocking cations: (Figure 5.4) A low potassium 
concentration in the reperfusion solution decreased reperfusion CO recovery 
from 74.7+3.4% (n=6) to 60.49+1.1% (p< 0.05) (n=IO). A high potassium 
concentration (21 mM) in the reperfusion solution gave CO recoveries of 
62.6+6.9% (n=7) compared to the control values of 74.7+3.4% (n=6). Addition 
of Mg2 + or Mn2 + to a high potassium containing reperfusion solution improved 
post-ischaemic CO recoveries from a control value of 75.8+2.8 % to 91.0+2.0% 
(p< 0.002) (n=6, Mg2+ +K+ group) and 92.3+ 1.3 % (p< 0.002) (n=ll, 
Mn2+ +K+group). 
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FIGURE 5.4 Cardiac output recoveries expressed as a % of pre-ischaemia 
values for heans reperfused using a low or high potassium concentration or high 
potassium in conjunction with one of the ca2+ channel blocking cations 
(function was measured 10 minutes into the work period before and after 
ischaemia). 
* p<0.002 treated vs control. 
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vi) Additional interventions. 
a) The effect of internal or external ca2 + blocker pre-treatment: Ryanodine 
gave CO recoveries of 97.5+ 1.8% (p<0.002) (n=ll) and nisoldipine 84.8+5.1 % 
(n=6) compared to control values of 82.3+ 1.8 % (n=8) and 82.1 +2.0% (n=8). 
b) ca2+ antagonist added to the already stunned heart: (Figure 5.5) Nisoldipine 
in late reperfusion (after 15 minutes) decreased cardiac output from 47. 7 + 1.8 to 
39.3+2.4 ml/min (n=6). This decrease in cardiac output was reversed on 
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FIGURE 5.5 Decreased cardiac output with late ca2+ antagonist treatment 
(with nisoldipine) of the isolated rat heart. Cardiac function reverts to normal on 
washout (removal from perfusate) of the antagonist. 
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Summary of findings of study. 1) Increased cytosolic ca2 + overload at the 
onset of reperfusion by compounds that increase trans-sarcolemmal ca2 + 
fluxes, exacerbates reperfusion stunning. 
2) Compounds that decrease reperfusion trans-sarcolemmal ca2+ influx or 
release from the SR decreases the severity of stunning. 
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CHAPTER6 
The Na+ /H + Exchanger and its Role in Reperfusion Stunning and 
Arrhythmias. 
a) Rationale. 
It is proposed that a rise in cytosolic ca2 + during ischaemia and especially 
during reperfusion contributes toward reperfusion injury (Nayler, Poole-Wilson 
and Williams, 1979; Poole-Wilson et al., 1984; Jennings, Reimer and 
Steenbergen, 1985; Kusuoka et al., 1987; Steenbergen et al., 1987; Kitikaze, 
Weisman and Marban, 1988; Opie and Coetzee, 1988; Marban et al., 1989; 
Marban, 1991a; 1991b; Opie, 1991c; Chapter 3). There is good evidence that the 
increase in total tissue ca2 + content during reperfusion is closely correlated to 
functional and morphological damage (Nayler, 1983; Tani, 1990; Steenbergen et 
al., 1990). Alternatively, a transient rise in cytosolic ca2 + during reperfusion 
may cause reversible injury in the form of depressed mechanical function and 
arrhythmias. This concept is supported by the data showing that interventions 
that limit trans-sarcolemmal ca2 + ion fluxes during reperfusion, also improve 
mechanical function (Chapter 5) and lessen arrhythmias (Opie and Coetzee, 
1988). 
Hypothetically, ca2 + may enter reperfused cells via ca2+ channels (Chapter 5), 
or through trans-sarcolemmal passive influx along the concentration gradient, or 
indirectly via activity of the Na+ /H + exchanger and consequently that of the 
Na+ /Ca2+ exchanger (Tani and Neely, 1989; Dennis et al., 1990; Murphy et al., 
1991; Karmazyn, 1988). Recent evidence also suggests that Na+ may enter the 
cell via the pathologically modified Na+ -channels during ischaemia, activate 
Na+ /Ca2 + exchange during reperfusion, and thus also contribute to ca2 + 
overload (Ver Donck and Borgers, 1991). 
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Pretreatment by amiloride decreased reperfusion mechanical stunning in the 
isolated Langendorff perfused rat heart (Tani and Neely, 1989; Murphy et al., 
1991; Scholz et al., 1992). Amiloride derivatives more specifically inhibiting 
Na+ /H + exchange, decreased ischaemic (Karmazyn, 1988) and reperfusion 
arrhythmias (Dennis et al., 1990). There is therefore indirect evidence for the 
role of Na+ /H+ exchange in reperfusion injury. 
The aim of the present study was to compare the effects of potent and very 
specific Na+ /H+ exchange inhibitor, HOE 694 (Schmid et al., 1992) with those 
of amiloride, an established inhibitor of this exchanger in the heart (Tani and 
Neely, 1989; Dennis et al., 1990). The end points of our study were reperfusion 
stunning and arrhythmias in the isolated rat heart model. We also wished to 
ascertain whether the protective effect afforded by amiloride was purely due to 
its Na+ /H + exchange inhibitory properties or to its various nonspecific 
properties. Because amiloride decreases the rise in cytosolic ca2 + 
concentrations during ischaemia (Murphy et al., 1991), it is possible that some of 
the effects previously found could be due to limitation of ischaemic damage 
thereby lessening reperfusion injury (Opie, 1989b). We therefore also tested both 
reperfusion and pretreatment by amiloride or HOE 694 for effects on 
reperfusion stunning and arrhythmias. 
b) Experimental procedures, materials and methods. 
i) Models used. 
Isolated perfused (working, or Langendorff-mode aortic perfused) rat hearts 
were subject to global ischaemia and reperfusion (Neely et al., 1973). 
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During experiments using the Langendorff model, left ventricular developed 
pressure was used as an index of mechanical function. For these experiments an 
ultra-thin "Clingfilm" balloon was inserted into the left ventricle through the 
mitral valve and inflated to a diastolic pressure of 4-8 mmHg (Qiu and Hearse, 
1992). 
ii) Experimental protocols 
1) Experimental protocol used for the workin~ heart model: The protocol was as 
described in chapter 4 with the exception that hearts were exposed to 20 minutes 
of total global ischaemia at an epicardial left ventricular temperature of 
36.5 +0.5°C. 
During the last 5 minutes of perfusion before ischaemia (pre-treatment), or for 
the first 2 minutes of the 5 minutes Langendorff reperfusion, one of the 
Na+ /H + exchange inhibitors or the vehicle used to dissolve the compound 
(placebo) was infused into the heart. When hearts were reperfused with 
inhibitors, the standard perfusion medium was used for the remainder of the 
experiment after the initial 2 minute drug infusion. Reperfusion mechanical 
function was assessed in the work mode for 30 minutes. 
2) Experimental protocol used for Lan~endorff model: Hearts were perfused in 
the Langendorff mode for 20 minutes (while left ventricular pressures were 
recorded). Hearts were treated with amiloride for 5 minutes before being made 
ischaemic for a further 30 minutes. The 30 minute ischaemic period was selected 
to match the ischaemic time used by Tani and Neely (1989) in their experiments 
using the same model and concentrations of amiloride during pretreatment 
Hearts in this series were now reperfused for 30 minutes and mechanical 
function (left ventricular pressure) monitored. These hearts were not paced. 
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Developed pressure and heart rate were used to calculate the stroke-work index 
(SWI) before and after ischaemia. The SWI recovery was expressed as a 
percentage of the pre-ischaemic SWI value. 
SWI=Developed pressure X Heart rate. 
% RECOVERY of SWI = (Reperfusion SWI)XlOO 
(Pre-ischaemic SWI) 
iii) Coronary effluent collection: Effluent samples were collected from 0-15 sec, 
from 15-30 sec, from 30-60 sec and from 60-120 sec after the initiation of 
reperfusion. These and an aortic sample were immediately analysed on an IL 
1302 blood-gas analyser (Instrumentation Laboratory, Milan, Italy.) to determine 
p02, pC02, and pH and an AMDEV Lytening 6 electrolyte analyser (Danvers, 
Massachusetts, USA) to measure coronary effluent Na+, K+ and ca2+. 
iv) Reperfusion arrhythmias: During the first 2 minutes of reperfusion, a left 
ventricular pressure trace was recorded (chart speed of lOmm/sec) to monitor 
the incidence of ventricular tachycardia (VT) and/ or ventricular fibrillation 
(VF) (For definitions, see chapter 2). 
v) Materials: Amiloride was obtained from Sigma Chemicals (St Louis, 
Missouri), while the HOE 694 was supplied by Hoechst AG (Frankfurt, 
Germany). Amiloride was dissolved in dimethyl sulfoxide (DMSO) (highest 
concentration used was 0,1 % V /V) and the HOE 694 was soluble in deionised 
water. Both compounds altered perfusate pH which required correction of the 
stock solution when fresh solutions were made up every day. 
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c) Results 
1) Effect of HOE 694 and amiloride pretreatment on reperfusion function and 
arrhythmias in hearts with left atrial cannulation. 
HOE 694. After 30 minutes reperfusion, AO recoveries were 36.0+3.8% (5) for 
control hearts and 56.5 + 2.6 % (5) (p<0.05) for hearts treated with 10-8M HOE, 
38.5+3.6% (5) for control hearts and 50.6+3.9% (7) (p<0.05) for hearts treated 
with 10-7M HOE, and 38.2+2.4% (5) for control and 52.9+2.7% (5) (p<0.05) 
for hearts treated with 10-6M HOE (Figure 6.1). There was thus no dose 
dependent effect 
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FIGURE 6.1 Histogram showing aonic output (AO) recoveries (as a percentage 
of their pre-ischaemic value) after 10, 20 and 30 minutes reperfusion in heans 
pretreated with HOE 694 (10-6 to 10-BM) and their control groups. 
HOE=HOE 694. 
* p<0.05 vs control. 
** p<0.02 vs control. 
Pretreatment by HOE 10-8M had no effect on the incidence of reperfusion 
arrhythmias. HOE 10-7M decreased the incidence of reperfusion VT from 80% 
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(controls) to 14% (p<0.05) and VF from 60% to 0% (p<0.05). With 10-6M 
pretreatment, the incidence of VT was decreased from 80 % to O % (p<0.05) and 
the incidence of VF decreased from 40 % to O % (p =ns ). Although not significant, 
10-7 and 10-6M HOE decreased the average time in VF from 70.7+46.1 sec to 0 
sec at both concentrations (Figure 6.2). 
Control (14) 
HOE 10-8 (6) 
HOE 10-7 (7) 
HOE 10-8 (6) 
Control (20) 
HOE 10-8 (8) 
HOE 10-7 (11) 
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FIGURE 6.2 Horizontal histogram showing average time in reperfusion 
ventricular tachycardia (VT) and I or ventricular fibrillation (VF) for groups of 
heans pretreated (for 5 minutes before ischaemia) or reperfused (for initial 2 
minutes) with vehicle (control) or one of three concentrations of HOE (10-6 to 
10-BM). In order to simplify figures, control data was pooled. 
()=number of heans per group. HOE=HOE 694. 
VT= Ventricular tachycardia. VF= Ventricular fibrillation. 
NSR=Normal sinus rhythm. 
* p<0.05 vs control. ** p<0.002 vs control. 
Amiloride. Two concentrations of amiloride were selected to serve as a 
reference for the new compound we tested. We used 10-3M, effective in 
protecting from reperfusion stunning the Langendorff perfused rat heart (Tani 
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and Neely, 1989). We also used amiloride 10-5M, which is anti-arrhythmic in the 
Langendorff model (Dennis et al., 1990). Pretreatment of the working heart with 
10-3M amiloride did not protect the heart against reperfusion stunning (Figure 
6.3). 
Only the lower concentration of amiloride oo-5M) given as pretreatment was 
effective in decreasing stunning. After 30 minutes reperfusion, AO recoveries for 
10-5M were 41.6+2.7% (6) for control and 55.8+4.0% (6) (p<0.05) for treated 
hearts. 
Only the higher concentration of amiloride (lo-3M) given as pretreatment was 
effective in decreasing the incidence of reperfusion VT and VF. Both amiloride 
concentrations used decreased the average time in VT and VF but did not 
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FIGURE 6.3 Histogram showing aonic output (AO) recoveries (as a percentage 
of the pre-ischaemic value) after 10, 20 and 30 minutes reperfusion of heans 
pretreated with amiloride JO-3M or 10-5 Mand their control groups. 
AMIL =Amiloride. 
* p<0.05 vs control. 
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Control (12) 
Amil 10-8 (7) 
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FIGURE 6.4 Horizontal histogram showing average time in ventricular 
tachycardia (VT) and !or ventricular fibrillation (VF) for groups of hearts 
pretreated (for 5 minutes before ischaemia) or reperfused (initial 2 minutes) with 
vehicle (control) or one of two concentrations of amiloride oa-3 or Ja-5 M). In 
order to simplify figures, control data was pooled. 
()=number of hearts in the group. 
AMIL=Amiloride. 
VT= Ventricular tachycardia. 
VF= Ventricular fibrillation. 
NSR=Normal sinus rhythm. 
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TABLE 6.1 Incidence of reperfusion arrhythmias (VT and VF) after 
pretreatment of the working heart with amiloride or HOE 496 for 5 minutes 
before the onset of ischaemia. 
Pretreatment VT VF 
Control 4/5 4/5 
Amiloride 1 o-3M 1 /7* 0/7* 
Control 5/6 4/6 












HOE 10- M 2/5* 1/5 
* p<0.05 
VT= Ventricular tachycardia. 
VF= Ventricular fibrillation. 
Incidence expressed as a number of hearts developing the arrhythmia out of 
the total number of hearts perfused. 
2) Effect of HOE 694 and amiloride added during the reperfusion period in 
hearts with left atrial cannulation. 
HOE 694. The same three concentrations of HOE were used in the reperfusion 
solutions. At 10-7M, AO recoveries were 42.4+ 3.8 % (6) for control hearts and 
65.4+5.5 % (l l)(p<0.05) for treated hearts after IO minutes reperfusion, 
41.0+ 1.3 % for control hearts and 67.1 +3.7% (p<0.002) for treated hearts after 
20 minutes, and 36.4+ 1.2 % for control and 62.4+3.2 % (p<0.002) for treated 
hearts after 30 minutes reperfusion (Figure 6.5). 
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FIGURE 6.5 Histogram showing aortic output (AO) recoveries (as a percentage 
of the pre-ischaemic value) after 10, 20 and 30 minutes reperfusion with HOE 
694 (10-6 to 1a-8M) added only during the initial 2 minutes of reperfusion 
phase. 
HOE=HOE 694. 
* p<0.05 vs control. 
** p<0.002 vs control. 
HOE reperfusion decreased the incidence of reperfusion VF and VT in the 
treated hearts when compared with the controls. The most effective 
concentrations were 10-7 and 10-8M (Figure 6.2). HOE reperfusion also 
decreased the average time in VF dramatically compared with the control group. 
Amiloride. Reperfusion with amiloride (lo-3M or 10-5M) offered no protection 
against reperfusion stunning in the working heart but 10-5M did decrease the 
incidence of reperfusion VT from 100 to 28 % (p<0.05) and VF from 60% to O % 
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(p<0.05). Average time in VF was also reduced by both amiloride concentrations 
used in reperfusion (Figure 6.4 and Table 6.2). 
TABLE 6.2 Incidence of reperfusion arrhythmias durin~ post-ischaemic 
reperfusion of working heart using either one of the Na /H + exchange 
inhibitors in the reperfusion period only (first 2 minutes). 
Reperfusion VT VF 
Control 4/6 3/6 
Amiloride 10-3M 2/6 1/6 
Control 5/5 3/5 
Amiloride 10-5M 2/7* 0/7* 
Control 
6 6/6 3/6 HOE 10- M 5/8 0/8 
Control 
7 6/6 4/6 HOE 10- M 2/11* 1/11* 
Control 
8 7/8 4/8 HOE 10- M 0/10** 0/10* 
* p<0.05 ** p<0.002 
For definitions of VT, VF and incidence of arrhythmias, see Table 5.1. 
3) Coronary effluent electrolyte composition: Coronary effluent electrolyte 
compositions were similar in control and treated hearts. During the early (first 
15 sec) reperfusion phase, coronary effluent Na+ and K + concentrations 
increased and pH values were decreased but normalised within the first minute 
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FIGURE 6.6 Line graph showing Na+ and K + efflux from heans pretreated 
with HOE 694 (10-6M). The broken line represents Na+ and the solid line K + 
concentrations in coronary effluent during the first 2 minutes of reperfusion. 
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FIGURE 6.7 Line graph showing coronary effluent pH (solid line) and ca2+ 
concentration (broken line) in the first 2 minutes of reperfusion of heans 
pretreated with HOE 694 (J(T6M). 
4) Lan"endorff perfused hearts and amiloride pretreatment: 
Langendorff perfused hearts recovered well when pretreated with 10-3M 
amiloride. In this case, hearts subjected to 30 minutes ischaemia were protected 
from reperfusion stunning. Post-ischaemic mechanical recoveries were 59+ 1 % 
for control and 74+4% (p<0.05) for treated hearts after 30 minutes reperfusion 
(for data at 10 and 20 minutes see Figure 6.8). 
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FIGURE 6.8 Histogram showing recovery of stroke work index (SWI) after JO, 
20 and 30 minutes reperfusion of Langendorf/ perfused heans pretreated with 
amiloride (JV-3M). 
* p<0.05 vs control. 
Summary of the findin&s of study. 1) HOE 694 in very low concentrations 
decreased reperfusion stunning and arrhythmias in the rat heart model. 
2) Activity of the Na+ /H + exchanger plays a role in reperfusion stunning 
and arrhythmias. 
3) Although HOE 694 protected the working heart against reperfusion 
stunning either when given before ischaemia or upon reperfusion only, 





Attenuated Reperfusion Stunning with Inhibitors of the ca2 + A TP-ase 
Pump of the Sarcoplasmic Reticulum 
a) Rationale. 
While both cytosolic ca2+ overload (Kusuoka et al., 1987; Marban et al., 1989; 
Opie, 1989a; Marban et al., 1990; Marban 1991a; Chapter 5) and increased 
formation of oxygen derived free-radicals (Myers et al., 1985; Przyklenk and 
Kloner, 1986; Bolli et al., 1990) have been implicated in the genesis of 
reperfusion stunning, it is now recognised that these mechanisms are not 
mutually exclusive (Opie, 1989b; Hearse, 1991a). Therefore compounds or 
procedures that interfere with ca2 + ion increases in the early reperfusion period 
may diminish reperfusion stunning. Thus far, it has been shown that, 1) increased 
intracellular ca2 + oscillations (increased amplitude of ca2 + transients) occur in 
reperfused, stunned hearts (Kusuoka et al., 1990), ·and that 2) ryanodine, which 
inhibits abnormal intracellular ca2+ oscillations (Kihara and Morgan, 1991) 
decreases the incidence of arrhythmias (Thandroyen et al., 1988; Kihara and 
Morgan, 1991) and attenuates stunning (Chapter 5). 
Hypothetically, part of the excess cytosolic ca2+ present during ischaemia and 
in the early reperfusion period may originate from the sarcoplasmic reticulum. 
Alternatively, augmented ca2 + transients found by Kusuoka et al (1990) may 
contribute to reperfusion stunning by damaging ca2 + sensitive contractile 
organelles or by causing ATP wastage (Barry et al., 1987; Kusuoka et al., 1990; 
Benzi and Lerch, 1992) during ischaemia and early reperfusion. 
Whereas in previous studies (Porterfield, Kusuoka and Weisman, 1987; Chapter 
5) it was ca2 + release from sarcoplasmic reticulum that was inhibited, in the 
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present study we inhibited uptake of ca2+ into the sarcoplasmic reticulum. We 
used two novel inhibitors of the sarcoplasmic reticulum ca2 + A TP-ase pump, 
namely, cyclopiazonic acid (Lahouratate, Quiniou and Leoty, 1992; Pery-man et 
al., 1993) and thapsigargin (Thastrup et al., 1990; Kirby et al., 1992) to inhibit the 
uptake of cytosolic ca2 + into the sarcoplasmic reticulum. Although most of the 
published data characterising these two compounds has been done on isolated 
SR vesicles, recent data shows that these compounds are also effective in 
blocking the ca2 + A TP-ase pump in multicellular rabbit cardiac preparation 
(Baudet, Shaoulian and Bers, 1993). We propose that inhibition of the ca2+ 
A TP-ase pump may deplete the sarcoplasmic reticulum of ca2 + and I or thereby 
decrease intracellular ca2+ oscillations, and may improve post-ischaemic 
mechanical function. 
b) Experimental procedures, materials and methods 
i) Model used: Isolated perfused working rat hearts were perfused with a 
standard Krebs-Henseleit buffer subject to global ischaemia and reperfusion. 
ii) Experimental protocols. 
1) Protocol for mechanical function studies: To determine reperfusion 
function after global ischaemia, the working heart model was used. 
Hearts were subjected to 20 minutes total global ischaemia at a myocardial 
temperature of 35.5 ±0.5°c before being reperfused in the Langendorff mode 
for 5 minutes. Hearts were pre-treated or reperfused with CPA (10-6-10-SM) or 
thapsigargin (lo-6 or 2.5x10-8M). Pre-treated hearts were perfused with either 
compound for 3 minutes before ischaemia was initiated while hearts reperfused 
with the compounds were reperfused with the compound for 2 minutes at the 
onset of reperfusion in the Langendorff mode before normal drug-free perfusion 
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was initiated for a further 3 minutes. Hearts that developed reperfusion 
ventricular fibrillation were excluded as ventricular fibrillation causes post-
fibrillation contractile dysfunction (Koretsune and Marban, 1989). 
2) Ischaemic contracture study: In a separate series of experiments, hearts 
were perfused in the Langendorff mode, made to work for 10 minutes and pre-
ischaemic mechanical function determined. At the end of the pre-ischaemic work 
period, a left ventricular balloon was inserted into the ventricle via the left 
atrium (Qiu and Hearse, 1992) and inflated to a diastolic pressure of 4-8 mmHg. 
Hearts were now pretreated with either vehicle, or one of the two compounds 
used in this study. The hearts were then made ischaemic, and diastolic pressure 
monitored to determine the time to onset, and amplitude of ischaemic 
contracture. At the end of the 20 minutes ischaemia, hearts were clamped with 
pre-cooled Wollenberger tongs and stored at -70°c until biochemical assays were 
performed on the tissue samples. 
iii) Metabolic profile: For details see chapter 4. 
iv) Expression of data: Amplitude of ischaemic contracture was presented as a 
percentage ( % ) of the pre-ischaemic left ventricular developed pressure value. 
Time to onset of contracture was determined by measuring the time from the 
onset of ischaemia to the time when the ischaemic diastolic pressure had 
increased by 2 mmHg (Qiu and Hearse, 1992). 
v) Pharmacolo~c A2ents: Cyclopiazonic acid was obtained from Sigma 
Chemicals (St Louis, Missouri, USA). CPA was dissolved in dimethyl sulfoxide 
(DMSO). 
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Thapsigargin was obtained from LC Chemical Corporation (USA). The 
compound was also dissolved in DMSO and the stock was diluted to the 
appropriate concentration for use. The final DMSO concentration (infused into 
the heart) was 0.1 % for 10-6 M thapsigargin and 0.002 % for 2.5x10-8M 
thapsigargin. 
vi) Cyclopiazonic acid and thapsigar~in dose response in the non-ischaemic 
~ The dose response of the working rat heart to these compounds was 
determined by perfusing a separate series of working hearts with a perfusion 
medium containing 10-8, 10-7, and 10-6 moles of thapsigargin or CPA per liter of 
KH buff er. The different concentrations of the inhibitor ( either CPA or 
thapsigargin) were added successively to the same hearts and aortic output, 
coronary flows and left ventricular pressures were measured after 10 minutes of 
perfusion at each concentration. 
c) Results 
I) Cyclopiazonic acid and thapsigar~n dose response in the non-ischaemic 
heart 
Cyclopiazonic acid decreased aortic output and coronary flow in a dose 
dependent manner in the non-ischaemic working heart when infused in the micro 
to nanomolar concentration range (Figure 7.1 ). Control aortic output values in 
the CPA group were 41.2±2.3 ml/min and fell to 87±2 % of the control value 
after a 10 minutes perfusion with 10-8M CPA. Aortic output values were further 
reduced to 76±3 % (p<0.05) of the control value after a 10 minutes perfusion 
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FIGURE 7.1 Dose responses curve for cyclopiazonic acid in the isolated 
working non-ischaemic rat hean. The compound was infused for JO minutes at 
each concentration and aonic and coronary flows measured. After these 
measurements were completed, the next concentration was administered. 
* p<0.05 vs control. 
** p<0.002 vs control 
Thapsgargin elicited a weak negative inotropic response with control hearts 
generating aortic output values of 46.2±4.4 ml/min. After a 10 minutes perfusion 
with 10-8M thapsigargin AO values decreased to 96± I% of the control value. A 
further 10 minutes perfusion with 10-7M decreased aortic output to 92± I% of 
the control value and 10 minutes perfusion with 10-6M caused a fall to 81 ±4 % of 
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FIGURE 7.2 Dose responses curve for thapsigargin in the isolated working non-
ischaemic rat hean. The compound was infused for 10 minutes at each 
concentration and aonic flow and coronary flow was measured. After these 
measurements were completed, the next concentration was administered. 
I. Mechanical recoveries after global ischaemia. 
A. Pre-treatment with CPA (Figure 7.3): Hearts pre-treated with CPA (lo-6 
and 10-7M) had better aortic output recoveries than the control group. The lower 
concentration of CPA ( 1 o-8M) had no effect on reperfusion function, resulting in 
reperfusion AO recoveries of 67.4±2.2 % (n=5) compared to control values of 
73.7±2.6 % (n=7) after 15 minutes work. 
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AORTIC OUTPUT RECOVERY (~) 
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FIGURE 7.3 Reperfusion aonic output recoveries of heans pre-treated with 
vehicle (control) or one of three concentrations of cyclopiazonic acid (CPA) 
(10-6-u;-BM). 
* p<0.05 vs control. 
** p<0.002 vs control. 
Pre-treatment with the optimal CPA concentration oo-7M) (Figure 7.4) before 
ischaemia gave aortic output (AO) values of 42.1 ± 1.3 ml/min (7) before 
ischaemia and 39.4± 1.9 ml/min after 15 min work during reperfusion. This 
corresponds to an AO recovery of 93.3±1.6% compared to 78.2±3.0% 
(p<0.002) for control untreated hearts. Pre-ischaemic coronary flows for treated 
hearts were 15.1 ±0.5 ml/min and reperfusion values were 15.0±0.5 ml/min (at 
15 minutes work). Control hearts had AO of 44.9± 1.1 ml/min (12) before 
ischaemia and 35.2± 1.6 ml/min after ischaemia. There were no differences in 
coronary flows before and after ischaemia in the control group (Table 7.1 ). 
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TABLE 7.1 Reperfusion function of the working rat heart before and after 20 minutes global ischaemia with CPA pretreatment (Pre) or CPA at the time of 
reperfusion (Rep). Data is presented as means± standard error of the mean. 
Pre-ischaemia Reperfusion ( l 5min) 
CF AO DP SP CF AO DP SP 
Control 16.0 44.9 17 117 16.1 35.2 17 108 
0.7 1.1 0 1 0.8 1.6 0 2 
CPA Pre 15.1 42.1 17 115 15.2 39.4 17 114 
0.4 1.3 0 2 0.5 1.9 1 2 
CPA Rep 17.2 45.3 16 114 17.5 409 16 110 
0.8 1.5 0 3 0.6 2.0 0 2 
AO = Aortic output 
CF = Coronary flow. 
DP = Diastolic pressure. 
SP = Systolic pressure. 
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FIGURE 7.4 Aonic output recoveries (at 5, 10 and 15 minutes reperfusion) of 
heans pretreated before 20 minutes global ischaemia (pre), or reperfused with 
cyclopiazonic acid (CPA) (10-7M)(post) or vehicle (control). 
* p<0.05 vs control. 
** p<0.002 vs control. 
Pre-treatment with thapsigargin. (Figure 7.5): Pretreatment with thapsigargin 
(2.5x10-8M) protected the heart against reperfusion stunning. AO values for 
control hearts were 45.1±1.0 ml/min before ischaemia and 28.4±2.1 ml/min (6) 
at 5 minutes work after ischaemia. In hearts pretreated by thapsigargin, the mean 
reperfusion aortic output value improved to 44.4±4.4 ml/min (6) after ischaemia 
(Table 7.2) compared with the reperfusion value of 28.5±3.7 ml/min in controls. 
Hearts pre-treated with higher doses of thapsigargin ( 10-6M) had AO outputs of 
44.0±3.2 ml/min (8) before ischaemia and AO of 3.0± 1.5 ml/min 10 minutes 
after reperfusion. Of eight hearts pre-treated, only 3 hearts generated any AO 
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after ischaemia. Even these 3 hearts had totally failed by the 15 minutes work 
period. Coronary flow values after ischaemia were decreased with pre-ischaemic 
values of 18.7±0.8 ml/min and reperfusion values of 11.4±1.9 ml/min (at 10 
minutes work). Control hearts had AO of 44.6± 1.8 ml/min (14) before 
ischaemia and 33.9±2.1 ml/min after ischaemia. There were no differences in 
coronary flow values before and after ischaemia in the control group. 
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FIGURE 7.5 Aonic output recoveries (at 5, 10 and 15 minutes reperfusion) of 
heans pretreated with thapsigargin (Thaps) (10-6 or 2.5x10-8 M) or with vehicle 
( control) before 20 minutes global ischaemia. 
* p<0.05 vs control. 
** p<0.002 vs control. 
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TABLE 7.2 Repert:usion fu_nction_ of the wor~ing ~at heart before and aft~§ 20 
minutes global 1schaemia with thaps1gargm (Thaps) (2.5X10 M) 
pretreatment (Pre) or thapsigargin at the time of reperfusion (Rep). Data is 
presented as means ± standard error of the mean. 
Pre-ischaemia Reperfusion( 15min) 
CF AO DP SP CF AO DP SP 
Control 18.9 45.1 11 99 16.6 28.4 12 87 
0.4 1.0 1 2 0.8 2.1 2 2 
Thaps Pre 17.3 45.8 13 111 18.3 44.8 14 104 
1.1 2.7 3 4 0.8 3.7 4 2 
Thaps Rep 19.4 48.5 11 105 19.3 38.0 11 95 
1.0 1.9 1 3 1.5 3.2 1 2 
AO= Aortic output 
CF = Coronary flow. 
DP = Diastolic pressure. 
SP = Systolic pressure. 
B, Reperfusion with CPA: Pre-ischaemic aortic outputs of hearts treated with 
CPA oo-7M) during reperfusion were 45.3±1.5 ml/min and that of control 
hearts were 44.9±1.1 ml/min. The reperfusion function recoveries(%) for CPA 
hearts, were 85.8± 1.5 % after 5 minutes work, 89.3± 1.5 % after 10 minutes, and 
stabilised at 90.2 ± 2. 7 % after 15 minutes work. The control hearts had A 0 
recoveries of 71.2±2.4 % after 5 minutes work, 77.3±3.1 % after 10 minutes and 
78.2±3.0% (12) after 15 minutes (Figure 7.4). Coronary flows were 17.2±0.8 for 
the treated group and 16.8±0.7 ml/min for the control group. The post-ischaemic 
coronary flow values for these two groups were unchanged. 
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Reperfusion with thapsigargin (Figure 7.6): Reperfusion with (2.5x10-8M) 
thapsigargin improved early reperfusion AO recovery. Pre-ischaemic values 
were 48.5± 1.9 ml/min and reperfusion values 38.0±3.8 ml/min (6) after 15 
minutes work 
Reperfusion with high thapsigargin concentrations oo-6M) improved early 
reperfusion function (86.7±3.0% at 5 minutes reperfusion) but caused a rapid 
decline in function towards 15 minutes reperfusion (61.4±5.0% ). Thapsigargin 
reperfusion had no effect on post-ischaemic coronary flows. 
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FIGURE 7.6 Aonic output recoveries (at 5, 10 and 15 minutes reperfusion) of 
heans made globally ischaemic for 20 minutes and reperfused with thapsigargin 
(Thaps) (J0-6M or 2.5x10-8M) for 2 minutes. 
* p<0.05 vs control. ** p<0.002 vs control. 
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II. Cyclopiazonic acid, thapsigargin, and ischaemic contracture (Figure 7. 7). 
Pre-treatment of the isolated rat heart with CPA or thapsigargin had no effect on 
the time to onset of contracture, but did influence the magnitude of contracture. 
Pretreatment with CPA (10-7M) or thapsigargin (2.5x10-8M) decreased the % 
contracture to 8.1±3.9% (n=6) and 3.7±3.7% (p<0.05) (n=6) respectively 
compared to a control value of 23.4±7.7% (n=8). High concentrations of 
thapsigargin oo-6M) increased the magnitude of ischaemic contracture to 
33.6±5.4% compared with both CPA (10-7M) (8.1±3.9%)(p<0.05) 
and thapsigargin (2.5x10-8M) (3.7±3.7%) (p<0.05). 
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0 -• -, 0 Control CPA 10-7 Thape 2.fSX10 Thape 10 
- Time to Contraoture ~ fe Contracture 
FIGURE 7.7 Histogram presenting data for the time to onset of. and magnitude 
of ischaemic contracture for heans pretreated with CPA (10-7M), thapsigargin 
(10-6 or 2.5xJ0-8M), or vehicle (control). 
* p<0.05 vs control. 
** p<0.05 vs Thaps (10-6M). 
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III. Cyclopiazonic acid, thapsigargin. and post-ischaemic metabolic status 
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FIGURE 7.8 Histogram presenting tissue ATP, PCr, and cAMP levels at the 
end of 20 minutes ischaemia in control and drug pre-treated heans. 
* p<0.05 vs Ischaemia group. 
Pretreatment with the A TP-ase pump inhibitors had no effect on the end 
ischaemic cAMP or PCr levels. Both thapsigargin concentrations (2.5x10-8 and 
10-6M) decreased the tissue ATP levels at the end of ischaemia. Control post-
ischaemic ATP levels were 1.2±0.26 µmol/g (n=8) compared with 0.5±0.05 
µmol/g (p<0.05)(n=6) and 0.45±0.11 µmol/g (p<0.05)(n=6) respectively. 
There were no differences in tissue cAMP levels between control and drug pre-
treated groups. 
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Summary of findings of study. 1) Inhibition of ca2 + A TP-ase pump of the 
sarcoplasmic reticulum (SR) before ischaemia or during reperfusion 
protected the isolated working rat heart against reperfusion stunning. 
2) These findings support the proposal that the SR may contribute to 
reperf~sion stunning by i) being a source of excess cytosolic ca2+ during 
ischaemia and reperfusion (Kusuoka et al., 1990) and/or, ii) by contributing 
to augmented intracellular ca2+ transients (oscillations) which may 
damage the contractile apparatus or contribute to ATP depletion in the 




Thapsigargin and Cyclopiazonic acid: Antiarrhythmic Properties of 
Specific Inhibitors of the Sarcoplasmic Reticulum ca2 + A TP-ase Pump 
after Coronary Artery Ligation, 
a) Rationale. 
Despite many recent advances in the treatment of ischaemic heart disease, 
sudden cardiac death associated with ventricular fibrillation remains a major 
cause of mortality in Western society (Suravicz, 1985). Recently the proposal has 
been made that excess ca2 + oscillations may play an important role in ischaemic 
ventricular fibrillation (For a review, see Lubbe et al., 1992). Oscillatory release 
of ca2 + from intracellular stores is a primary event underlying changes in the 
transient inward current which contributes to arrhythmogenic activity (Kass et 
al., 1978; Kass, Tsien and Weingart, 1978). 
Hypothetically, such oscillations, if magnified, could play an important role in the 
genesis of ventricular arrhythmias both during ischaemia and reperfusion. 
Ryanodine and caffeine, both acting on the sarcoplasmic reticulum to modulate 
intracellular ca2 + fluxes, have antiarrhythmic properties (Thandroyen et al., 
1988; Kihara and Morgan, 1991). If ca2+ oscillations from the sarcoplasmic 
reticulum play a major role in the initiation or perpetuation of serious ventricular 
arrhythmias, then specific inhibition of the metabolic pump taking up ca2 + from 
the cytosol into the sarcoplasmic reticulum would also be expected to be 
antiarrhythmic. 
Ischaemic and reperfusion arrhythmias were provoked in the isolated rat heart 
model by coronary artery ligation and release (reperfusion). Thapsigargin, which 
is thought to be very specific, and inhibits 60-70 % of the ca2 + A TP-ase pumps 
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in isolated cardiac sarcoplasmic reticulum (Thastrup et al., 1990; Sagara and 
Inesi, 1991; Kirby et al., 1992), was infused into regionally ischaemic hearts and 
the incidence of ischaemic and reperfusion arrhythmias was monitored. In a 
separate series of experiments, a second specific and possibly more potent ca2 + 
ATP-ase pump inhibitor, cyclopiazonic acid (Seidler et al., 1989), was used. 
b) Experimental procedures, materials and methods. 
i) Model Used; Male Long-Evans rat hearts perfused in the Langendorff mode 
were used for all perfusions. 
ii) Perfusion fluid: The Krebs-Henseleit perfusion buffer used for the ischaemic 
arrhythmia study was modified to contain a potassium concentration of 4.8 mM. 
For the reperfusion arrhythmia study, the ca2+ concentration was 2.5 mM to 
increase the incidence of reperfusion arrhythmias under control conditions 
(Coetzee et al., 1990). The buffers were gassed with 95 %02 and 5 %CO2, and 
maintained at 37°c. 
The left anterior descending coronary artery was ligated, electrocardiograph 
(ECG) electrodes were attached to the aortic cannula and the right ventricle and 
the incidence of ischaemic and reperfusion arrhythmias were monitored by 
means of an ECG recording (for details see Chapter 4). 
iii) Protocols used. 
A. Protocol for ischaemic arrhythmia study. 
1) Hearts were allowed a 10 minutes equilibration period before the drug or 
vehicle (DMSO 0.01-0.1 %) infusion was initiated and maintained for the 
duration of the experiment After 5 minutes treatment the left anterior 
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descending coronary artery was ligated and drug infusion rate adjusted to the 
new (post-ligation) coronary flow rate (Figure 8.1 ). 
2) In a second series of hearts, hearts were allowed a 10 minutes equilibration 
period, the coronary artery was ligated, and drug or vehicle infusion was initiated 
5 minutes after ligation. The ligation was left in position for 30 minutes and the 
coronary flow, heart rate, left ventricular pressure (monitored with a balloon) 






(time min) 5 t 5 30 min ischaemia 
Drug ECG & LVP Monitored 
LAD • Left anterior descending 
ECG • Electrocardiogram 
LVP • Left ventricular pressure 
FIGURE 8.1 Diagrammatic representation of the protocol used for the 
ischaemic affhythmia study. Drug infusion was initiated 5 minutes before or 
after (not indicated in figure) coronary anery ligation and the incidence of 
ischaemic affhythmias monitored for the 30 minutes of coronary anery ligation. 
B. Protocol for reperfusion arrhythmia study. 
Hearts were stabilized for 10 minutes before the drug or vehicle infusion was 
initiated. After 5 minutes infusion, left anterior descending coronary artery 
ligation was employed to induce regional ischaemia for 8, 10, 15, 20, 25 or 30 
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minutes. Reperfusion was achieved by cutting the ligature across a polyvinyl 
sheath which encompassed the coronary artery. Coronary flow, heart rate, and 
ECG were again recorded throughout the experiment and for the first 2 minutes 
of reperfusion (Figure 8.2). 
LAD artery 
Ligation Reper fusion 
' ' 1-------1--------1-------------------1---------1 (time t 
5 min) 5 
Drug 
8 - 30 min 
lschaemia 
LAD • Left anterior descending 
ECG • Electrocardiogram 
LVP • Left ventricular pressure 
ECG & LVP 
Monitored 
FIGURE 8.2 Diagrammatic representation of the experimental protocol used 
for the reperfusion a"hythmia study. 
iv) Metabolic profile. 
Hearts were freeze-clamped for later biochemical analysis using Wollenberger 
tongs pre-cooled in liquid nitrogen, after 15, 20 or 30 minutes of ischaemia for 
tissue high energy phosphate determinations. Adenosine triphosphate (ATP} and 
phosphocreatine (PCr) were assayed spectrophotometrically at 340 nm in 
samples from ischaemic and non-ischaemic myocardium (for details pertaining to 
assay methods, see chapter 4). 
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v) Evaluation of Ventricular Arrhythmias. 
For a definition of arrhythmias in this model, see chapter 4. 
vi) Mechanical function studies. 
Left ventricular pressure was monitored using left ventricular cannulation (20G 
Abbocath-T catheter) or an ultrathin "Clingfilm" balloon inserted into the left 
ventricle (Tani and Neely, 1989; Qiu and Hearse, 1992). The cannula or balloon 
was attached to a Stratham Gould P23ID pressure transducer and the left 
ventricular developed pressure and ECG was recorded with a Lectromed chart 
recorder. 
Coronary flow and heart rates were monitored throughout the experiment 
vii) Pharmacolo2ic A2ents. 
Thapsigargin and cyclopiazonic acid was prepared as in chapter 7. The two doses 
(10-6M thapsigargin and 10-7M cyclopiazonic acid) used for these arrhythmia 
studies were chosen to have similar negative inotropic effects, both decreasing 
aortic flow by about 15-20 % (See chapter 7). 
c) Results 
1) Arrhythmias and Thapsiear2in. 
A. Ischaemic ventricular arrhythmias: (Figure 8.3) The incidence of 
ventricular fibrillation in control hearts was 83 % while in the treated hearts it 
was 0% (p<0.002). The duration of ventricular fibrillation was 389.6+ 102 sec for 
control hearts (12) and O sec for treated hearts (12) (p<0.05). The duration of 
ventricular tachycardia and the number of ventricular premature beats was 
similar for control and treated hearts. 
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Thapsigargin treatment initiated 5 minutes after coronary artery ligation 
decreased the incidence of ischaemic ventricular fibrillation from 77 % ( control) 
(9) to 14 % (7) (p<0.05). 
There were no difference in the coronary flow values or heart rates between 
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FIGURE 8.3 Ischaemic arrhythmias. Horizontal histogram presenting the 
absolute time (in minutes) of the duration of ischaemic ventricular tachycardia 
or fibrillation in individual Langendorf! perfused heans during 30 minutes 
ischaemia. Control heans are represented by the top 12 bars while thapsigargin 
treated heans are represented by the bottom 12 bars. The number of ventricular 
premature beats (VPBs) are presented to the right of each bar. Note major 
antiarrhythmic action of thapsigargin. 
VT= Ventricular tachycardia. 
VF= Ventricular fibrillation. 
Thaps = Thapsigargin 1 o-6 M. 
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Post-ischaemic levels of adenosine triphosphate and phosphocreatine were 
measured in the ischaemic and non-ischaemic zones. Tissue ATP levels in the 
ischaemic zone were lower than those from the non-ischaemic zone in all hearts 
except in thapsigargin treated hearts after 15 and 20 minutes ischaemic. ATP 
levels were 2.40+0.14 µmol/g in the ischaemic tissue and 2.83+0.15 µmol/g in 
the non-ischaemic tissue of thapsigargin treated hearts after 15 minutes 
ischaemic, and 2.30+0.18 µmol/g and 2.78+0.30 µmol/g respectively after 20 
minutes ischaemic. The absence of a tissue gradient for ATP coincided with a 
decrease in the incidence of reperfusion arrhythmias at 15 and 20 minutes 
reperfusion in the thapsigargin treated groups (Table 8.1 ). 
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TABLE 8. 1 ATP and PCr values after 15, 20 and 30 minutes ischaemia in the 
ischaemic and non-ischaemic region of control, Thaps (thapsigargin) and CPA 





15 min ISCHAEMIA 
CONTROLS(n=7) 
Ischaemic 2.12+0.21* 1.57+0.3 ** N on-ischaemic 3.24+0.16 3.05+0.20 
THAPS HEARTS(n=7) 
Ischaemic 2.40+0.14 0.98+0.14** N on-ischaemic 2.83+0.15 2.43+0.26 
CPA HEARTS(n=6) 
Ischaemic 2.09+0.20* 1.12+0.26* 
N on-ischaemic 3.39+0.21 2.77+0.36 
20 min ISCHAEMIA 
CONTROLS(n=7) 
lschaemic 1.67+0.20* 1.33+0.23** N on-ischaemic 3.17+0.17 3.24+0.24 
THAPS HEARTS(n=7) 
Ischaemic 2.30+0.18 1.69+0.21 
N on-ischaemic 2.78+0.30 2.41 +0.44 
CPA HEARTS(n=7) 
Ischaemic 2.34+0.23* 1.95+0.21 
N on-ischaemic 3.36+0.23 3.31 +0.59 
30 min ISCHAEMIA 
CONTROLS(n=7) 
Ischaemic 2.03+0.26* 1.77+0.19 
N on-ischaemic 3.63+0.24 2.63+0.50 
THAPS HEARTS(n=6) 
Ischaemic 2.12+0.17* 1.43+0.17 
N on-ischaemic 3.28+0.19 1.86+0.42 
CPA HEARTS(n=7) 
lschaemic 1.77 +0.19 * 1.51 +0.43* 
N on-ischaemic 3.31 +0.10 3.16+0.20 
* p<0.05 vs non-ischaemic myocardium. 
** p<0.002 vs non-ischaemic myocardium. 
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B. Reperfusion ventricular arrhythmias: There was a direct correlation 
between the incidence of reperfusion arrhythmias and the ischaemic time, up to 
about 20 minutes. The incidence of reperfusion ventricular fibrillation increased 
from 29 to 67, 81 and 90% in control hearts subjected to 8, 10, 15 or 20 minutes 
ischaemia respectively. After 25 and 30 minutes there was a decrease to 56 % (9) 
and 45 % (11) respectively. With thapsigargin (10-6M) treatment, the incidence of 
reperfusion ventricular fibrillation was reduced to 0, 0 (p<0.05), 25 (p<0.002), 
46 (p<0.05), 38 and 27 % respectively (Figure 8.4). During reperfusion of the 10 
and 15 minutes ischaemia groups, the incidence of reperfusion ventricular 
tachycardia was reduced from 83 to 0% (p<0.002) and 87 to 45 % (p<0.05) 
respectively (Figure 8.5). Table 8.2 presents absolute values for time in VF and 
VT ( of groups) under control and drug treatment conditions. 
These differences in the incidence of reperfusion arrhythmias occurred without 
any significant difference in the heart rate or coronary flow of the treated 
compared with the control hearts (data not shown). 
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FIGURE 8.4 Reperfusion ventricular fibrillation. Histogram presenting the 
percentage incidence of reperfusion ventricular fibrillation in control and 
thapsigargin treated Langendorf! perfused heans after 8, 10, 15, 20, 25 or 30 
minutes of regional ischaemia. 
For additional information, see Table 8.2. 
* p<0.05 vs control. 
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FIGURE 8.5 Reperfusion ventricular tachycardia. Histogram presenting the 
percentage incidence of reperfusion ventricular tachycardia in control and 
thapsigargin treated Langendorf! perfused heans after 8, JO, 15, 20, 25 or 30 
minutes of regional ischaemia. 
* p<0.05 vs control. 
135 
TABLE 8.2 Reperfusion arrhythmias showing absolute va~es and durations for control hearts and hearts perfused with thapsigargin ( 10 M). 
Ischaemic time n VPBs VT VF 
(no) time (sec) 
IO min 
Control 6 25±8 * 8±3* 72±l9 Thapsigargin 6 3±0.4 0 0 15 min 
Control 16 9+1 8±1 95±8 Thapsigargin 20 6±1* 12±2 89±15 20min 
Control 10 10±5 8±2 99±11 Thapsigargin 13 11+3 7±1 103±2 25 min 
Control 9 21±6 9±4 71±17 Thapsigargin 7 20±4 7±3 61±26 30min 
Control 10 10±4 18±7 58±15 Thapsigargin 15 18±4 8±1 72±12 
Control hearts were perfused with DMSO 0.1 %. 
n = number of hearts done per group. 
VPBs = Ventricular premature beats (presented as an absolute value). 
VT = Ventricular tachycardia and ventricular fibrillation (VF) is presented as a time (seconds). 
* p<0.05 vs controls. 
2) Arrhythmias and Cyclopiazonic acid. 
A. Ischaemic ventricular arrhythmias (Figure 8.6): The incidence of 
ventricular fibrillation in control hearts was 83 % while the incidence in the 
treated hearts was 16 % (p<0.05). The duration of ventricular fibrillation was 
101.7+ 7.8 sec for control hearts (6) and 120 sec for treated hearts (only one heart 
developed ventricular fibrillation). The time in ventricular tachycardia was 
259.5+84.6 sec (6) for control hearts and 47.6+31.7 sec (6) (p<0.05) for 
cyclopiazonic acid treated hearts. Only one treated heart developed ventricular 
fibrillation while five control hearts fibrillated. 
Treatment by cyclopiazonic acid initiated 5 minutes after coronary artery ligation 
decreased the incidence of ischaemic ventricular fibrillation from 77 % ( control) 
(9) to O % (8) (p<0.05). 
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Ischaemic values for coronary flow and heart rate were unchanged by 
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fIIffl NORMAL RHYTHM ~ VT - VF 
FIGURE 8.6 Jschaemic arrhythmias. Control heans are represented by the 
top 6 bars while cyclopiazonic acid (CPA) treated heans are represented by the 
bottom 6 bars. For Junher details, see legend to Figure 8.3. 
B. Reperfusion ventricular arrhythmias: The incidence of reperfusion 
ventricular fibrillation increased from 50, to 83, to 100 % in control hearts 
subjected to 10, 15 or 20 minutes of ischaemia. At 25 and 30 minutes there was a 
decrease in the incidence of ventricular fibrillation to 71 and 62 % respectively. 
With cyclopiazonic acid oo-7M) treatment the incidence of reperfusion 
ventricular fibrillation was reduced to 33, 40, 14 (p<0.05), 44, and 50 % 
respectively (Figure 8. 7). These differences in the incidence of ventricular 
fibrillation occurred without any differences in the heart rate or coronary flow of 
the treated compared with the control hearts. 
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The number of ventricular premature beats was consistently higher in the 
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FIGURE 8. 7 Reperfusion ventricular fibrillation. The incidence percentage 
of reperfusion ventricular fibrillation in control and cyclopiazonic acid treated 
Langendorf! heans subject to JO, 15, 20, 25 and 30 minutes ischaemia. For 
additional information, see Table 8.2. 
CPA = Cyclopiazonic acid J0-7M. 
* p<0.05 vs control. 
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TABLE 8.3 Reperfusion arrhythmias presented as absolute values (VPBs) 
and durations (VT and VF) for control hearts and hearts perfused with 
cyclopiazonic acid (CPA) (lo-7M). 
Ischaemic time n VPBs 
(no) 
lOmin 
Control 6 8±1 
CPA 6 14±3 
15 min 
Control 6 7±3 
CPA 10 15±5 
20min 
Control 7 11±3 
CPA 7 29±8 
25 min 
Control 7 20±7 
CPA 9 32±6 
30min 
Control 8 36±6 
CPA 8 33±6 
Control hearts were perfused with DMSO 0.01 %. 















VPBs = Ventricular premature beats (presented as absolute values). 
VT = Ventricular tachycardia and ventricular fibrillation (VF) is presented as 
a time (seconds). 
* p<0.05 vs controls. 
** p<0.002 vs controls. 
3) Mechanical Function during Coronary Arter:y Ligation. 
Coronary artery ligation decreased the rate-pressure product of all hearts by 
+60 %. Rate-pressure product values of the drug treated hearts increased over 
the next 25 minutes and were 14508+675 (thaps) (7) (p<0.05) and 14636+ 1365 
(CPA) (8) (p<0.05) compared with 10859+663 (9) for controls (Figure 8.8). 
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FIGURE 8.8 Rate-pressure product before and during coronary artery 
ligation. The rate-pressure product for control and drug treated he ans are 
presented. The solid bar represents the rate-pressure product before coronary 
anery ligation, the cross-hatched bar the value 5 minutes after ligation and the 
dotted bar the value 25 minutes after drug or vehicle treatment was initiated. 
* p<0.05 vs control. 
Summary of findin2s of study. 1) Excess internal ca2 + ion oscillations play an 
important role in the genesis and perpetuation of ischaemic and 
reperfusion ventricular fibrillation. 
2) The use of two specific inhibitors (Seidler et al., 1989; Kirby et al., 1992) 
of uptake of ca2 + ions into the sarcoplasmic reticulum, decreased the 




Endothelin Release during Ischaemia and Reperfusion and its Role in 
Reperfusion Injury. 
a) Rationale. 
Endothelin is an endogenous 21-amino-acid peptide with multiple biological 
actions (Yanagisawa et al., 1988). It contracts vascular and non-vascular smooth 
muscle in vitro, produces a sustained pressor response in vivo and exerts a 
positive inotropic effect on atrial and ventricular cardiac muscle (for recent 
reviews see Lerman et al., 1990; Nayler, 1990; Simonson and Dunn, 1990; 
Rubanyi and Parker-Botelho, 1991). 
Endothelin may play an important cardiovascular regulatory and I or 
pathophysiological role. When endothelin was injected into the coronary 
circulation of isolated rabbit hearts, dose-dependent vasoconstriction, increased 
outflow of prostacyclin and impaired diastolic relaxation was observed 
(Karwatowska-Prokopczuk and Wennmalm, 1990). Furthermore, endothelin, by 
virtue of its ability to mobilize intracellular ca2+ (Vigne et al., 1990), could 
hypothetically contribute to cytosolic ca2 + overloading of cardiomyocytes, and 
therefore reperfusion injury (Opie, 1989a; Nayler, 1990). In rat cardiac 
membranes, ischaemia causes time-dependent externalization of endothelin-1 
binding sites (Liu, Casley and Nayler, 1989), thus increasing the number of 
receptor sites available for the interaction with blood-borne endothelin. A 
possible role for endothelin in myocardial infarction is suggested because 
circulating levels of endothelin increased within hours of onset of myocardial 
infarction ( or presentation) in humans (Miyauchi et al., 1989, Salminen et al., 
1989, Yasuda et al., 1990, Stewart et al., 1991). An endothelin-antibody reduced 
experimentally-induced infarct size in the rat heart (Watanabe et al., 1991). 
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The hypothesis tested in this study was that endogenous endothelin plays a role 
in events associated with or leading to myocardial ischaemia and/ or post-
ischaemic reperfusion damage (Nayler, 1990). Several models of ischaemia were 
used to test whether endogenous endothelin was released into the coronary 
circulation. The influence of exogenous endothelin on post-ischaemic coronary 
perfusion pressure and recovery of reperfusion mechanical function (reperfusion 
vascular and myocardial stunning, respectively) was also studied. 
b) Experimental procedures, materials and methods. 
i) Model Used: For all functional and endothelin-release studies, rat hearts 
perfused with a Krebs-Henseleit buffer on the isolated working rat heart and 
Langendorff perfusion system were used ( for details see chapter 4 ). 
ii) Experimental protocol: Four experimental protocols were used in this study. 
Protocol 1: Endothelin release durin~ ischaemia and reperfusion. 
To determine whether endogenous endothelin is released during ischaemia 
and/ or reperfusion, hearts were perfused in the Langendorff mode at a constant 
pressure of 100 cm H20 for 15 minutes (equilibration period). They were then 
subjected to different models of ischaemia and reperfused under constant 
pressure for up to 60 minutes. Coronary effluent samples were collected at the 
end of the equilibration period ( 10 to 15 minutes after mounting), during 
ischaemia and, depending on the model, from O to 5, 5 to 30 and 30 to 60 minutes 
of reperfusion. 
Model 1: For this model, low flow ischaemia for 90 or 180 minutes was used 
(Owen et al., 1990). Hearts were perfused at a constant flow rate of 0.5-0.6 
ml/min with the standard perfusion medium and the coronary effluent collected 
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quantitatively in one (90 minutes) or two (180 minutes) sample(s). During 
reperfusion (5-60 minutes), coronary effluent was recirculated. 
In a variation of this model, the perfusates used during ischaemia contained 1 % 
foetal calf serum. 
Model 2: In the second model, global ischaemia for various periods of time was 
used (Chapter 5). Total ischaemia was induced by shutting off aortic flow for 20 
or 30 minutes, hence no coronary effluent was obtained during ischaemia in this 
case. The temperature was maintained between 35 and 36°c. Reperfusion was in 
the non-recirculating (20 minutes ischaemia) or recirculating mode (30 minutes 
ischaemia). In the latter case, aprotinin (6 K IU /ml) was added to the perfusate. 
Protocol 2: Effect of endothelin on coronary perfusion pressure and left 
ventricular systolic pressure in control hearts. 
Rat hearts (approximate weight 0.9-1.1 g) were perfused in the Langendorff 
mode until a stable coronary flow, about 8 to 11 ml/min, was obtained. The left 
ventricle was cannulated with a teflon cannula (Abbocath-T), connected to a 
pressure transducer and left ventricular systolic pressure was continuously 
recorded Coronary perfusion pressure was measured with a second transducer at , 
a point in the aortic cannula approximately 3 cm above the heart. After an initial 
equilibration period (about 15 minutes) under constant pressure, constant flow 
perfusion was initiated at the flow rate equivalent to that obtained at the end of 
the ( constant pressure) equilibration period, thus preventing the development of 
myocardial ischaemia due to endothelin-induced vasoconstriction. After 
stabilisation of the left ventricular systolic and coronary perfusion pressure 
traces, endothelin-2 ( 1 ng (0.4 pmol) to 1 µg ( 400 pmol) was slowly injected by 
cumulative dosing into the perfusion medium directly above the heart in volumes 
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between 0.1 and 0.3 ml at 2.5 minute intervals (Fukuda et al., 1989). A perfusion 
medium containing 0.1 % bovine serum albumin (BSA) was used to check the 
effect of injection on perfusion pressure. The vasoactive effect of endothelin on 
the coronary circulation was assessed from the changes in coronary perfusion 
pressure and the inotropic effect from the changes in maximum systolic 
ventricular pressure. 
Protocol 3: Effect of endothelin-2 on coronary perfusion pressure durin~ 
reperfusion. 
Hearts were perfused retrogradely at constant pressure for 10 minutes and the 
coronary flow rate was determined. Hearts were then perfused at a constant flow 
rate until a stable baseline was obtained (pre-ischaemic control), followed by a 1-
hour low-flow (0.5 ml /min) perfusion in the absence of foetal calf serum. 
Constant flow reperfusion at the pre-ischaemic rate was resumed, a stable 
pressure baseline obtained (6-11 minutes after onset of reperfusion) and 
endothelin-2 added cumulatively at doses ranging from 0.1 ng (0.04 pmol) to 1 µg 
(400 pmol). The resulting dose-response-curves were analyzed as above. 
Protocol 4: Effect of endothelin on reperfusion mechanical function. 
After 5 minutes of aortic perfusion in the Langendorff mode at a constant 
pressure of 100 cm H20, perfusion was changed to one of constant flow for 5 
minutes at the flow rate determined at the end of the Langendorff equilibration 
period. This was followed by perfusion in the work mode for IO minutes. 
Following the measurement of functional parameters (pre-ischaemic control), 
the hearts were subjected to total global ischaemia for 20 minutes before being 
reperfused for 5 minutes in the Langendorff mode at a constant flow rate, equal 
to the pre-ischaemic rate. Langendorff reperfusion was followed by 40 minutes 
perfusion in the working mode and a final 5 minute Langendorff perfusion under 
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constant pressure (73 mm Hg). The total time for each experiment was 90 
minutes. The left ventricle was cannulated for pressure measurements as above. 
Hearts were paced at 5 Hz for the entire experiment except during ischaemia and 
the first 2 minutes of reperfusion. 
Endothelin-2 was injected into the aorta via a T-piece as a bolus dose of 100 or 
200 ng at the onset of reperfusion. The effect of endothelin on reperfusion 
mechanical function was assessed by measuring the aortic output prior to 
ischaemia and 10, 20, 30 and 40 minutes after the onset of post-ischaemic work. 
The results were expressed as percentage recoveries ( % ) of the pre-ischaemic 
value. The effect of endothelin-2 on aortic output of non-ischaemic control 
hearts (ischaemic period replaced by Langendorff perfusion) was determined for 
the same time points in separate experiments. 
iii) Materials and methods for measurement of endothelin. 
For materials and methods used for endothelin measurement see chapter 4. 
c) Results 
1) Basal endothelin release 
The basal endothelin release rate was determined in hearts using normoxic 
perfusate. Due to the complete cross-reactivity of the antibody, all three 
endothelin species would presumably be quantified. The results are presented in 
Table 9.1 Endothelin release was constant up to 180 minutes and amounted to 
0.69±0.02 pg/min/g heart weight Neither the heart rate nor the coronary flow 
changed significantly over this time period (ANOVA-1, p>0.05). 
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TABLE 2.1 Basal endothelin (ET) release from isolated rat hearts. 
Sampling period Heart rate Coronary flow ET-release 
(min post-mounting) (bpm) (ml/min/g) (pg/min/g) 
10-15 310+27 7.4+0.2 0.71 +0.05 
25-30 318+ 10 7.3+0.1 0.66+0.05 
55-60 285+16 7.9+ 1.2 0.63+0.03 
85-90 321 +30 7.3+ 1.1 0.68+0.07 
115-120 297+ 15 6.6+ 1.2 0.68+0.05 
145-150 288+ 17 6.2+0.9 0.68+0.04 
175-180 264+ 14 5.9+ 1.0 0.69+0.04 
Values are presented as mean ± S.E.M., n=5. The total amount of effluent 
collected for each period was column-chromatographed. ET release is 
expressed per min and g wet wt None of the three variables measured 
changed significantly over the entire course of the experiment (p>0.05). 
2) Endo~enous endothelin in ischaemia and reperfusion 
To determine if the isolated rat heart releases endogenous endothelin during 
ischaemia and after subsequent resumption of coronary perfusion, the 2 different 
experimental models of ischaemia (described earlier in this section) were chosen, 
perfusate samples collected from these models and analyzed for endothelin. 
Since various sera have been shown to increase stimulated endothelin-secretion 
of endothelial cells (Hexum et al., 1990, Ristimaki et al., 1991), foetal calf serum 
was added to the perfusate in one model. The results obtained with the low-flow 
model of ischaemia are presented in Figure 9.1 and Table 9.2. Compared to the 
basal (pre-ischaemic) secretion rate, endothelin release was greatly reduced 
during an ischaemic period of 90 or 180 minutes (p<0.01). On reperfusion (0-5 
minutes), immunoreactive endothelin increased 3.9-fold (p<0.05) in hearts 
subjected to 180 minutes of ischaemia in the presence of 1 % foetal calf serum 
while the increase was only 1.4-fold in its absence (p>0.05, Figure 9.1, Table 9.2). 
After 90 minutes of ischaemia, endothelin release rate increased non-
significantly 1.4- and 1.15-fold in the presence and absence of foetal calf serum, 
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respectively (p>0.05, Table 9.2). Between 5 and 30 minutes of reperfusion the 
release rates declined to or below control levels. 









Pre-l 0-90 min I 90-180 min I 0-6 min RP 6-80 min RP 
0 With FCS - Without FCS 
FIGURE 9.1 Endothelin release in low-flow ischaemia and reperfusion. Heans 
were perfused under control conditions, then in the absence and presence of 1 % 
foetal calf serum (FCS) under low-flow (0.5 ml/min) hypoxic conditions for 180 
minutes (/) and subsequently reperfused under normoxic conditions for 30 
minutes (RP). 
Means± S. E. M. 
n=6-7. 
* p<0.05 vs pre-ischaemic control. 
** p<0.01 vs pre-ischaemic control. 
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TABLE 9.2 Endothelin (ET) release during low-flow ischaemia (I) in the 
presence and absence of foetal calf serum (FCS) and on reperfusion (RP). 
90 min Ischaemia 
With 1 % FCS (n=7) Without FCS (n=6) 




control 0.93±0.13 0.74±0.10 
I 0-90 0.63±0.oo5a 0.07±0.008 0.05±0.003a 0.07±0.007 
I 90-180 - - - -
RP0-5 1.32±0.29 1.38±0.16 0.89±0.26 1.15±0.22 
RP 5-30 0.24±0.03a 0.27±0.04 0.17±0.01 a 0.24±0.02. 
180 min Ischaemia 
With 1 % FCS (n=7) Without FCS (n=6) 
Sampling ET release Change over ET release Change over 




control 0.66±0.05 0.78±0.16 
I 0-90 0.19±0.02a 0.28±0.03 0.06±0.007a 0.08±0.01 
I 90-180 0.24±0.02~ 0.36±0.04 0. 06±0. 007a 0.09±0.01 
RP0-5 2.60±0.63 3.94±0.92 I.l0±0.23b 1.44±0.15 
RP 5-30 0.64±0.17 0.95±0.18 0.18±0.03 0.23±0.03 
Values are presented as mean ± S.E.M. 
Experimental protocol. aP<0.01; bp<0.05. 
The model is described under 
In a model of 20 minutes of global ischaemia, endothelin release on reperfusion 
was initially also, albeit non-significantly increased ( 1.32-fold, p>0.05), similar to 
controls between 5 and 30 minutes, and again non-significantly increased 
between 30 and 60 minutes (Table 9.3). Total global ischaemia for 30 minutes 
resulted in release rates (0.67±0.05 pg/min/g) which were not higher than 
controls (0.62±0.07 pg/min/g, p>0.05). Thereafter, release declined below 0.15 
pg/min/g (p<0.01, data not shown). 
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TABLE 9.3 Endothelin (ET) release on reperfusion (RP) subsequent to 20 
minutes global ischaemia. 
Sampling period ET release Change over 
(pg/min/g) control 
(-fold) 
Pre-ischaemic control 0.73+0.07 
RP 0-5 min 0.92+0.10 1.32+0.17 
RP 10-15 min 0.69+0.07 1.04+0.21 
RP 25-30 min 0.66+0.04 0.96+0.12 
RP 55-60 min 0.85+0.07 1.31 +0.30. 
Values are presented as mean ± S.E.M., n=7. All effluent collections were 
made in the non-circulating mode of perfusion. No statistically significant 
changes were observed (P<0.05). 
3) Effect of endothelin-2 on the coronary perfusion pressure of non-ischaemic 
and ischaemic isolated rat hearts 
Bolus injections of endothelin-2 provoked dose-dependent increases in coronary 
perfusion pressure within the range of Ing to lµg per heart (Figure 9.2, 
diamonds). The vehicle for endothelin-2 had only a transient reversible effect 
The perfusion pressure increased slowly and reached a maximum after 1 to 3 
min. This pressure was maintained for at least 5 minutes except when the highest 
doses were administered. Coronary perfusion pressure increased from 65±2.1 
(baseline) to a maximum of 134±7.5 mm Hg ( + 106% increase). The threshold 
dose for the vasoconstrictive action was """20 ng, and the EC50 calculated by non-
linear regression analysis of pooled data was 69 ng per heart 
Hearts made ischaemic through low-flow perfusion for 1 hour reacted more 
readily to exogenous endothelin-2 (0. lng to lµg) than normoxic hearts (Figure 
9.2, crosses): the baseline coronary perfusion pressure was 93±2.4 mmHg and 
increased to a maximum of 188±4.5 mmHg ( + 238 % ) at 1 µg endothelin-2. The 
threshold dose was below 1 ng, and the EC50 calculated by non-linear regression 
of pooled data was 1.9 ng per heart; Figure 9.2). 
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CORONARY PERFUSION PRESSURE (mmHg) 
200.--~~~~~~~~~~~~~~~~~~~~---, 
60'-+-+*-+-~t-----t-~+--+~~---t~-+-~+---t-~+--+~-+---' 
10·• 10·• 10·1 10·• 
ENDOTHELIN-2 (g) 
-*- Low-flow laohaeml• --+- No laohaemla 
FIGURE 9.2 Dose response curve for the effect of endothelin-2 on coronary 
perfusion pressure in control and reperfused heans. Endothelin was applied to 
heans perfused at constant flow without (controls, diamonds) or subsequent to 1 
hour of low-flow ischaemia (reperfused heans, crosses). Data are expressed as 
absolute pressure readings (mmHg) as a function of endothelin-2 dose (g per 
hean) applied cumulatively at 2.5 minute intervals. The mean curve was fitted by 
non-linear regression and the EC50 determined as 69 (control) and 1.9 
(reperfusion) ng endothelin-2 per hean. Means± S.E.M., n=3. 
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10·• 10 -• 10 _, 10 -• 0 
ENDOTHELIN-2 (g) 
FIGURE 9,3 Dose response curve for endothelin-2 action on maximum systolic 
ventricular pressure of constant flow-perfused isolated rat heans. Details as for 
Figure 9.2. The mean EC50 for the positive inotropic response was 185 ng 
endothelin-2 per hean. 
4} Effects of endothelin-2 on mechanical function in control and reperfused 
hearts. 
i) Effect on systolic developed pressure and aortic output: Measurement of 
systolic developed pressure reflected the effect of endothelin-2 on the inotropic 
state of the heart Under constant flow perfusion conditions (Langendorff mode, 
1.25 mmol/l ca2+), the baseline systolic developed pressure was 36±2.3 mmHg, 
the threshold dose for the positive inotropic effect was ::::50 ng, the maximum 
systolic developed pressure 65± 1.8 mmHg ( + 81 % increase), and the EC50 was 
185 ng per heart (Figure 9.3). 
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In the isolated working heart, the same dose of endothelin-2 (100 ng) had no 
significant influence on aortic output (inotropy) over 40 minutes post application 
(Table 9.4). Coronary flow was reduced, albeit not significantly (p>0.05 at all 
time points). 
TABLE 9.4 Time-dependence of aortic output (AO) and coronary flow (CF) in control working hearts (no ischaemia in the absence and presence of 100 ng endothelin-2. 
Control 
AO (ml/min) AO recovery ( % ) CF (ml/min) 
Reference 45.1±2.4 100 15.6±0.5 lOmin 44.7±4.2 99±2.0 15.3±0.4 20min 44.0±2.2 98±2.0 15.6±0.5 
30min 43.3±2.4 96±1.9 15.6±0.5 40min 42.7±2.6 95±2.4 15.3±0.4 
+ lOOng Endothelin 
AO (ml/min) AO recovery ( % ) CF (ml/min) 
Reference 44.0±2.0 100 16.0±2.0 10 min 46.0±2.4 105±4.5 12.5± 1.5 
20min 44.0±4.0 101±3.0 13.5±1.5 
30min 40.5±3.5 93±4.0 14.0±2.0 40min 39.5±2.0 90±2.0 14.5±1.5 
Reference refers to the reference point 10 min after onset of work ( =pre-ischaemic control of Table 9.5) followed, in this series, by 20 minutes normoxic perfusion. 10, 20, 30, and 40 minutes refers to the corresponding time points after this 20 minutes normoxic perfusion and thus correspond to the same time points post-ischaemia of Table 9.5 and Figure 9.4. The aortic output recoveries and coronary flow rates in the presence of endothelin are not significantly different from the respective control values (p>0.05). 
ii) Effect on post-ischaemic reperfusion function: Since endothelin is a positive 
inotropic agent, the influence of endothelin on heart function during post-
ischaemic reperfusion was studied. The influence of a 20 minutes global 
ischaemic period on reperfusion function in controls and hearts treated with 100 
ng or 200 ng endothelin-2 at the onset of reperfusion is shown in Figure 9.4 and 
Table 9.5 Aortic output was significantly lower between 10 and 40 minutes of 
reperfusion compared to pre-ischaemic controls (p<0.01 and 0.05, respectively). 
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100 ng endothelin-2 given at the onset of reperfusion improved heart 
performance up to 20 minutes and worsened it thereafter (20 to 40 minutes). 
These changes may partly be due to concomitant changes in coronary flow which 
was reduced time-dependently during reperfusion (p<0.05 up to 30 minutes). 
The higher dose of endothelin (200 ng) reduced aortic output throughout 
reperfusion compared to the corresponding control values (p<0.05, except at 10 
minutes). The coronary flow reduction was similar to that observed with the 
lower dose of endothelin. 
AORTIC OUTPUT RECOVERY (II.) 








10 20 30 
REPERFUSION TIME (min) 
• ....--, 
40 
- CONTROL O • 100 ng ET-2 § • 200 ng ET-2 
FIGURE 9.4 Influence of endothelin-2 on recovery of aonic output on 
reperfusion. The post-ischaemic aonic output recovery between JO and 40 
minutes of reperfusion in the absence (Control) and presence of JOO or 200 ng 
endothelin-2 given at the onset of reperfusion was plotted. For pre-ischaemic 
reference values see Table 9.5. 
Means ± S.E.M., n=7 (control and JOOng endothelin-2) and 3 (200 ng 
endothelin-2). * p<0.05 vs control. 
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TABLE 9,5 Influence of endothelin-2 on recovery of aortic output (AO) after 
ischaemia. Coronary flow (CF) is given for comparison. 
Control 
Time point AO (ml/min) AO recovery ( % ) CF (ml/min) 
Control 48.0±2.21 100 16.3± 1.2 
lOmin 36.6±2.21 77±1.9 16.1 ± 1.1 
20min 37.3±2.12 78± 1.9 16.2± 1.2 
30min 38.7±2.22 80±1.7 16.6±1.3 
40min 39.8±2.1 82± 1.8 16.5± 1.3 
+ 100 ng endothelin 
Time point AO (ml/min) AO recovery ( % ) CF (ml/min) 
Control 47.0±3.4 100 16.8± 1.41 
lOmin 41.1 ±3.8 88±3.44 11.3± 1.12 
20min 39.7±3.22 85±3.3 11.9± 1.12 
30min 36.1±3.52 75±4.94 12.7±1.2 
40min 34.5±4.1 70±4.3 13.7± 1.2 
+ 200 ng endothelin 
Time point AO (ml/min) AO recovery ( % ) CF (ml/min) 
Control 44.5±5.5 100 17.0±1.02 
IOmin 30.0±1.4 68±4.04 13.0±0.62 
20 min 28.0±1.4 63±5.53 13.5±0.5 
30min 26.5±2.5 60±1.53 14.5±0.5 
40min 25.5±2.5 59±1.4 15.0± 1.0 
Values are mean ± SEM, r.=7 (lOOng ET-2). The experim~ntal protocol is 
described in the r,ethods. p<0.01 vs, pre-ischaemic value; p<0.05 vs. pre-
ischaemic value; p<0.01 vs. control (no endothelin); 4p<0.05 vs. control. 
Summary of findini:s of study. 1) Immunoreactive endothelin was released 
under basal, ischaemic and reperfusion conditions in picogram amounts. 
2) Endothelin release rate was reduced during ischaemia and increased on 
reperfusion. 
3) Exogenous endothelin caused coronary vasoconstriction in reperfused 
hearts with a 30-fold higher potency than in hearts not subjected to 
ischaemia. 
4) Mechanical reperfusion function was initially improved and later 




DISCUSSION, SUMMARY AND CONCLUSIONS 
10.1 Possible Mechanisms Contributing to Reperfusion ca2 + Overload 
and Stunning. 
10.1.1 Sarcolemmal ca2 + Fluxes. 
i) Enhanced ca2 + influx at reperfusion. Data obtained in this study ( chapter 5) 
indicate that increased cytosolic ca2 + overload at the onset of reperfusion by 
compounds that increase transsarcolemmal ca2 + fluxes, exacerbates 
reperfusion stunning (Figure 5.2). 
Although cytosolic ca2 + overload is proposed as one major cause of mechanical 
stunning (Bolli, 1990), thus far the evidence has been indirect Marban and co-
workers ( 1989) measured intracellular ca2 + during ischaemia and 2.5 minutes 
after reperfusion using nuclear magnetic resonance spectrometry. During 
ischaemia, they observed an increase in time averaged intracellular free ca2 + 
which had decreased to normal ( or below normal) within 2.5 minutes of 
reperfusion. They did not however measure intracellular free ca2 + levels at the 
onset of reperfusion. In a recent study Kusuoka and co-workers ( 1990) found 
substantially increased systolic ca2 + transients in reperfused stunned hearts, but 
do not report on findings right at the onset of reperfusion. It therefore remains 
uncertain whether there is an increase in free cytosolic ca2 + during early 
reperfusion. In this study ( chapter 5), the hypothesis that ca2 + influx ( and 
possible cytosolic ca2 + 'overload') is responsible for post ischaemic stunning 
was tested as certain interventions at the time of reperfusion or before ischaemia 
may be expected to reduce or exacerbate reperfusion injury and stunning. The 
use of Ca2 + influx enhancing procedures at the time of reperfusion exacerbated 
stunning. This finding supports Kusuoka and co-workers ( 1987) who by using low 
extracellular ca2+ concentrations in the reperfusion solution improved post-
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ischaemic mechanical function. Low ca2 + (0.5 mM) reperfusion solutions were 
also used by Kuroda and co-workers (1986) with improved reperfusion 
recoveries, but these experiments were performed with ca2 + concentrations of 
2.5 mM in the working phase when mechanical function measurements were 
made. This makes direct comparisons between the two sets of data difficult The 
data obtained during the present study indicate that there is a dose dependent 
decrease in recovery of function with an increase in ca2 + concentration of the 
early reperfusion solution. 
Similar trends were obtained using the positive inotropic agents Bay K 8644, 
isoproterenol or forskolin during early reperfusion. They all had a detrimental 
effect on the post-ischaemic mechanical function when given at the time of 
reperfusion. Although the effect of a low ca2 + concentration in the reperfusion 
solution has been investigated before, the use of inotropes at the onset of 
reperfusion, and their effects on function have not been studied. The effects of 
inotropes (late in reperfusion) on the already stunned heart has been 
investigated (Mercier et al., 1982; Ellis et al., 1983; Becker et al., 1986) to 
ascertain their ability to improve contractile function in these stunned hearts. 
There appears to be a short period during early reperfusion when the heart is 
more susceptible to reperfusion damage caused by ca2 + influx and overload. 
The use of agents enhancing ca2 + influx should therefore be restricted to "late" 
reperfusion when the heart is less prone to ca2 + induced damage. 
ii) Inhibition of ca2 + influx. In contrast, agents thought to inhibit ca2 + fluxes 
(nisoldipine), when given at the time of reperfusion, improved post-ischaemic 
mechanical function (Figure 5.3). These agents included nisoldipine, one of the 
more specific organic ca2+ antagonists (Kass, 1983) and the inorganic ca2+ 
channel blockers Mn2+ or Mg2+. Although magnesium is a normal constituent 
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of the extracellular fluid, it has ca2 + channel blocking properties when used in 
high concentrations (Lansman, Hess and Tsien, 1986). Manganese is also a strong 
ca2 + channel blocking agent but at much lower concentrations (Kass and Tsien, 
1975). Both Mn2 + and Mg2 + maintained mechanical arrest during their 
infusion in the early reperfusion period. It was not clear whether the protective 
effect lay in their ability to maintain mechanical arrest during early reperfusion 
or their ca2+ blocking action. In this study a high K + (21 mM) solution at the 
time of reperfusion maintained arrest, but did not improve functional recovery of 
the heart When a high K + was used in conjunction with Mn2 + or the high 
Mg2 + solution, the functional recoveries were significantly improved and were 
comparable with those of the groups of hearts reperfused with a normal K + 
concentrations and one of the cations added. Therefore the protection with high 
Mg2 + or Mn2 + was not acting by inducing mechanical arrest during the early 
reperfusion period. Data obtained using these inorganic ca2 + channel blockers 
lends further support to the hypothesis that the prevention of ca2 + influx at the 
time of reperfusion has a protective effect on the post-ischaemic heart 
Surprisingly, nisoldipine, when given at the onset of reperfusion, improved 
reperfusion function in the rat heart model. Calcium antagonists have been used 
during reperfusion in an attempt to reduce ca2 + influx, but ca2 + influx was 
merely delayed (rather than prevented) after 30 or 60 minutes of ischaemia 
(Nayler et al., 1988). This finding may be due to the fairly long ischaemic episode 
used in that study causing more severe ischaemic and subsequent reperfusion 
damage. Reperfusion after 30 minutes ischaemia, may cause irreversible injury 
(Jennings et al., 1985). These authors found that no long term protection was 
achieved when nifedipine was used in the reperfusion solution after these 
extended periods of ischaemia (Nayler et al., 1988). Calcium antagonists have 
previously been used to attenuate stunning (Nayler, Buckley and Leong, 1990; 
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Przyklenk and Kloner, 1988; Przyklenk et al., 1989). The treatment was 
commenced before ischaemia and maintained throughout ischaemia and 
reperfusion (N ayler, Buckley and Leong, 1990), or given only during reperfusion 
or 30 minutes after reperfusion (Przyklenk and Kloner, 1988). The fact that 
ca2 + antagonists have marked haemodynamic and vasodilator effects make the 
interpretation of the latter groups results difficult It is possible that the 
beneficial effects seen may be due to increased coronary flows and/ or a 
reduction in afterload (systemic blood pressure) in this model. However, in one 
specific study, low doses of intracoronary nifedipine were used late in 
reperfusion to attenuate stunning in the absence of any systemic haemodynamic 
changes (Przyklenk et al., 1989). The mode of action of the late administration of 
this drug is unknown but may relate to the presence of formed blood cells 
present in the dog model and absent from our isolated crystalloid perfused rat 
heart model. 
Based on these findings, we have proposed a two-phased model for ca2 + as 
pathogen for stunning (Opie and Du Toit, 1992). In the first and causative phase, 
there may be a brief period of cytosolic ca2 + overload which is followed by the 
second phase associated with hypocontractility and an apparent shonage of 
activator ca2 +. 
10.1.2 Possible Role for the Sarcoplasmic Reticulum in Ischaemia /Reperfusion 
Cytosolic ca2 + Overload and Stunning. The role of the SR in mechanical 
stunning has thus far been explored with limited success. Besides the entry of 
ca2 + by the voltage dependent ca2 + channels, another possible source of 
cytosolic ca2+ overload is the sarcoplasmic reticulum (SR) (Pesaturo and 
Gwathmey, 1990). Reperfusion with sudden generation of free radicals (Hearse, 
Humphrey and Bullock, 1978) may be associated with release of ca2+ from the 
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SR (Shattock, Hearse and Matsuura, 1990), so that interventions that reduce such 
ca2 + release and recycling may attenuate stunning. 
i) Reperfusion function following sarcoplasmic reticulum ca2 + release 
inhibition during ischaemia and/or reperfusion. Ryanodine is thought to be an 
agent which in low concentrations acts to open the ca2 + channel of the SR 
(Rousseau, Smith and Meisner, 1987), whereas higher concentrations close the 
channel (Marban and Wier, 1985; Inui et al., 1988) thus effectively acting as an 
internal ca2 + blocker which inhibits intracellular ca2 + release and oscillations 
(Kihara and Morgan, 1991). In this study, the use of ryanodine before ischaemia 
or at the onset of reperfusion, improved reperfusion function (Figure 5.3). The 
ryanodine concentration we used was low (3xl o-9 M) but was similar to that 
having a negative inotropic effect in the perfused rat heart (Thandroyen et al., 
1988), and close to that (lo-8 M) which decreased the Ca2+ signal and peak 
systolic pressure in the isolated rat atria (Northover, 1991 ). Infusion of ryanodine 
at the time of reperfusion attenuated stunning as shown by a better post-
ischaemic mechanical function. These data support a role for excess ca2 + 
cycling through the SR or release of ca2+ from the SR in the genesis of 
stunning. 
Possible mechanism of protection of ryanodine: Kusuoka and co-workers 
( 1990) reported that the stunned heart exhibited an increase in amplitude of 
Ca2 + transients ( diastolic I systolic). They suggest that these increases in cytosolic 
ca2 + transients would require that more ATP be spent in ca2 + sequestration 
which may in turn explain the decreased efficiency of energy utilization of the 
stunned myocardium (Laster et al., 1989). This proposal may also explain why 
some research groups (Krause, Jacobus and Becker, 1989; Limbruno et al., 1989) 
found decreased function of the SR ca2 + A TP-ase pump in the stunned heart 
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Inadequate tissue ATP in direct proximity to the SR may cause decreased pump 
function if ATP were compartmentalised in the myocyte (Bricknell, Daries and 
Opie, 1981). Ryanodine by its ca2+ modulating action may hypothetically 
decrease excessive ca2 + transients, thus helping to remove the cause of 
stunning. 
ii) Reperfusion function followin2 SR Ca2 + A TP-ase pump inhibition during 
ischaemia and/ or reperfusion. 
Ryanodine (chapter 5) and ruthenium red (Benzi and Lerch, 1992), two 
inhibitors of release of ca2 + from the SR when given during reperfusion, are 
both able to improve reperfusion stunning, thereby supporting the concept that 
excess cycling of ca2 + may contribute to post-ischaemic mechanical dysfunction. 
Because it is believed that ischaemic and reperfusion induced cytosolic ca2 + 
overload (Bolli, 1990), or excess reperfusion intracellular ca2+ cycling 
(Kusuoka et al., 1990; Benzi and Lerch, 1992) may exacerbate stunning, we 
tested the effects of ca2 + A TP-ase pump inhibitors given before ischaemia and 
during reperfusion mechanical function (stunning). Given before ischaemia, 
these A TP-ase pump inhibitors may cause SR and cytosolic ca2 + depletion by 
increased Na+ /Ca2+ exchange activation (Baudet, Shaoulian and Bers, 1993) 
and given during reperfusion, these compounds may decrease potentially 
harmful ca2 + oscillations and ATP wastage. 
Pre-treatment of the isolated rat heart with either cyclopiazonic acid or 
thapsigargin in the appropriate concentrations before ischaemia attenuated 
reperfusion stunning in this study ( chapter 7). These improved functional 
recoveries may have been due to drug induced depletion of SR ca2 + which 
could attenuate the extent of ca2 + overload that occurs during ischaemia and 
reperfusion, because inhibition of the ca2 + uptake pump is associated with i) 
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depletion of ca2+ from the SR, and ii) increased activity of the sarcolemmal 
Na+ /Ca2+ exchanger to extrude ca2+ (Baudet, Shaoulian and Bers, 1993). It is 
of interest that Mitchell and co-workers (1992) found that pre-ischaemic 
depletion of SR ca2 + using thapsigargin or ryanodine could mimic 
preconditioning in the isolated rat heart model. Their proposed mechanism of 
pre-conditioning is that inositol triphoshate induces ca2 + release from internal 
ca2+ stores (SR) before ischaemia, decreases the intracellular ca2+ levels in 
these stores and thus decreases intracellular ca2 + overload during ischaemia 
and reperfusion. Similarly, high Mg2 + containing cardioplegic arrest solutions, 
which are thought to deplete the SR of ca2 +, attenuate the severity of ischaemic 
injury when compared with high K + arrest solutions which are thought to induce 
pre-arrest SR ca2+ loading (Steenbergen et al., 1990). 
Possible mechanism of protection of CPA and thapsigargin: If one assumes 
that the elevated cytosolic ca2 + levels associated with ischaemia require that 
more ca2 + be sequestered into the SR and more ATP be consumed (Barry et 
al., 1987; Benzi and Lerch, 1992), transient inhibition of the ca2+ ATP-ase 
pump activity would be expected to have an ATP sparing effect in ischaemic 
tissue. 
Although it has been proposed that increased ca2 + cycling during ischaemia 
may cause elevated ATP consumption (and wastage) (Barry et al., 1987), the 
data obtained in this study ( chapter 7) indicate that CPA and thapsigargin did not 
have an ATP sparing effect on the ischaemic heart. Post-ischaemic ATP levels of 
thapsigargin (lo-6 and 2.5x10-8 M) treated hearts were lower than those of 
control and CPA treated hearts. Despite similar tissue ATP levels at the end of 
ischaemia, there was a difference in functional recoveries observed when 
comparing the two thapsigargin treated groups with one another. This finding 
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would suggest that the protection afforded by these A TP-ase pump inhibitors is 
not related to high energy phosphate preservation. Although thapsigargin ( 10-6 
and 2.5x10-8M) decreased tissue ATP levels, reperfusion function with the low 
concentration (2.5XI0-8M) of the compound was better than with the higher 
concentration. 
Specificity of these compounds: Cyclopiazonic acid is a specific and very 
potent inhibitor of the SR ca2 + A TP-ase pump of cardiac (Lahouratate, 
Quiniou and Leoty, 1992; Mitchell et al., 1992; Pery-man et al., 1993), and 
vascular smooth muscle (Shima and Blaustein, 1992). Although no data are 
available to quantify the percentage inhibition of cardiac SR ca2 + A TP-ase 
pumps by cyclopiazonic acid, it totally inhibits caffeine-evoked increases in 
tension in vascular smooth muscle (Shima and Blaustein, 1992) and ca2+ 
transport into isolated canine cardiac SR vesicles (Lahouratate, Quiniou and 
Leoty, 1992 ). 
It has recently been shown that both cyclopiazonic acid and thapsigargin are able 
to partially block SR ca2 + uptake in multicellular rabbit cardiac preparation 
(Baudet, Shaoulian and Bers, 1993). These authors (Baudet, Shaoulian and Bers, 
1993) also found that although both compounds decreased ca2+ uptake into the 
SR, cyclopiazonic acid had the more expected effect in that it significantly 
slowed relaxation time in their preparation. This was in contrast with 
thapsigargin that slowed contraction but had very little effect on myocyte 
relaxation time. From these data, and our own findings, it would seem that 
thapsigargin may have other sites of action in the intact myocyte which may 
explain the unexpected data we obtained with high concentrations of the 
compound. 
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Concentration related effect of thapsigargin: A low concentration of 
thapsigargin given at the onset of reperfusion was ineffective in preventing 
stunning. This finding may be due to only partial inhibition of ca2 + A TP-ase 
pump (Thastrup et al., 1990; Shima and Blaustein, 1992) which would allow 
continued ca2 + cycling between the SR and the cytosol Although a higher 
concentration of thapsigargin (10-6M) only had a weak negative inotropic action 
in the non-ischaemic heart, it worsened reperfusion stunning when given before 
ischaemia or at the onset of reperfusion. The detrimental effects of high 
concentrations of the compound may be ascribed to its ability to increase 
cytosolic ca2 + concentrations by causing ca2 + leakage from unidentified ca2 + 
stores (Thastrup et al., 1989). The effect of high concentrations of thapsigargin 
(given during reperfusion) on reperfusion function mimic those observed with 
inotropes in other parts of this study ( chapters 5 & 9). During reperfusion, there 
was an initial increase, followed by a later decrease in mechanical function. 
Ischaemic contracture was used as an index of cytosolic ca2 + levels during 
ischaemia. Although there were no differences in the time to onset of 
contracture, the amplitude of ischaemic contracture was higher in hearts treated 
with the high thapsigargin concentration than in the CPA and low thapsigargin 
treated hearts. This may indicate that the higher concentrations of thapsigargin 
increased the ischaemic ca2 + concentrations. The transient increase in the 
cytosolic ca2+ levels observed in vascular smooth muscle (Dick and Sturek, 
1993) during thapsigargin ( 10-6M) treatment, may also occur in myocytes, and 
could explain the increase in the magnitude of ischaemic contracture ( a 
reflection of ca2 + levels) observed after pretreatment with this concentration of 
thapsigargin. 
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Reservations of studies with thapsigargin and cyclopiazonic acid: Although 
these compounds protected against stunning, they are both negatively inotropic 
agents when used in the working heart model ( chapter 7). Data concerning the 
inotropic action of thapsigargin in cardiac tissue are at present scarce and 
contradictory. Data presented in chapter 7 show that thapsigargin is a weak 
negative inotrope in the working heart model but not in the Langendorff model 
which is in accord with findings in isolated guinea pig myocytes (Lewartowski 
and Wolska, 1993). These data are contradicted by the finding that thapsigargin 
almost abolishes cell shortening in isolated rat ventricular myocytes (Kirby et al., 
1992) at virtually the same concentration. 
Another weakness is that our study and those of others cannot fully exclude other 
sites of action for the two compounds studied. Nonetheless, these compounds 
appear to be valuable tools to aid the study of intracellular ca2 + fluxes in 
cardiac tissue. Extensive further clinically applicable investigation would 
however be needed before any possible application to patients. 
iii) The possible role of the sarcoplasmic reticulum in mechanical stunning. Two 
independent studies (Limbruno et al., 1989; Krause, Jacobus and Becker, 1989) 
examined the function of the ca2 + A TP-ase pump of SR vesicles obtained from 
stunned hearts. They found that A TP-ase pump function of these vesicles was 
less effective in sequestering ca2 + than the A TP-ase pumps from normal hearts. 
Other than the ca2 + uptake abnormalities, some studies have implicated the 
release channels of the SR in stunning (Hohl, Galeb and Altschuld, 1992; Davis, 
Lebolt and Feher, 1992). 
Contrary to these findings, Kusuoka and co-workers ( 1990) found that 
intracellular ca2 + transients were augmented in the stunned reperfused heart 
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Their findings were supported by those showing that ca2 + uptake of stunned SR 
ca2 + A TP-ase vesicle was 17 % higher than that of control vesicles (Lamers et 
al., 1993). These increased ca2+ oscillations should be associated with increased 
SR ca2 + A TP-ase pump activity, which may explain the increased oxygen 
consumption of the stunned myocardium (Laster et al., 1989). These data would 
imply that neither release from, nor uptake of ca2 + into the SR is at fault, but 
that the contractile apparatus in the stunned heart may be less sensitive to 
activator ca2 + during early reperfusion. 
10.1,3 Role of the Na+ /H + Exchanger in Stunning. 
In this study (chapter 6), inhibition of Na+ /H + exchange activity before 
ischaemia or at the onset of reperfusion attenuated reperfusion stunning (Figure 
6.1 and Figure 6.5). Although a transient increase in cytosolic ca2 + levels 
associated with stunning has been linked to ca2 + entry via the ca2 + channel 
(Chapter 5; Opie and Du Toit, 1992), other entry pathways may contribute to this 
ca2+ overload. The possible contribution of the Na+ /H + exchanger has been 
explored but with limited success mainly due to the nonspecificity of the 
inhibitors previously available. Also, these compounds when given throughout 
the experiment (Karmazyn, 1988; Sack et al., 1992) or before ischaemia (Scholz 
et al., 1992; Tani and Neely, 1989; Murphy et al., 1991), may by an anti-ischaemic 
action indirectly decrease reperfusion stunning. 
The myocardial Na+ /H + exchanger is stimulated by a decrease in intracellular 
pH or an increase in extracellular pH (Lazdunski, Frelin and Vigne, 1985). 
During ischaemia, myocyte pH decreases (Jacobus et al,. 1977) and Na+ 
increases (Regan et al,. 1980; Jennings et al,. 1985; Tani and Neely, 1989; 
Murphy et al,. 1991). Lazdunski and co-workers (1985) hypothesised that the low 
intracellular pH during ischaemia would activate the Na+ /H+ exchanger on 
165 
reperfusion, thereby increasing Na+ accumulation during early reperfusion. This 
proposal was confirmed by Tani and Neely (1989) who showed that there was a 
slow gradual increase in tissue Na+ levels during 30 minutes ischaemia followed 
by a sudden sharp rise during reperfusion. Amiloride pretreatment largely 
eliminated this rapid Na+ rise during reperfusion, but had very little effect on 
the slow influx of Na+ during ischaemia. During ischaemia, Na+ may thus enter 
the myocyte though the previously described (Ver Donck and Borgers, 1991) 
modified Na+ -channel. Tani and Neely (1989) also found that the intracellular 
Na+ level after 2 minutes reperfusion was linearly related to the 45ca2 + uptake 
and to depression of reperfusion function. Reperfusion of the ischaemic heart 
with an acidotic solution (Kitikaze, Weisfeldt and Marban, 1988) also decreases 
reperfusion stunning. The improved mechanical function is presumably due to 
reduced Na+ /H + and consequently less Na+ /Ca2+ exchanger activity during 
reperfusion. 
Tani and Neely (1989) who studied a high concentration of amiloride (lo-3M) 
given upon reperfusion only, used a relatively short ischaemic time of 15 minutes 
in one protocol and 30 minutes in another protocol. After the short ischaemic 
time they could show no evidence of mechanical stunning in the Langendorff 
model. On the other hand, after 30 minutes ischaemia the very low mechanical 
function during reperfusion and the high uptakes of cytosolic 45ca2 + may 
suggest that some of the myocardium was irreversibly injured, so that by 
definition (see details of definition in chapter 4 ), true stunning was not present 
Thus there has as yet been no direct evidence favouring the view that inhibition 
of Na+ /H + exchange specifically during the reperfusion period could prevent 
reperfusion stunning and arrhythmias. 
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Amiloride specificity: The data obtained here and elsewhere with amiloride 
suffer from the defect that it is a relatively non-specific compound. Besides 
inhibiting Na+ /H + exchange, amiloride also inhibits i) the Na,K-ATP-ase 
(Kennedy et al., 1986), ii) the Na+ /Ca2+ exchanger in myocardial tissue 
(Kennedy et al., 1986), iii) sodium channels in various tissues (data not available 
for cardiac tissue) (Benos, 1982) and iv) sarcolemmal T-type ca2+ channels 
(Tang, Presser and Morad, 1988). Protection by amiloride against reperfusion 
injury may thus be afforded by any one, or, all of these properties of the 
compound. In studies where the inhibitor was given before ischaemia and/ or 
during ischaemia (Scholz et al., 1992; Tani and Neely, 1989; Dennis et al., 1990; 
Karmazyn, 1988; Sack et al., 1992), the compound may have had an anti-
ischaemic action. If the Na+ channel blocker lidocaine has anti-ischaemic 
properties (Gerstenblith et al., 1978; Wilson et al., 1993), then it would be 
reasonable to assume that any blocking properties that amiloride may have on 
the cardiac Na+ channel, would also be anti-ischaemic. This possible anti-
ischaemic property of the compound would also be expected to decrease 
reperfusion injury ( Opie, 1989b ). 
Possible reasons for discrepancies between data obtained usmg the 
Langendorff vs working heart model: Amiloride was used as a reference 
compound to compare its effects with those of HOE 694. We used an amiloride 
concentration (IO-3M) which protected the Langendorff perfused rat heart 
model against ischaemic and reperfusion damage after 30 minutes ischaemia 
(Tani and Neely, 1989). In our study, this concentration protected the 
Langendorff (non-working) preparation (Figure 6.8), but not the working heart 
model against reperfusion stunning (Figure 6.3). The working heart model was, 
however, protected against reperfusion stunning by lower concentrations ( 10-
5M) of the compound. The exact reason for this discrepancy in the functional 
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recovery between the two models is not clear but may be explained by one, or 
both, of the following factors. First, the Langendorff perfused (left ventricular 
balloon containing) heart performs isovolumic contractile work while the 
working heart performs both pressure and volume work Hence, it may be 
possible that the higher concentrations of amiloride together with ischaemia, 
detrimentally affected the recovery of the working heart These differences may 
therefore be due to the different work loads to which the types of perfused 
hearts are exposed. Second, judging by the very good (when compared with the 
working heart model) functional recoveries recorded with the Langendorff 
model after 30 minutes ischaemia ( our observation and those of Tani and Neely 
(1989)), it seems that the Langendorff model is not as sensitive a measure of 
functional recovery as the working heart model. The isovolumic Langendorff 
model may not be as critical in measuring and accentuating diastolic (muscle 
relaxation) abnormalities in the stunned heart If diastolic abnormalities are an 
important facet of stunning (which they appear to be), then these abnormalities 
may not be detected in the isovolumic model. The working heart model relies on 
normal relaxation characteristics for proper left ventricular filling to take place. 
Slower diastolic relaxation would decrease the diastolic left ventricular filling 
time and consequently decrease aortic output values. This matter needs further 
investigation to clarify the discrepancies observed. 
Reservations of these studies performed with HOE 694: Although HOE 694 
is thought to be a specific and potent inhibitor of the Na+ /H+ exchanger, few 
publications are available. Schmid and co-workers (1992) have shown that HOE 
694 is a potent inhibitor of the Na+ /H + exchanger in porcine cerebral 
capillaries. Data concerning its specificity on cardiac Na+ /H + exchange are not 
available. The absence of a dose-dependent effect with the three concentrations 
of HOE 694 tested in this study (chapter 6), may indicate that too narrow a 
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concentration range was used. It may be that the three concentrations used were 
all high enough to cause near-total inhibition of the Na+ /H + exchanger in this 
model. 
10.1.4 Role of Na+ /Ca2 + Exchanger in Stunning. 
Increased intracellular Na+ levels should activate the Na+ /Ca2+ exchanger 
and lead to ca2+ influx. Grinwald and Bosnahan (1987) have shown that 
elevated intracellular Na+ levels during hypoxia could indirectly contribute to 
ca2+ overload in the reoxygenation period. In support of these findings, Murphy 
and co-workers (1991), examined ischaemic myocardial Na+ and ca2+ gain 
using nuclear magnetic resonance. They showed that amiloride pretreatment 
decreased the intracellular rise of these two ions during ischaemia and improved 
reperfusion mechanical function. Reperfusion with a high extracellular Na+ 
solution (Kusuoka, De Hurtado and Marban, 1993) decreases reperfusion 
stunning, presumably by restricting reperfusion Na+ efflux and ca2 + influx via 
the Na+ /Ca2+ exchanger. The data presented by these groups (Murphy et al., 
1991; Grinwald and Bosnahan, 1987) suggests that the Na+ /Ca2+ exchanger 
contributes to transient reperfusion cytosolic ca2 + overload which could 
predispose to reperfusion stunning according to the proposals made earlier in this 
thesis ( chapter 5). 
Mechanism of ca2 + induced stunning: Early cytosolic ca2 + overload has 
been proposed as a mechanism for reperfusion arrhythmias, acting by induction 
of the transient inward current, (Iti) (Opie and Coetzee, 1988). Furthermore net 
ca2 + overload is thought to be instrumental in the genesis of other aspects of 
reperfusion injury, such as accelerated cell necrosis (Kass and Tsien, 1975). The 
actual mechanism of the ca2 + induced damage to the contractile mechanisms is 
still obscure. The data obtained with Mn2 + and Mg2 + added to the K + -arrested 
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hearts show that inhibition of contractile activity of the heart during early 
reperfusion cannot be the mechanism. Rather, excess ca2+ entry by the voltage 
dependent ca2+ channel and indirectly, by Na+ /H+ exchange activation 
appeared to play a role. Also, the SR may act as a ca2 + source or deplete 
cytosolic ATP levels by perpetuating cytosolic ca2 + oscillations. Speculating, 
excess cytosolic ca2 + could have activated ca2 + dependent enzymes proteases 
and phospholipases, with consequent damage to contractile organelles (Kass and 
Tsien, 1975), which would account for the proposed decrease in the 
responsiveness of the myofilaments to ca2 + (Marban, 1991 ). Another possibility 
is that the ca2 + antagonist could directly interact with the cell membrane to 
prevent the formation of free-radicals (Koller and Bergmann, 1989; Weglicki, 
Mak and Simic, 1990), however this proposal would appear to be excluded by the 
data with the Mn2+ and Mg2+. A remaining possibility is that excess cytosolic 
ca2 + is able to enhance formation of free-radicals (McCord, 1985). 
The use of ca2 + antagonists late in reperfusion in our isolated non-blood 
perfused heart did not improve mechanical function (Figure 5.5). The 
phenomenon of improved function with ca2 + antagonist treatment late in 
reperfusion (Przyklenk et al., 1989) may be specific to the blood perfused heart 
and may thus not be relevant in the isolated rat heart model. 
10.2 Abnormal Cytosolic ca2+ Fluxes and Arrhythmias. 
10.2.1 Role for the ca2+ Channel in Ischaemic and Reperfusion Arrhythmias. 
Calcium influx via sarcolemmal ca2 + channels may contribute to the elevated 
cytosolic ca2 + levels seen during ischaemic and reperfusion ventricular 
fibrillation. There is sound experimental evidence that ca2 + antagonists 
pretreatment can prevent ventricular arrhythmias during myocardial ischaemia 
and reperfusion (Thandroyen, 1982; Lubbe, McLean and Nguyen, 1983; Clusin et 
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al., 1982; Clusin et al., 1984). The heterogeneity of the action of ca2+ 
antagonists however make it difficult to determine whether these compounds 
have their anti-arrhythmic action by decreasing the ca2 + current or by their 
possible anti-ischaemic action. The efficacy of these channel blockers in 
decreasing reperfusion arrhythmias are less clear. While these compounds were 
found to be effective in decreasing reperfusion arrhythmias in the rat heart 
(Lubbe, McLean and Nguyen, 1983; Weishaar and Bing, 1980), these effects 
appear to be species related. Some research groups have shown ca2 + 
antagonists to be antiarrhythmic in the canine model (Coker and Parratt, 1983), 
while others found these channel blockers to be ineffective (Naito et al., 1981 ; 
Sheehan and Epstein, 1982). The efficacy of ca2+ antagonist treatment in the 
prevention of arrhythmias therefore seems species dependent 
10.2.2 Intracellular ca2+ Oscillations and Ventricular Arrhythmias. 
Both cyclopiazonic acid and thapsigargin decreased the incidence of ischaemic 
and reperfusion arrhythmias in this study ( chapter 8). Although the exact 
mechanisms responsible for the initiation of ischaemic and reperfusion 
arrhythmias are poorly understood, there is good evidence that excess cytosolic 
ca2+ (Thandroyen, 1982; Clusin, Buchbinder and Harrison, 1983; Ferrier, 
Moffat and Lukas, 1985; Coetzee and Opie, 1987; Opie et al., 1988; Opie and 
Coetzee, 1988) and abnormal intracellular ca2 + oscillations (Thandroyen et al., 
1988; Koretsune and Marban, 1989) may play a role in the genesis of certain 
types of ischaemic and reperfusion arrhythmias. These intracellular ca2 + 
oscillations are thought to be caused by the uptake and release of ca2+ from the 
sarcoplasmic reticulum overloaded with ca2+ (Kass et al., 1978). Direct 
intracellular ca2 + measurements show that during electrically induced 
ventricular fibrillation, intracellular ca2 + levels are elevated (Koretsune and 
Marban, 1989), and that small physiologic intracellular ca2 + oscillations are 
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augmented by the transition to ventricular fibrillation (Kihara and Morgan, 
1991). Ryanodine, and blocked the augmented ca2+ oscillations associated with 
ventricular fibrillation (Thandroyen et al., 1988; Kihara and Morgan, 1991). 
The incidence of reperfusion arrhythmias is related to the duration and the 
severity of ischaemia (Manning and Hearse, 1984). The SR ca2+ ATP-ase pump 
inhibitors (CPA and thapsigargin) tested in chapter 8 were used at a series of 
reperfusion times to confirm that the anti-arrhythmic properties of these 
inhibitors were not due to an anti-ischaemic action. These compounds did not 
merely move the bell-shaped curve to the right, thus delaying the vulnerable 
period, but decreased the incidence of arrhythmias in absolute terms. 
Reservations of these studies: Although these compounds have antiarrhythmic 
properties, they are negatively inotropic agents when used in the working heart 
model. The model for the arrhythmia study ( chapter 8) was an isovolumic 
Langendorff preparation, not performing external mechanical work in the 
conventional sense. U oder such conditions, cyclopiazonic acid (CPA) is a 
negative lusitrope but not a negative inotrope (Pery-man et al., 1993). Our 
mechanical data in the Langendorff model confirm reports showing that 
sarcoplasmic reticulum ca2 + A TP-ase pump inhibition with CPA in various 
models had only a slight negative effect on contractile parameters in the rat 
(Pery-man et al., 1993) and rabbit papillary (Lahouratate, Quiniou and Leoty, 
1992) and neonatal ventricular muscle (Agata, Tanaka and Shigenobu, 1993) 
preparation. This negative lusitropic effect was only apparent in models using 
isometric contraction as a measure of function (Pery-man et al., 1993). Hence the 
improved mechanical function in response to both agents found in the 
arrhythmia study (Figure 8.8) on the coronary ligated heart cannot be 
extrapolated to other more physiologic models. 
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10.2.3 Na+ /H + Exchan~e and Reperfusion Arrhythmias. 
The antiarrhythmic properties of high concentrations of amiloride have already 
been demonstrated in post-ischaemic (Dennis et al., 1990; Karmazyn, 1988) and 
ouabain-treated hearts (Lotan et al., 1992). We found that HOE 694 was 
antiarrhythmic at all concentrations used in this study (Figure 6.2 and Table 6.1 ), 
and also when only added upon reperfusion (Table 6.2). Our findings suggest 
that elevated Na+ /H + exchange activity plays a role in the genesis of 
reperfusion arrhythmias. The antiarrhythmic effect of HOE 694 when used in the 
reperfusion phase only, indirectly supports the hypothesis that a transient 
cytosolic ca2 + overload explains some reperfusion arrhythmias ( Opie and 
Coetzee, 1988). 
10.3 Endothelin and its Possible Involvement m Ischaemic and 
Reperfusion Injury. 
Endothelin release under different experimental conditions. 
In the isolated retrogradely perfused rat heart, there were low but constant levels 
of endothelin released into the coronary effluent under basal conditions. This 
stability is a prerequisite for the detection of possible changes induced by 
variations of the experimental protocol, and is consistent with available evidence 
suggesting that the peptide is continuously released from endothelial cells after 
intracellular processing (Hexum et al., 1990; Lerman et al., 1990). 
In our low-flow model of ischaemia, endothelin release was greatly reduced 
during the ischaemic period of 90 or 180 minutes. Since the whole effluent 
sample was collected and processed, loss of endothelin could be ruled out The 
low ischaemic flow rate could, however, explain a reduced rate of washout 
despite the same rate of release, resulting in a reduced rate of appearance in the 
coronary effluent Alternatively, the peptide could also be internalized. A 
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reduced endothelin release rate under low oxygen tension has also been reported 
for cultured porcine cerebral endothelial cells (Yoshimoto et al., 1991), while 
hypoxia increased endothelin secretion of cultured human endothelial cells 
(Kourembanas et al., 1991), mesenteric resistance vessels of the rat (Rakugi et 
al., 1990) and plasma immunoreactive concentrations in intact anaesthetised rats 
(Horio et al., 1991). The differences in absolute oxygen and/or carbon dioxide 
tensions in these models may account for the discrepant findings. 
On reperfusion, endothelin secretion was increased in the present study over the 
basal release rate, albeit statistically significant only in the group which had been 
subjected to ischaemia for three hours and in the presence of foetal calf serum. 
Serum of several species has been shown to stimulate endothelin synthesis of 
endothelial and other cells. When bovine adrenocortical capillary endothelial 
cells were cultured in the combined presence of Dulbecco's modified Eagle 
media and bovine serum albumin or foetal calf serum, the spontaneous release of 
endothelin was two to three times higher than without serum (Hexum et al., 
1990). Human serum stimulated the production of endothelin-1 by human 
vascular endothelial cells (Ristimaki et al., 1991). The enhanced secretion could 
be dependent on peptides found in the serum, of which at least thrombin, 
arginine-vasopressin and angiotensin II can stimulate endothelin secretion of 
cultured cells (Yanagisawa et al., 1988; Emori et al., 1989). More than 90 minutes 
of ischaemia were necessary in the present model to substantially increase 
endothelin release. A lack of storage of the preformed peptide and the 
dependence of secretion on transcriptional control may account for this finding 
(Hexum et al., 1990). A similar time-dependence of stimulated endothelin 
release has been reported for other models (Boulanger and Luscher, 1990; 
Ohlstein et al., 1991). 
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The present results obtained with a low-flow model of ischaemia are partly at 
odds with those recently reported by Watanabe and co-workers (1991). They 
induced regional ischaemia by ligating the left anterior descending coronary 
artery in intact animals. In their rats, plasma levels were significantly increased 
both during the reperfusion and occlusion (ischaemic) phase and remained 
elevated for at least 3 hours after reperfusion. These differences may be due to 
the totally different myocardial blood flow profiles in models of global low-flow 
and regional ischaemia, respectively. Additional extracardiac sources of 
endothelin are likely to have contributed to the increased plasma levels in their 
study, since the actual (cardiac) tissue levels, albeit also increased during 
ischaemia and on reperfusion, can only account for a small fraction of this 
increase (less than 10 %, based on a plasma volume at least IO-times higher than 
heart weight). 
Endo~enous vs exo~enous endothelin. 
The radioimmunoassay used in the present study did not distinguish between the 
various endothelin isomers, hence the relative amounts of endothelin-1, -2 and -3 
in the effluents are not known. Although the majority of published reports deal 
with endothelin-1, endothelin-2 is a stronger vasoconstrictor and has an even 
longer duration of action than endothelin-1 (Vane, 1991). We therefore chose 
this isomer to assess the potential effects of endogenous endothelin on the 
coronary circulation and myocardium, although the heart itself may not be the 
site of production of endothelin-2, in order to obtain maximum smooth muscle 
and long lasting myocyte effects. 
175 
Endothelin and ischaemic heart disease. 
Based on increased plasma endothelin levels in patients with ischaemic heart 
disease (Yasuda et al., 1989; Stewart et al., 1991), a possible association of the 
endothelins with cardiovascular disease has been proposed. Neubauer and co-
workers (1990, 1991) have recently shown in an isolated rat heart model that 
endothelin-1 is a potent coronary constrictor under hypoxic, reoxygenated and 
reperfusion conditions. Coronary flow was marginally increased (vasodilation) at 
one dose (40 pmol, =dOO ng) of endothelin-1 in hearts subjected to mild hypoxia, 
and decreased (vasoconstriction) in hearts subjected to severe hypoxia for 60 
minutes. The highest dose (400 pmol, :::::: 1 µg), produced almost complete 
coronary occlusion irrespective of the model used. These data suggest that, in 
their model, irreversible injury was necessary for the coronary vasculature to 
become more sensitive to the constrictor effects of endothelin-1. In another study 
also using the Langendorff perfused heart at high (35 ml/min) constant coronary 
flow rates, Stewart and Baff our ( 1990) found a dose-dependent increase in 
coronary perfusion pressure and decrease in left ventricular developed pressure 
in ischaemic hearts. Since endothelium-dependent-relaxing-factor (EDRF)-
mediated relaxation was found to be unimpaired, their finding would suggest that 
either ischaemia could stimulate production of endogenous endothelin by the 
coronary bed or sensitise the coronary vasculature to the constrictive effects of 
the exogenously applied peptide. 
The present results ( chapter 9) confirm previous findings obtained in intact 
animals and isolated vessel preparations in that endothelin constricted the 
coronary vascular bed in a dose-dependent manner, resulting in a twofold 
increase in coronary perfusion pressure within the dose range of 1 ng to 1 µg 
( ::::::0.4 to 400 pmol) endothelin-2. On the other hand, exogenous endothelin 
applied to reperfused hearts subsequent to one hour of low-flow ischaemia was 
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approximately 30 times more potent a vasoconstrictor than in hearts not 
previously made ischaemic. This finding supports the proposition that ischaemia 
and/ or reperfusion sensitises the coronary vasculature for endothelin-induced 
vasoconstriction. Although we have used exactly the same dose range (0.1 to 
1000 ng per heart, 0.04 to 400 pmol), it is difficult to compare our findings with 
those of Neubauer and co-workers (1991 ), since 1) the degree of ischaemic injury 
in their models is likely to differ from that in our low-flow model, 2) they used 
perfusion at constant pressure with measurement of coronary flow, and 3) their 
dose response curves were not analyzed in terms of EC50 values. Nonetheless, 
our results presented here are in qualitative agreement with theirs. 
The total amount of endogenous endothelin released within 30 minutes of 
reperfusion is about 10 to 30 pg, depending on the duration of ischaemia and the 
presence or absence of foetal calf serum (Table 9.2). These amounts come close 
to the threshold doses of exogenous endothelin which elicited an increase of the 
coronary perfusion pressure in hearts made ischaemic for 1 hour, but not 
normoxic hearts (Figure 9.2). 
Influence of endothelin on recovery of reperfusion mechanical function 
(myocardial stunning). 
In an earlier study ( chapter 5) using the working rat heart model, post-ischaemic 
contractile function is reduced by about 25 % in controls but by about 50 % in 
hearts subjected to positive inotropic agents given at the onset of reperfusion. 
Isoproterenol, forskolin, and Bay K 8644 administered during early reperfusion 
had a detrimental effect on subsequent post-ischaemic mechanical function 
(stunning). The mechanism involved may be due to early cytosolic ca2+ 
overloading (Nayler, 1983; Opie, 1989a). However, positive inotropic agents 
given later in reperfusion to already stunned hearts improved contractile 
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function (Mercier et al., 1982; Taegtmeyer et al., 1985; Becker et al., 1986). It was 
therefore of interest to test whether endothelin could contribute to the aetiology 
of early (up to 10 minutes) or late reperfusion stunning (Opie, 1991c). 
To evaluate the effect of endothelin on reperfusion function, its positive 
inotropic effect had to first be quantified in this model. Surprisingly, the dose of 
endothelin ( 100 ng) which produced a consistent, albeit small positive inotropic 
effect in the Langendorff-perfused heart (Figure 9.3), had no significant 
influence on aortic output in the working heart compared to controls (Table 9.4). 
This finding may partly be due to the concomitant vasoconstriction resulting in a 
reduced coronary flow (Table 9.5) which was avoided in the Langendorff model 
by perfusion at a constant flow rate. Hence, the potential positive inotropic effect 
of 100 ng endothelin on post-ischaemic reperfusion work is largely offset by 
coronary vasoconstriction. 
Ideally, the influence of endothelin on reperfusion function should be assessed at 
several endothelin concentrations. We chose two large doses greatly exceeding 
the amounts released on reperfusion in the present model (Table 9.2) and which, 
based on published evidence (Vigne et al., 1990), may be expected to increase 
the cytosolic ca2 + concentration. As shown in Figure 9.4, a dose of 100 ng 
endothelin-2 (about 40 nmol/1) improved aortic output up to 10 minutes and then 
(40 minutes) worsened it compared to controls. The higher dose (200 ng) exerted 
a more consistent negative influence on aortic output recovery. These data are in 
agreement with the two-stage model of reperfusion stunning whereby agents 
thought to increase cytosolic ca2 + first have an early positive inotropic effect 
followed by a later negative effect (Opie and Du Toit, 1992). Since the 
concentrations of endothelin required to produce these effects were about 3,500 
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times higher than those released upon reperfusion, released endothelin is 
unlikely to contribute to myocardial mechanical stunning. 
There are at least three reasons why the present results may differ from those in 
humans. Although the isolated asanguineous Langendorff heart model is an 
accepted and widely used model, the crystalloid perfusion medium may have a 
different effect on endothelin release to whole blood. The coronary flow rate is 
also much higher in this model. Second, species differences cannot be ruled out 
and, third, endothelin internalized during ischaemia or reperfusion could not be 
measured. 
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SUMMARY AND CONCLUSIONS. 
Our understanding of the mechanisms of reperfusion injury has improved 
significantly in recent years. The concept of reperfusion injury has rapidly 
evolved from being an issue of debate in the late 1980s to its present status 
where the involvement of either ca2 + overload or oxygen derived free-
radicals in reperfusion injury are both no longer questioned. The potential 
clinical relevance of reperfusion stunning in particular has now also been 
recognised (Bolli, 1992; Patel et al., 1988; Kloner et al., 1990) and will no 
doubt be the focus of numerous studies in the future. 
The aim of this study was to investigate the effects of altered ca2 + fluxes 
on the severity of reperfusion injury and the possible entry pathways 
contributing to the proposed ca2 + overload. 
Sarcolemmal ca2 + entry pathways. Data (past and present) from our 
laboratory suggest that reversible reperfusion injury ( arrhythmias and 
stunning) is modulated by interventions and compounds altering ca2 + 
fluxes across both the sarcolemma and sarcoplasmic reticulum. In this 
study, pharmacologic (nisoldipine) and inorganic ca2+ channel blockers 
(Mg2 + and Mn2 +) acting on the voltage dependent L-type channel, given 
at the onset of reperfusion, decreased the severity of reperfusion injury. By 
using a ca2+ agonist (Bay K 8644), inotropes (isoproterenol or forskolin) 
or high ca2 + concentrations during early reperfusion, subsequent stunning 
was exacerbated. These data suggest that interventions increasing early 
reperfusion ca2 + fluxes through the L-type ca2 + channel exacerbate 
stunning and favor the hypothesis that early intracellular ca2 + overload 
may cause subsequent contractile dysfunction. These data also suggest that 
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inotropic interventions should be restricted to "late" reperfusion when the 
heart is less prone to ca2 + induced reperfusion injury. 
This study also provided conclusive evidence for a role for the Na+ /H + 
exchanger in the present model of reperfusion injury. The data presented in 
this thesis demonstrates that the novel and evidently very specific 
Na+ / H + exchange inhibitor HOE 694, when given before ischaemia, or at 
the onset of reperfusion, protects against reperfusion stunning and 
arrhythmias. The data also indicate that this compound is a more potent 
inhibitor of Na+ /H + exchange than amiloride at similar concentrations. 
Because Na+ /H + and Na+ /Ca2+ exchange are thought to be linked, our 
results again argue for a role of transient cytosolic ca2 + overload in the 
genesis of these aspects of reperfusion injury. These data may be of great 
clinical relevance where myocardial reperfusion in the presence of this type 
of inhibitor could potentially attenuate these pathophysiological 
consequences of reperfusion. Na+ /H + exchange inhibition appears to be 
an effective means of attenuating reperfusion stunning and arrhythmias 
without jeopardising mechanical function of the heart Although its clinical 
application has not been investigated, these inhibitors may offer a means of 
reducing reperfusion injury without the undesired inotropic effects still 
plaguing therapies based on ca2 + channel blockers. 
Intracellular Ca2 + fluxes and reperfusion injury. Inhibition of 
intracellular ca2 + fluxes by compounds blocking ca2 + release from the 
sarcoplasmic reticulum (ryanodine), or inhibiting sarcoplasmic reticulum 
ca2 + A TP-ase pump activity (thapsigargin and cyclopiazonic acid) reduced 
reperfusion stunning and the incidence of ischaemic and reperfusion 
ventricular arrhythmias. Although the findings with the sarcoplasmic 
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reticulum ca2 + A TP-ase pump inhibitors have shown promise, they are at 
present inconclusive as the possibility that these compounds may act on 
other sites in the myocyte cannot be excluded. Until the myocardial site of 
action of these compounds is better characterised, the exact mechanism by 
which these compounds protected against reperfusion injury remains 
inconclusive. Pretreatment of the isolated rat heart with these compounds 
decreased the severity of reperfusion stunning and/ or ventricular 
arrhythmias in the rat heart, possibly by, i) inhibiting intracellular ca2 + 
oscillations and/ or, ii) by depleting the sarcoplasmic reticulum of ca2 +. 
Endothelin and reperfusion injury, Endothelin, thought by some to play 
a role in reperfusion stunning, is released in very small amounts in the rat 
heart during low-flow ischaemia. Although endothelin is released in 
fourfold higher concentrations during reperfusion, these small amounts are 
unlikely to cause or even contribute to mechanical stunning. A possible 
local effect of endothelin not released from the myocyte cannot however 
be excluded. Endothelin is a potent vasoconstrictor and may play a role in 
the development and/ or aggravation of reperfusion vascular damage. 
Reservation to the study. Although these studies were performed using 
pharmacological compounds to modulate ca2 + fluxes, no cytosolic ca2 + 
measurements were performed. In order to have conclusive evidence that 
increased cytosolic ca2 + fluxes were associated with elevated cytosolic 
ca2 + levels on reperfusion, I would have to perform cytosolic ca2 + 
measurements by one of the non-invasive measuring techniques 
(bioluminescence, fluorescence or nuclear magnetic resonance techniques). 
These measurements fell beyond the scope of this study and should ideally 
be performed in the future. 
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CONCLUSIONS. This study therefore provides evidence that 
transsarcolemmal and intracellular ca2+ fluxes during reperfusion play an 
important role in the genesis of reperfusion stunning and arrhythmias. 
These transsarcolemmal fluxes are mediated via ca2 + channels, and/ or 
the Na+ /H+ and Na+ /Ca2+ exchangers. Furthermore, intracellular 
ca2 + flux through the sarcoplasmic reticulum 1) ryanodine channel, 
and/ or 2) the ca2 + uptake pump, also appears to contribute to 
abnormalities of intracellular ca2 + homeostasis and early reperfusion 
arrhythmias and stunning. By using pharmacologic compounds or 
interventions to modulate myocardial ca2 + fluxes at the onset of 
reperfusion, the severity of reperfusion injury may be significantly reduced. 
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